Volume 36, issue 2 by Canadian Medical Association
Western University
Scholarship@Western
Canadian Journal of Surgery
4-1-1993
Volume 36, issue 2
Canadian Medical Association
Follow this and additional works at: https://ir.lib.uwo.ca/cjs
Part of the Surgery Commons
This Book is brought to you for free and open access by Scholarship@Western. It has been accepted for inclusion in Canadian Journal of Surgery by an
authorized administrator of Scholarship@Western. For more information, please contact tadam@uwo.ca, wlswadmin@uwo.ca.
Recommended Citation
Canadian Medical Association, "Volume 36, issue 2" (1993). Canadian Journal of Surgery. 221.
https://ir.lib.uwo.ca/cjs/221
Canadian Journal of Surgery 
Journal canadien de chirurgie
Vol. 3 6 ,  N o. 2 , April 1 9 9 3  avril
• Venous Investigation and Treatment
• Tumour Progression
• Morbidity After Abdominal 
Hysterectomy
Sponsors/Parrains
■ : '■■; :
.
V ... t-i.
" i
■
■
| ‘ —  si
Royal College of Physicians and Surgeons o f Canada/College royal des medecins et ch irurgiens du Canada 
Canadian Association of General Surgeons/Association canadienne des chirurgiens generaux 
Canadian Orthopaedic Association/Association canadienne d’orthopedie 
Canadian Society for Vascular Surgery/Societe canadienne de chirurgie vasculaire
Canadian Society of Cardiovascular and Thoracic Surgeons/Societe canadienne des ch irurgiens cardiovasculaires et thoraciques 
Canadian Society of Surgical Oncology/Societe canadienne d'oncologie chirurgicale
Publisher/Editeur :
Canadian Medical Association/Association medicale canadienne
:
rr^ r:r?,
MAJOR DEFECT LEVELS
IN D U S T R YSTANDARD STANDARD
MICRO-TOUCH Surgical Gloves set the 
standard o f quality within the industry.
1. Data on file.
2. Based on acceptable levels
for major defects: holes, pinholes 
and tears.
•Trademark
MICRO-TOUCH Surgical 
Gloves have long been 
the leading brand. Now 
they’re more sensitive, 
flexible and comfortable. 
Doctors choose them 2 
to 1 over our previous 
gloves.'
• SENSITIVITY
Advanced latex formula 
provides greater tactile 
sensitivity.
• PROTECTION
Look for the Johnson & 
Johnson stamp of 
quality on every glove. 
It’s your assurance of 
superior protection.
• FLEXIBILITY
Low modulus latex 
formulation reduces 
hand fatigue.
• COMFORT
Curved fingers and 
adequate finger length 
make movement easy.
Canadian Journal of Surgery 
Journal canadien de chirurgie
Vol. 36, No. 2, April 1993 avril 
ISSN 0008-428X
QUILL ON SCALPEL 
PLUME ET SCALPEL
Getting the Message Heard — W ho Should Be the Messenger?
M.J. Wexler
111
Operation Tundra Storm
C. Heughan
113
Cutaneous Malignant Melanoma
W.J. Temple
115
HOW I DO IT
COMMENT JE M'Y PRENDS
Modified Technique for Radial Artery Cannulation
J. Thavanathan, C. Heughan
116
CSVS REVIEW ARTICLE 
ARTICLE DE REVUE DU SCCV
State of the Art of Venous Investigation and Treatment
W.G. Jamieson
119
ORIGINAL ARTICLES 
ARTICLES ORIC.INAUX
The Case of Canadian General Surgeons: Getting the M essage Heard
R.H. Railton, W.G. Tholl, C.A. Sanmartin
129
A Perspective on Tumour Progression
W.S. Kendal
133
Pin-Site Radioulnar Synostosis After External Fixation of a Distal Radial 
Fracture: Two Case Reports
J.H. Roth, R. Vandersluis
137
Initial Nonfunction in Cadaveric Renal Transplantation
F.R. Sutherland, W. Bloembergen, M. Mohamed, T. Ostbye, 
N. Klar, A.I. Lazarovits
141
Verrucous Carcinoma of the Genital Tract: Is It a Distinct Entity?
D.I. Robertson. R. Maung, M.A. Duggan
147
“No Stent, No Diversion” Mathieu Hypospadias Repair
M. McCormack, Y. Homsy, Y. Laberge
152
The Morbidity of Abdominal Hysterectomy
M.E. Boyd, P.A. Groome
155
Late Anastomotic Laceration After Ileocolic Resection in Childhood
C.A. Paterson, J.C. Langer, G.S. Cameron, R.M. Issenman,
M.J. Marcaccio
162
CIS, VOL. 36, NO. 2. APRIL 1993 105
Allevyti*creates a uniquely 
controlled environment fo r  easier, 
safer care, and faster healing.
Today’s science and technology is now an 
integral part of wound healing. The results: 
dramatic benefits for patients, caregivers, 
and time/cost management.
F'ar superior to yesterday’s hydrocolloid 
dressings, Allevyn’s amazing product 
characteristics are revolutionizing the way 
we think about wound care, with fewer, 
faster, less painful wound dressings.
Result: clean, fast wound healing.
No hydrocolloid odour, no meltdowns, 
no dressing residue to remove, no adhesive 
skin trauma, no messy, time-consuming 
maintenance.
Allevyn and its complementary Smith 
& Nephew products are the new standards 
in wound care. You’ll see the difference 
immediately, and so will your patients.Allevyn
Were changing how you think about wound care.
Smiths Nephew
Leading the evolution.
A
Call our Customer Action Centre, toll-free, at 800-463-7439, for more information about Allevyn now, 
and for one of our Registered Nurse representatives to visit and arrange an on-site demonstration of the remarkable benefits of Allevyn.
* Reg. Trademark
An Unusual Intraoperative Complication of Stapled Colorectal 
Anastomosis: Report of a Case and Review of the Literature
V. Bard, Z, Cohen, T. Ross
165
Foot Infections in Diabetics: the Antibiotic Choice
S. K. Asfar, M. Al-Arouj, A. Al-Nakhi, A. Baraka,
T. Juma, M. Johny
170
Foreign Bodies in the Rectum
M. Yaman, M. Deitel, C.J. Burul, B. Shahi, B. Hadar
173
Soft Tissue Sarcomas: a Plea for Proper Management
P.L. Munk, A.D. Vellet, V, Bramwell, R. Bell.
A. Hammond, C. Beauchamp
178
The Advanced Trauma Life Support Program in Manitoba: a 5-Year 
Review
J. Ali, M. Howard
181
A Comparison Between Expanded Polytetrafluoroethylene and Plasma 
Tetrafluoroethylene Grafts for Hemodialysis Access
P.T. Barron, J.L. Wellington, J.W. Lorimer, C.W. Cole,
D. Moher
184
SPONSORS' NEWS 
NOUVELLES DES PARRAINS
Canadian Association of General Surgeons 187
Canadian Orthopaedic Association 187
Canadian Society for Vascular Surgery 188
Canadian Society of Cardiovascular and Thoracic Surgeons 189
Canadian Society of Surgical Oncology 189
Correction 114
SESAP VII Question/Question SESAP VII 145
Notices/Avis 151
Book Reviews/Critiques de livres 154
SESAP VII Critique/Critique SESAP VII 159
Books Received/Livres Refus 164
C over p ic tu re / P h o to  cou ve rtu re
A classic case of chronic venous insuf­
ficiency, demonstrating lipodermato- 
sclerosis and venous ulceration (see 
article pages 119 to 128).
Notice of Change of Address/Avis de changement d’adresse 168
Classified Advertising/Annonces classees 191
Advertisers’ Index/Index des annonceurs 192
CJS, VOL. 36. NO. 2. A P R IL  1993 107
Take It To 
A Higher Court
Ask about our 
in-hospital 
evaluation program. 
You and your staff 
set the criteria and 
procedures.
We will guarantee 
the most cost 
effective manner in 
which to implement 
a successful 
evaluation.
Western & Atlantic
Provinces:
1-800-668-9045
Ontario:
1-800-268-5577
Quebec:
1-800-668-9067
E T H  I C O N
The verdict is in.
Coated VICRYL™ (Polyglactin 910) suture outperforms.
tty it for yourself.
• Polyglactin 370 and calcium stearate coating 
assure smooth tie-down and accurate 
placement of knot.
• Polyglactin 370 and calcium stearate coating 
virtually eliminates tissue drag, minimizing 
tissue trauma.
• Soft strand virtually eliminates glove and 
finger cuts while tying.
Unique in-vivo properties are proven to 
offer greater tensile strength over a longer 
period of time and quicker absorption, 
minimizing the risk of post op infection.
New RELAY* Single Strand Delivery System 
offers a state-of-the-art package, providing 
a tangle-free strand that virtually eliminates 
suture kinking.
Coated VICRYL
(Polyglactin 910) suture
OUTPERFORMS
•Trademark MEDICAL PRODUCTS Data on file
Canadian Journal of Surgery 
Journal canadien de chirurgie
Sponsors/Parrains:
Royal College of Physicians and Surgeons of Canada/College royal des medecins et chirurgiens du Canada 
Canadian Association of General Surgeons/Association canadienne des chirurgiens generaux 
Canadian Orthopaedic Association/Association canadienne d’orthopedie 
Canadian Society for Vascular Surgery/Societe canadienne de chirurgie vasculaire
Canadian Society of Cardiovascular and Thoracic Surgeons/Societe canadienne des chirurgiens cardiovasculaires et thoraciques 
Canadian Society of Surgical Oncology/Societe canadienne d’oncologie chirurgicale
Publisher/Editeur:
Canadian Medical Association/Association medicale canadienne
Canadian Journal of Surgery 
Journal canadien de chirurgie
Coeditors
Coredacteurs
ROGER G. KEITH, Saskatoon 
JONATHAN L. MEAKINS, Montreal
Associate Editor 
Redactrice associee 
GILLIAN PANCIROV
Book Review Editor 
Redacteur, critiques de livres 
JAMES P. WADDELL, Toronto
Editorial Board 
Conseil de redaction 
LUC DESCHENES, Quebec
JEAN DESLAURIERS, Quebec
D. MICHAEL GRACE, London
KENNETH A. HARRIS, London
JOHN F. JARRELL, Calgary
JOHN K. MacFARLANE, Vancouver
ERNEST W. RAMSEY, Winnipeg
CECIL H. RORABECK, London
NIS SCHMIDT, Vancouver
WALLEY J. TEMPLE, Calgary
JAMES P. WADDELL, Toronto
EARLE S. WRIGHT, St. John’s
Canadian Medical Association 
Association medicale canadienne
President
Presidente
RONALD F. WHELAN, MD
Secretary General 
Secretaire general 
LEO-PAUL LANDRY, MD
Director o f  Publications 
Directrice des publications 
STEPHEN PRUDHOMME
Editor-in-Chief o f  Publications 
Redacteur en chef des publications 
BRUCE P. SQUIRES, MD, PhD
Assistant Director (Journals)
Directrice adjointe (Journaux)
ANN BOLSTER
Manager, Specialty Journals 
Gestionnaire des journaux specialises 
GILLIAN PANCIROV
Associate Editor, Specialty Journals 
Gestionnaire adjointe des journaux specialises 
PEGGY ROBINSON
Assistant to Manager, Specialty Journals 
Adjointe administrative, journaux specialises 
LIANNE JOHNSEN
Translation
Traduction
ANTOINETTE VIDAL
Indexer 
Mise en index 
HEATHER EBBS
Publications Committee 
Comite des publications
STUART M. MacLEOD, MD (Chairman/President)
GILLES BEAUCHAMP, MD
ROGER G. KEITH, MD
R. P. BRYCE LARKE, MD
FREDERICK H, LOWY. MD
JOCK MURRAY, MD
LISE NADEAU-BHERER, MD
CHRISTINE NEWMAN, MD
Production Manager 
Gestionnaire de la production  
KATHRYN A. FREAMO
Assistant Production Manager 
Gestionnaire adjointe de la production 
NANCY POPE
Electronic Production Coordinator 
Coordonnatrice de la production electronique 
JENNIFER E. RAICHE
Manager, Classified Advertising  
Gestionnaire des annonces classees 
BEVERLEY KIRKPATRICK
Assistant to Manager, Classified Advertising  
Adjointe administrative, annonces classees 
DEBORAH RODD
(613) 731-9331, fax (613) 523-0824
Marketing and Advertising Sales 
Marketing et publicite
KEITH HEALTH CARE COMMUNICATIONS 
Toronto: (416) 278-6700, 
fax (416) 278-4850 
Montreal: (514) 695-1582, 
fax (514) 695-3972
CAY, VOL. 36, NO. 2, APRIL 1993 109
Canadian Journal of Surgery 
1867 Alta Vista Dr.
Ottawa, ONK1G3Y6 
Phone: (613) 731-9331  
Telex: 053-3152  
Fax: (613) 523-0937
All editorial m atter in the Canadian Jour­
nal o f Surgery (CJS) represents the opin­
ions of the authors and not necessarily 
those of the Canadian Medical Association 
(CMA).
The CMA assumes no responsibility or 
liability for damages arising from any 
error o r omission or from the use of any 
information or advice contained in CJS, 
including articles, editorials, reviews, 
letters and advertisements.
Detailed instructions to contributors, in 
English and French, appear on pages 100 
and 101 of the February 1993 issue.
All reproduction rights are reserved.
CJS is printed by RBW Graphics, Owen 
Sound, Ont. and published every 2 
m onths (February, April, June, August, 
October, December). Postage is paid at 
Owen Sound. Publications mail registra­
tion no. 5375. US 2nd-class postage paid 
at US Office of Publication: Champlain, 
NY (USPS no. 762-530).
Annual (1993) subscription rates for 
Canada: Royal College of Physicians and 
Surgeons of Canada, Canadian Associa­
tion of General Surgeons, Canadian Or­
thopaedic Association, Canadian Society 
for Vascular Surgery, Canadian Society of 
Cardiovascular and Thoracic Surgeons 
and Canadian Society o f Surgical Oncolo­
gy members $25 (included in annual mem­
bership fee); nonm em bers $58 ($32 for 
trainees in surgery in Canada only); for all 
o ther countries $63. Single copies (cur­
rent issue) $9, back issues $10. (Note: in 
Canadian $ to Canadian addresses and in 
US $ to all o ther addresses.) Canadian 
orders are subject to 7% GST.
Address changes and requests for sub­
scriptions: Information Technology, CMA, 
PO Box 8650, Ottawa, ON K1G 0G8. 
US address changes: CJS, PO Box 1518, 
Champlain, NY 12919-1518 . CJS ap­
pears in th e  follow ing in d e x in g / 
abstracting services: Index Medicus, Cur­
rent Contents, Science Citation Index, 
Biological Abstracts, Chemical Abstracts, 
Excerpta Medica, Nutrition Abstracts and 
Reviews, Index to Dental Literature, Hel­
minthological Abstracts and Index to Sci­
entific Reviews.
All prescription drug advertisements have 
been cleared by the Pharmaceutical Adver­
tising Advisory Board.
ccab FA A BCCPP Amm
©  1993 Canadian Medical Association
Journal canadien de chirurgie 
1867, prom. Alta Vista 
Ottawa, ON K1G 3Y6 
Telephone: (613) 731-9331  
Telex : 053-3152  
Fax: (613) 523-0937
Tous les articles a caractere editorial dans 
le Journal canadien de chirurgie (JCC) 
rep resen ted  les opinions de leurs auteurs 
et n ’engagent pas l’Association medicale 
canadienne (AMC).
L’AMC n ’assume aucune responsabilite 
des dommages resu ltan t de toute erreur 
ou omission, ou de l’utilisation de rensei- 
gnem ents ou de conseils contenus dans le 
JCC, y compris les articles, editoriaux, 
comptes rendus, lettres et annonces.
On trouvera des renseignements detail- 
les aux contributeurs, en anglais et en 
frangais, aux pages 100 et 101 de cette 
livraison de fevrier 1993.
Tous droits de reproduction reserves.
Le JCC est imprime par RBW Graphics, 
Owen Sound (Ont.) e t publie aux 2 mois 
(fevrier, avril, ju in , aout, octobre, decem- 
bre). Port paye a Owen Sound. Courier de 
publications n° 5375. Tarif postal 2e classe 
US; port paye au bureau de publication 
aux E tats-U nis: Champlain, NY (USPS n° 
762-530).
Taux annuels d ’abonnem ent pour le Ca­
nada (1993) : membres du College royal 
des medecins et chirurgiens du Canada, 
l’Association canadienne des chirurgiens 
generaux, l’Association canadienne d’or- 
thopedie, la Societe canadienne de chirur­
gie vasculaire, la Societe canadienne des 
chirurgiens cardiovasculaires et thoraci- 
ques et la Societe canadienne de chirurgie 
oncologique, 25 $ (compris dans les frais 
annuels d’adhesion); non-membres, 58 $ 
(32 $ pour les stagiaires en chirurgie au 
Canada uniquement); tous les autres pays 
63 $. Exemplaires individuels (volume 
courant), 9 $; volumes anterieurs, 
10 $. (Note : en devise canadienne aux
adresses au Canada et en devise americai- 
ne a toutes les autres adresses.) Les 
commandes au Canada sont assujetties a 
la TPS de 7 %.
Adresser les demandes d'abonnem ent et 
les changements d'adresse a : Technologie 
de l’information, AMC, CP 8650, Ottawa, 
ON K1G 0G8. Changem ents d ’adresse aux 
Etats-Unis : CJS, PO Box 1518, Cham­
plain, NY 12919-1518 .
Le JCC est resume et fiche dans l’index 
des services specialises suivants : Index 
Medicus, Current Contents, Science Cita­
tion Index, Biological Abstracts, Chemical 
Abstracts, Excerpta Medica, Nutrition 
Abstracts and Reviews, Index to Dental 
Literature, Helminthological Abstracts et 
Index to Scientific Reviews.
Toutes les annonces de medicaments pres­
en ts ont ete approuvees par le Conseil 
consultatif de publicity pharmaceutique.
PAAB
C C P P Ainm
©  Association medicale canadienne 1993
110 JCC, VOL. 36, N° 2, AVRIL 1993
*
QUILL ON SCALPEL 
PLUME ET SCALPEL
Getting the Message Heard —  Who 
Should Be the Messenger?
Marvin J. Wexler, MD, FRCSC, FACS
President, Canadian Association o f  General Surgeons. Department o f Surgery, McGill University,
Royal Victoria Hospital, 687 Pine Ave. W, Montreal, QC H3A 1A1
I n this issue of the journal (pages 129 to 132), Railton, Tholl and 
Sanmartin highlight some changes 
facing general surgery: the serious­
ly diminishing supply of Canadian- 
trained general surgeons; the in­
creasing age of its practitioners; the 
rapidly changing practice profile 
(but not a declining one as Railton, 
Tholl and Sanmartin suggest); the 
marked increase in Canadian medi­
cal schools in the numbers of wom­
en, who may have family commit­
ments and personality traits that 
make the heavy temporal and physi­
cal demands of general surgery a 
less attractive choice for specializa­
tion; and the changing lifestyle de­
mands of today’s younger practi­
tioner. These are but a few of the 
many issues facing the specialty. 
Others include problems of identity 
and image, serious maldistribution 
and lack of adequately trained sur­
geons for rural practice (where the 
general surgeon is often the only 
surgical specialist and is required to 
perform in areas traditionally out­
side the scope of general surgery as 
defined by those in the ivory tower) 
and the rapid growth of specializa­
tion.
The Canadian Association of 
General Surgeons (CAGS) was 
formed in 1977 because of a grow­
ing need for an organization to 
serve the interests of general sur­
geons in Canada. The specialty was 
becoming fragmented by the forma­
tion of subspecialties; consequently, 
the voice of general surgery was 
becoming weakened, as political
and economic changes affecting the 
practice of medicine took place. The 
objectives of the CAGS were four­
fold:
• To bring together Canadian 
general-surgery specialists to main­
tain and improve the standards of 
care in general surgery.
• To support both primary and 
continuing educational programs in 
general surgery.
• To advance knowledge in the 
field of general surgery.
• To represent the views of Ca­
nadian general surgeons.
As part of his CAGS presidential 
address,1 Railton was one of the 
first to enumerate and warn of the 
serious manpower shortages loom­
ing in general surgery. As he point­
ed out, other reports2-5 have ad­
dressed the undersupply, changes 
in practice and need to redefine 
general surgery. These were all 
CAGS presidential addresses. Oth­
ers have addressed equally impor­
tant and challenging aspects. Lang- 
er6 traced the important contribu­
tions of and need for high-quality 
general surgical research. Duff7 
stressed that “There are cogent 
arguments, based on economics and 
care-delivery issues to preserve gen­
eral surgery. Making this choice 
will commit general surgeons to 
accept the concept of scientific gen- 
eralism and to the development of 
the specialty of general surgery in 
the social context.”
In a national specialty survey in 
1988 by the Royal College of Physi­
cians and Surgeons of Canada
(RCPSC), the College concluded 
that there was a shortfall of 62 
general surgeons.8 This review was 
carried out by the CAGS under the 
able leadership fo Dr. Frank Tur­
ner, immediate past-president of the 
Association, who at that time was 
chairman of the CAGS Manpower 
Practice and Economics Committee. 
Not only did the review demon­
strate a shortage of general sur­
geons, but it also highlighted the 
gross inaccuracy of the manpower 
database being used by government 
planners. Only 1517 (56%) of the 
2683 general surgeons listed were 
confirmed as practising full-time 
general surgery, and 204 new gen­
eral surgeons were identified.
Clearly, the “message” has been 
heard by the CAGS, and its leader­
ship has tried to deliver that mes­
sage to its constituency and to 
government and policymakers but 
with a limited audience in the latter 
instance.
Over the years, the CAGS has 
developed a large but effective com­
mittee infrastructure to accomplish 
its objectives. This has been in 
close collaboration with the RCPSC 
and the provincial medical-surgical 
associations, each of which has an 
executive member on the the CAGS 
board of directors. In turn, the 
CAGS has had adequate input and 
representation on the various com­
mittees of the RCPSC, the provin­
cial surgical associations and the 
American College of Surgeons 
(ACS) and its Advisory Council for 
Surgery. As a result, both the
WEXLER
RCPSC and ACS have placed a 
moratorium on further subspeciali­
zation and creation of certificates of 
special competence, which serve to 
fragment care. Subcertification will 
only intensify and increase turf bat­
tles to the detriment of the patient. 
Territorial battles typically arise 
when there is excessive specializa­
tion, too many superspecialists and 
too few patients. As pointed out by 
Silen,8 we should not be seeking to 
create monopolies but rather be 
directed toward an overall improve­
ment in the care of the whole 
patient. Yet only last month did the 
CAGS appear before a RCPSC task 
force to oppose the application of 
the otolaryngologists to change the 
name of their specialty to Otolaryn­
gology, Head and Neck Surgery! 
Community hospitals and the 
health care system cannot afford to 
replace retiring general surgeons 
with the several specialists that 
would be required to provide the 
same service.
After countless hours of debate 
and hard work by the CAGS Educa­
tion Committee (the only body that 
brings together all the program 
directors in surgery), a core curricu­
lum for “surgery in general’’ has 
been approved and introduced in 
surgical training programs. Includ­
ed is a flexible year for those con­
templating rural practice, whereby 
exposure may be obtained in spe­
cialty areas traditionally outside the 
scope of general surgery. In addi­
tion, exposure to community and 
rural practice is now being given at 
most universities with RCPSC ap­
proval of up to 6 months of such 
rotations during training. I have no 
doubt that this will be infinitely 
more effective in providing the 
much needed surgeons to under­
serviced areas than the ineffective 
incentive and disincentive measures 
used by some provincial govern­
ments.
At the other extreme, dialogue,
interaction and general surgical rep­
resentation at the CMA and on its 
committees have been minimal to 
nonexistent. The “Committee of Af­
filiates” organized by the CMA sev­
eral years ago to address this prob­
lem, has been relatively ineffective 
and lacking substance and purpose. 
The CMA has the resources, the 
political savvy and, as Railton, 
Tholl and Sanmartin point out, ac­
cess to government and the policy­
makers. The CAGs welcomes the 
opportunity to become involved and 
work to influence government poli­
cy, but the CMA must redefine its 
primary role from “that of a facilita­
tor and information broker to bring 
together various groups . . .  to 
present a unified voice to govern­
ment.” Policy statements on moth­
erhood issues such as cigarette 
smoking, euthanasia, abortion and 
sexual abuse are important. Howev­
er, the CMA must also deal with 
issues specific to a particular group 
when appropriate.
The reasons for declining man­
power in the specialty of general 
surgery are multiple but include 
such political and economic issues 
as the following:
•  Government allocation of 
funds for a limited number of resi­
dency slots and a refusal to fund 
extra training necessary to provide, 
once again, the “old-time general 
surgeon, who could patch up any­
one coming through the hospital 
doors.”9
•  Inadequate compensation. The 
lifestyle of the general surgeon is 
among the most difficult, with 
emergencies, trauma and plenty of 
potentially lethal situations. Yet, 
across the country, the general sur­
geon is among the lowest paid of all 
surgical specialists and faces in­
creased restraints by global and 
individual capping of income in 
most provinces.
•  Stresses of rural practice. 
“Unlike family physicians, rural
surgeons don’t have the luxury of 
decreasing stress by setting up 
group practices and sharing on-call 
duties because the patient volume 
rarely provides work for more than 
one general surgeon.”10 Yet on-call 
coverage must be provided 24 
hours a day. A major legal break­
through occurred recently when a 
Quebec surgeon being sanctioned 
by his hospital board for his refusal 
to provide continuous emergency 
and on-call services due to fatigue 
received favourable judgement from 
the Quebec Superior Court. This 
would not have been achieved with­
out the moral and financial support 
of the Quebec Association of Gener­
al Surgeons.
•  Medical politics. In terms of 
resource allocation, general surgery 
departments are often undervalued 
in the university and its teaching 
hospitals and by government. The 
present trend toward powerful re­
gional boards made up of individu­
als of diverse background has fur­
ther weakened support.
The CMA, with its purported ac­
cess to the federal, provincial and 
territorial ministers of health in 
setting joint policy initiatives and to 
the National Coordinating Commit­
tee for Postgraduate Medical Train­
ing, must be prepared to receive the 
input of the national specialty socie­
ties. In this instance, it must make 
a commitment to general surgery to 
lobby politically and economically 
on behalf of that specialty and to 
forget the concept of a unified voice 
for all physicians. In the United 
States, the ACS, a representative 
body of all surgical specialists (and 
the AMA) has made commitments 
to general surgery that have broad­
ened the influence of general sur­
geons at all levels. It has lobbied 
hard and represented well before 
congress and congressional commit­
tees and has achieved significant 
economic gains for general surgery, 
as reflected by the new Resource-
i
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Based Relative Value Scale 
(RBRVS) and in the revision of 
Current Procedural Terminology 
(CPT) codes as they affect general 
surgery and thus Medicare and 
Medicaid payments. The CMA must 
do the same. The problem is not 
the message but the messenger. 
Clearly, the fate of both general 
surgery and general surgeons can­
not be decided by politicians and by 
health economists. The CAGS is 
committed to “getting the message 
heard.”
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Operation Tundra Storm
Christopher Heughan, MB, BChir, FRCSC
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The Barer-Stoddart report1 has caused widespread predictions 
of doom in surgical coffee rooms. 
Responses, reactions and reports 
have spawned a mass of committees 
and subcommittees whose unfortu­
nate members have had to read the 
2.5-cm thick report.
I have the dubious accomplish­
ment of having had to read the 
report twice. What follows may en­
lighten those surgeons whose read­
ing is confined to the Canadian 
Journal o f Surgery and the sports 
pages of the newspaper.
The first important thing to un­
derstand is that the report was 
commissioned by the federal, pro­
vincial and territorial deputy minis­
ters of health and is not to be 
regarded as a research paper. The 
conclusions are those that appeal to 
the sponsors and will generate
agreement, good references and fur­
ther reports.
The forces that spawned the re­
port are the well-known financial 
problems of increasing health care 
costs combined with stagnant trans­
fer payments. Less well publicized 
is the fact that spending money on 
health has nowhere near the politi­
cal impact of paving roads, install­
ing sewers or commissioning mili­
tary helicopters.
The next important point to rec­
ognize is that although we all may 
argue about the reasons for these 
increased costs, our political mas­
ters know full well that the sole 
reason is that too many doctors 
undertake too many “non-trivial” 
procedures that have no therapeutic 
benefit. This fact explains the strik­
ing absence in this, and indeed in 
most other reports, of any reference
to the expensive politicization of 
health care. This is exemplified by 
the proliferation of hospitals built 
during the halcyon days of 50-cent 
dollars to reward the faithful and 
maintained during the 1990s for 
reasons of local employment, status 
and distribution of cash flow to 
communities who vote right.
Once the enemy is identified, the 
tactics to neutralize it described by 
Barer and Stoddart are almost the 
same as those employed with such 
dramatic success in the Gulf War. 
The first step is to stir up public 
opinion against the foe — not a 
major task in the case of doctors. 
We perversely insist on scratching 
for a living among the fleshpots of 
Toronto, Montreal and Vancouver 
and care little for the welfare of 
Canadians in Frobisher Bay or Inu- 
vik. We prefer to stick things into
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our trusting patients rather than 
talk to them. We use residents as 
ghost operators to increase our al­
ready bloated incomes and, as if this 
was not enough, independent 
“studies” have now “proved” that 
10% of us sexually molest our pa­
tients,2 and 50% of us know a 
colleague who indulges in this rep­
rehensible habit.
The second step is the war itself. 
The opening battles should be 
those in which victory is certain. 
The otherwise inexplicable attack 
on academics — a habitually cheap 
and docile group — is merely an 
opening foray against poorly 
trained and equipped conscripts 
who are already demoralized and 
ready to desert after a decade of 
bureaucratic warfare. Furthermore, 
their leaders will find block funding 
and providing of “envelopes” by 
“collective, coordinated and negoti­
ated mechanisms” an attractive way 
to convert quarrelsome, intractable 
neurosurgeons and gynecologists to 
a state of beggarly dependence.
The life cycle of the evolving 
doctor is described in a fashion 
reminiscent of that other unwanted 
parasite, the human immunodefi­
ciency virus, and areas vulnerable 
to attack are identified. A reduction 
in the frequency of payment by 
fee-for-service assures effective 
sanctions to remove the weapons 
available for defence or counterat­
tack. Immigrant doctors, refugees 
and all six sects of graduates of 
foreign medical schools are likewise 
selected as targets for bureaucratic 
bomb and mortar attacks. The cen­
tres for command, control and com­
munications located in the Canadi­
an Medical Association,3 the provin­
cial medical associations and the 
Royal College of Physicians and 
Surgeons of Canada have been re­
quired to respond.3' 6 All have al­
ready tasted the smart weapons of 
capping, proration, cuts in educa­
tional and research funding and 
closures of beds and operating 
rooms. These combined with 
threats of medical unemployment 
(as in Germany) and compulsory 
rural service (as in China) guarantee 
a muted or absent counterattack.
The final strategy is to assure 
civil war between the factions of the 
enemy. To pit the technical against 
the cognitive, family physicians 
against orthopods, the loose alli­
ance of pediatric subspecialists 
against the toiling masses of “gen­
eralist specialists” and medical 
school against medical school over 
who will absorb the 10% cut in 
enrolment all assure a level of strife 
and discord sufficient to justify fur­
ther attacks launched in the name 
of restoring orderly government.
What is the solution? Clearly, it 
must be a piece of cynical “realpoli- 
tik” thinly disguised as a noble 
issue of principle. 1 would suggest 
that the Royal College immediately 
create a specialty of medical eco­
nomics to train doctors and resi­
dents in the use of modern strategy 
and the production and use of so­
phisticated weapons. Governments, 
reorganized hospital boards, admin­
istration and nursing form a cohe­
sive alliance. The problem is with 
the noisy, loosely organized and 
disruptive mass of physicians, 
whose impact is reminiscent of hav­
ing a motorcycle gang camping in a 
cozy middle-class suburb. We need 
more training in the use of political 
AK-47s and bureaucratic Patriot 
missiles.
I am noble and self-sacrificing 
enough to volunteer to be chairper­
son of the new specialty committee. 
Also, it would be a wonderful step­
ping-stone to the lucrative rubber 
chicken circuit after Greg Stoddart 
and Morris Barer have had their 
turns.
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Correction
On page 23 of the February 1993 
issue of the Journal, the legend to 
Figure 1 of Dr. Hamilton's paper 
“The Use of Blood in the Resuscita­
tion of the Trauma Patient” con­
tained an error. The reference to 
increased acidosis should have been 
to increased alkalosis. This legend 
should read as follows: “Hemo­
globin-oxygen dissociation curve. 
Relationship of hemoglobin to oxy­
gen as function of saturation versus 
partial pressure of oxygen. Increased 
alkalosis, decreased 2,3-diphospho- 
glycerate (DPG) and decreased tem­
perature all shift curve to left, inter­
fering with unloading of oxygen in 
terminal vascular bed.”
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QUILL ON SCALPEL
Cutaneous Malignant Melanoma
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Director o f surgery. Tom Baker Cancer Centre, Calgary, Alta. Member, Editorial Board,
Canadian Journal of Surgery
The review of the melanoma experience at the British Co­
lumbia Cancer Agency in the Octo­
ber 1992 issue of the Journal 
(pages 589 to 597) serves as a 
reminder of the significant change 
in the management of this disease 
over the last decade in Canada. The 
rate of occurrence is increasing 
alarmingly. It has doubled both in 
British Columbia and in the western 
world in the last 20 years, from 6 to 
12 cases per 100 000 population.12 
Fortunately, no marked change in 
overall mortality has occurred de­
spite melanoma’s increasing preva­
lence. It may be that patients are 
presenting with thinner lesions for 
which surgery is curative. However, 
melanoma did ultimately cause 
death in one-third of the British 
Columbia study population. With a 
disease that may be screened so 
easily, it is mandatory that trials be 
developed for identifying lesions at 
a curable stage. Dysplastic nevi are 
recognized in 2% to 9% of the 
normal population3-4 and are pres­
ent in 30% of patients with melano­
ma. This association may provide 
physicians with a window of oppor­
tunity. The obvious, critical ques­
tion is whether long-term screening 
of people with dysplastic nevi will 
identify the majority of patients at 
risk for melanoma. It must also be 
determined whether screening and 
earlier diagnosis translates into 
fewer deaths. We cannot ignore the 
lesson learned in breast cancer in 
which screening mammography, de­
spite identifying earlier lesions, has 
had a limited impact on mortality.5
In the last 10 years, our philos­
ophy with respect to the surgical 
treatment of melanoma has also 
changed dramatically. Prospective 
randomized studies have been per­
formed to determine appropriate 
margins of excision, the value of 
prophylactic lymph-node dissection 
and the utility of prophylactic hy­
perthermic limb perfusion with che­
motherapy. After many years of 
radical local excision, the data now 
show that a 2-cm margin of exci­
sion for lesions greater than 1 mm 
in depth and a 1-cm margin of 
excision for lesions less than 1 mm 
are as safe as wider excisions. Phe­
nomenal savings have been 
achieved by avoiding hospitalization 
required to obtain a 5-cm margin of 
excision, which was the old stan­
dard of the early 1980s. Excision 
with primary repair is now done as 
an outpatient procedure under local 
anesthesia. Further data on the 
value of prophylactic lymph node 
dissection and limb perfusion 
should be published in the near 
future. However, the available ran­
domized trials, including prelimi­
nary reports of ongoing trials, have 
not indicated significant value for 
lymph node dissection or perfusion 
in terms of cure. Although random­
ized trials seem expensive and ardu­
ous to perform, they are the most 
convincing method of determining 
appropriate treatment whenever 
management is controversial. Many 
times this process has provided an­
swers when our best clinical judge­
ment, based on an analysis of retro­
spective literature, has been want­
ing for the right conclusion. It is 
always frustrating that of the hun­
dreds of patients potentially avail­
able for trials such as the melanoma 
surgical trial, only a small fraction 
were entered into the study. Eight 
years were required for accrual 
when it should have been completed 
in 2 years.
This experience should demon­
strate conclusively that when there 
is controversy about treatment op­
tions, a randomized trial is the ideal 
arbitrator. A number of Canadian 
investigators, supported and orga­
nized by the National Cancer Insti­
tute of Canada Clinical Trials Unit, 
along with a number of American 
trial groups, deserve credit for their 
foresight in pursuing the option of 
a randomized study to determine 
the best operative approach for the 
melanoma patient.
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HOW I DO IT
COMMENT JE M’Y PRENDS
Modified Technique for Radial Artery 
Cannulation
Joseph Thavanathan, MB, BS; Christopher Heughan, MB, BChir, FRCSC
I n the operating room and in the intensive care unit, arterial can­
nulation is a very common proce­
dure, which can sometimes tax the 
skills of the expert. We describe an 
easy, modified technique for radial 
artery cannulation.
Method
Radial artery cannulation is indi­
cated for (a) hemodynamic monitor­
ing and (b) arterial blood sampling. 
At the wrist, the radial artery lies in 
a very superficial position in a 
groove formed medially by the ten­
don of the flexor carpi radialis and 
laterally by the prominent lateral 
border of the radius. The radial 
artery is easily palpable for a dis­
tance of 1 to 4 cm above the 
proximal flexion crease of the wrist. 
Arterial puncture is performed at 
this convenient site. Traditionally, 
the radial artery is located by plac­
ing the tips of the left index and 
long fingers in a longitudinal direc­
tion over the artery. The cannula is 
inserted by the right hand in a 
direction in which the radial artery 
is felt to be present. The judgement 
of this direction is not always
straightforward. In the modified 
technique, the radial artery is locat­
ed by placing the tips of the left 
index and long fingers side by side, 
straddling the artery at right an­
gles. For ease of technique, the 
long finger is shortened a little so 
that the tips of both fingers are at 
the same level. The tips of the 
fingers are then moved so that the 
radial artery is in the groove be­
tween the left index and long fin­
gers, and adjacent surfaces of both 
fingers feel the arterial pulse equal­
ly (Fig. 1). In this position, gentle 
pressure is exerted so that the 
radial artery is stabilized on the 
ventral surface of the radius in the 
groove between the fingers. The 
right hand inserts the cannula over 
the needle. The skin puncture is 
made 0.5 to 0.75 cm distal to the 
intended puncture site in the artery 
underneath the palpating fingers. 
The cannula is directed at approxi­
mately 30° to the skin surface 
toward the groove between the tips 
of the left index and long fingers. 
When the needle pierces the artery, 
flashback of blood is obtained, and 
cannulation proceeds in the usual 
manner.
With this technique, we find that
the radial artery can usually be 
cannulated at the first attempt. This 
reduces discomfort to the patient 
and the chances of the artery going 
into spasm and saves time for the 
operator. The reduced number of 
punctures minimizes the chance of 
infection.
Steps for radial artery cannula­
tion are as follows:
•  Support and dorsiflex the pa­
tient’s hand by placing a gauze 
roll or a 500-mL intravenous bag 
behind the wrist. Extreme dorsiflex- 
ion can tense the tissues overlying 
the artery and make palpation diffi­
cult and even obliterate the pulse. 
The extent of dorsiflexion is decid­
ed by what angle gives the easiest 
palpation of the artery. Approxi­
mately 30° to 60° of dorsiflexion 
seems appropriate.
•  Wear sterile gloves.
•  Clean the area with povidone- 
iodine solution and drape the area 
with sterile towels.
•  Provide local anesthetic infil­
tration with 1% lidocaine without 
epinephrine.
•  Select a 20-gauge, 5 cm 
(2-inch) catheter over the needle 
device.2
•  Locate the radial artery, stabi­
lize it and perform cannulation as 
described above. The bevel of the 
needle should face the ceiling.
•  When blood appears in the 
hub of the needle, introduce the 
device another 0.5 to 1 mm. Then 
hold the needle in this position and
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RADIAL ARTERY CANNULATION
FIG. 1. Radial artery is located by placing tips of left index and long fingers side by 
side straddling artery at right angles. Tips of fingers are moved so that radial 
artery is in groove between two fingers and adjacent surfaces of both fingers feel 
arterial pulse equally. Right hand inserts cannula over needle.
advance the cannula over the needle 
into the artery.
•  Exert pressure on the skin at 
the level of the tip of the cannula 
and remove needle. Transient re­
lease of pressure should result in 
free flow of blood down the cannula 
confirming good position.
•  Exert pressure again, connect 
the hub of the cannula to the 
connecting tubes and flush with 
heparinized saline.
•  Secure the catheter in place, 
apply sterile dressing and secure
the wrist in a neutral position to a 
board.
The same technique can be ap­
plied to other arteries.
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State of the Art of Venous Investigation 
and Treatment
CSVS REVIEW ARTICLE 
ARTICLE DE REVUE DU SCCV
William G. Jamieson, MD, FACS, FRCS, FRCSC*
Objective: To discuss current investigative and treatment modalities in all venous 
problems, ranging from telangiectasia to chronic venous insufficiency.
Data sources: A thorough review of current literature plus the author’s personal 
experience and ideas.
Data synthesis: Clinical interest and research into venous disease is increasing. 
Despite advanced investigative technology, the definitive management of chronic 
venous insufficiency remains controversial. Deep valvular reconstruction is now 
possible; however, indications for this type of procedure are rare.
Conclusion: The renewed interest in venous disease will likely lead to specific 
treatments for all aspects of venous disease, especially for chronic venous 
insufficiency.
Objectif: Analyser les modalites actuelles de recherche et de traitement concernant 
tous les problemes veineux, de la telangiectasie a Tinsuffisance veineuse chronique. 
Sources de donnee : Examen approfondi de la documentation actuelle et experience 
et idees personnelles de l’auteur.
Synthese des donnees : L’interet clinique et la recherche sur les maladies veineuses 
augmentent. Malgre les progres des techniques de recherche, le traitement formel de 
l’insuffisance veineuse chronique demeure controverse. La reconstruction valvulaire 
profonde est desormais possible, mais ce type de procedure est rarement de mise. 
Conclusion : L’interet renouvele pour les maladies veineuses aboutira probablement 
a des traitements specifiques pour tous les aspects des pathologies veineuses, 
particulierement l’insuffisance veineuse chronique.
S ince the 1950s, the investiga­tion and management of arterial 
disease has played a predominant 
role in the lives of vascular sur­
geons. Recently, however, renewed 
interest has been shown in all as­
pects of venous disease, possibly 
because all arteries are now readily 
accessible, blood-clotting problems 
have been largely mastered, excel­
lent prosthetic materials are at hand 
and major operations such as mid- 
aortic surgery and distal bypass are 
becoming routine. New investiga­
tive modalities in venous disease,
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such as descending venography, 
Doppler examination, air plethys­
mography (APG) and colour-flow 
duplex scanning, allow the clinician 
to carry out not only anatomical 
but also physiologic investigations 
in preparation for planned surgery. 
Because of the persistence and in­
genuity of surgeons such as McLa- 
chlin, Kistner, Taheri, Ragu, Dale, 
O’Donnell, Sladen and Bergan, re­
constructive surgery of the deep 
venous system is now possible with 
standardized techniques, and the 
results are encouraging.
In this paper I shall cover current 
and perhaps controversial thoughts 
regarding the anatomy (with em­
phasis on some newer concepts and 
their relationship to management 
strategies and recurrence prob­
lems), physiology, pathophysiology, 
investigation and management of 
venous disease of the lower extrem­
ity, omitting only deep and superfi­
cial thrombophlebitis.
Anatomy
The veins of the lower extremity 
can be divided into deep and super­
ficial, the division being based on 
the deep fascia. Management deci­
sions that will be discussed later 
use this division extensively in 
planned procedures.
Group 1
Telangiectasia (spider veins) and 
reticular veins (spider veins supply­
ing the telangiectasia) are associat­
ed with more symptoms than is 
generally recognized. Itching, burn­
ing and some bursting symptoms 
are common. Their cosmetic ap­
pearance may also cause the pa­
tients distress.
Group 2
The greater (or long) saphenous 
vein (GSV) starts in the anteromedi­
al position at the ankle in relation 
to the medial malleolus and ends in 
the fossa ovalis, uniting with the 
superficial femoral vein to form the 
common femoral vein. This vein is 
duplicated 10% of the time,1 and 
this fact is responsible for some
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recurrent varicosities after CSV.
The CSV has three terminal trib­
utaries: the superficial circumflex 
iliac vein, the superficial epigastric 
vein and the superficial pudendal 
vein. They are tributaries of the 
saphenofemoral junction, which 
must be sought and managed ap­
propriately in groin dissections. 
Failure to do a complete groin 
“clean-up” is the commonest cause 
of recurrent thigh varicosities caus­
ing symptoms of thigh reflux. In­
complete groin dissection is difficult 
to diagnose due to the often thick 
and scarred upper inner segment of 
the thighs. Duplex scanning or de­
scending venography will provide 
the correct diagnosis2 and are 
necessary because until the recur­
rences are dealt with symptoms will 
persist.2
The lesser (or short) saphenous 
vein (LSV) originates behind the 
lateral malleolus and has an incon­
sistent ending in the popliteal vein. 
It is emphasized that this vein may 
enter at a level below the knee 
joint, at the knee joint or considera­
bly higher in the posterior thigh. In 
21.4% of cases it joins the GSV.3 
The fact that the LSV enters the 
popliteal vein at varied positions is 
important when it is being consid­
ered for arterial bypass because it 
may be up to 7 cm longer than 
anticipated.4 Exact delineation of 
the extent of the LSV preoperative- 
ly is possible with duplex scanning.
Both the GSV and LSV are in 
intimate contact with the deep fas­
cia, and recent investigations indi­
cate that muscular contraction pro­
motes flow in these main trunk 
veins — a new concept of both 
venous return and reflux potential.5
Group 3
Tributaries of the GSV and LSV 
are in the subcutaneous tissue. 
These tributaries may become vari­
cose due to intrinsic metabolic
changes in the vein wall, whereas 
the main trunk of the vein often 
remains normal.
Group 4
Of the perforating and communi­
cating veins, the classic perforators 
(Cockett) in the medial calf join the 
deep system to the posterior arch 
vein and numbers three to seven. It 
is important to know that the perfo­
rators do not connect directly with 
the GSV and therefore stripping the 
GSV from knee to ankle does not 
alleviate incompetence of this perfo­
rator system. These medial perfora­
tors join the posterior arch vein, a 
tributary of the GSV. The same calf 
perforators are present on the later­
al side, but they are fewer in num­
ber and become incompetent much 
less often than do those in the 
medial group.6
There are three distinct and rela­
tively constant perforators above 
the classic calf perforators. In the 
mid-thigh, the Hunterian perforator 
joins the GSV with the superficial 
femoral vein. Medial to and just 
above the knee, a constant perfora­
tor (Dodd’s perforator) is found, 
and medial and inferior to the knee 
is another perforator (Boyd’s perfo­
rator). Both these perforators join 
the deep to the superficial venous 
system, all with valves. The signifi­
cance of these three perforating 
veins will be discussed under the 
section on sclerotherapy and sur­
gery for superficial varicose veins.7 
A good idea when mentally review­
ing reflux through perforating 
veins is to lump together the Cock­
ett, Dodd’s, Boyd’s and Hunterian 
perforators and the saphenofemoral 
and saphenopopliteal junctions to­
gether. All of these areas are impor­
tant sources of potential leakage 
from the deep system into the su­
perficial system of veins, giving rise 
to primary or especially recurrent 
varicose veins.
Group 5
The deep veins (those deep to the 
investing layer of fascia in the calf) 
comprise the posterior tibial, pero­
neal and anterior tibial veins and 
the soleus and gastrocnemius plex­
us of veins and tributaries. These 
enter the popliteal vein, become the 
superficial femoral vein (an unfortu­
nate name and poorly grasped by 
students as it is the main vein of the 
deep system of the thigh). The deep 
femoral vein joins the superficial 
femoral vein to become the common 
femoral vein, leading to the iliac 
vein and the inferior vena cava.
The most important points to 
remember about venous anatomy 
are set forth in Table I.
Physiology
Lower extremity blood flows 
from the superficial to the deep 
venous system. Venous valves are 
present in all veins, the exception 
being the iliac vein (only 30% have 
a valve). The most constant valve is 
present just distal to the entrance 
of the GSV into the common femo­
ral vein (89%).8 The valve in the 
popliteal vein has been called the 
“gatekeeper” valve because it pro­
tects the gastrocnemius and soleus 
plexus of veins from hypertension 
in the superficial femoral vein, a 
factor in selecting this area for 
valve transplantation.9
Venous flow is based on three 
components: a force to propel the 
blood proximally, such as gravity or 
the calf muscle pump (venous 
heart); an adequate, open outflow 
tract; and the presence of compe­
tent valves limiting reflux. Any dis­
ruption of these components will 
result in chronic venous hyperten­
sion. Conditions such as neurologic 
muscle atrophy impairing the calf 
muscle pump, iliac vein thrombosis 
or recanalized femoral veins with
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valve destruction are examples of 
conditions affecting the three basic 
physiologic necessities for normal 
venous blood flow. Ambulatory ve­
nous pressure (AVP) historically 
has been used by venous investiga­
tors to assess venous hypertension. 
On standing motionless, a needle 
placed in a vein in the dorsum of 
the foot and attached to a pressure 
gauge will indicate venous pressure 
at rest. Normal pressures are about 
100 mm Hg. With exercise the nor­
mal individual can reduce the dorsal 
venous pressures to 20 to 30 
mm Hg.
Patients with varicose veins can 
lower the pressure to around 50 
mm Hg and patients with severe 
venous stasis may not be able to 
reduce the pressure at all because 
of reversal of flow from the deep to 
superficial systems.10
The criteria for deep venous in­
sufficiency historically have been an 
AVP over 50 mm Hg and a refill 
time under 15 seconds. Recently, 
APG has been a reliable investiga­
tive tool that records venous refill 
time, ejection fraction and residual 
volume of venous blood.11 The re­
sidual volume recorded with the 
APG reflects the ambulatory venous 
pressure used historically. Two re­
cent superb monographs on venous 
physiology are available and are 
well worth reading for those inter­
ested in up-to-date, in depth, physi­
ologic investigation of venous prob­
lems.1213
Pathophysiology of Venous 
Problems of the Lower 
Extremity
Varicose Veins
The long-standing theory of vari­
cose-vein development has been a 
congenital absence or weakness of 
valves in the iliac vein and the 
upper common femoral and superfi­
cial femoral venous systems. This 
results in stasis, reflux, increased 
venous pressure and increased ve­
nous volume with resultant exten­
sion of the varicosities. This well- 
recognized theory is substantiated 
by the work of Regan and Folse, 
showing that children of patients 
with varicose veins have a paucity 
of these valves.14-16 Recently, intrin­
sic vein-wall changes have been 
noted by Rose and colleagues.17 A 
metabolic disturbance takes place in 
the vein wall, resulting in increased 
fibrosis, muscle tissue replaced by 
fibrous tissue and subintimal colla­
gen deposition. This leads to de­
creased contractility, stasis, dilata­
tion and valve incompetence. This 
latter theory could explain the de­
velopment of varicosities in tribu­
tary veins when the main trunks are 
competent and not dilated.17
Incompetence o f Perforating Veins
Historical theory of perforating 
vein incompetence was one of deep 
venous thrombosis (DVT), recanali­
zation with destruction of the deep 
valves and increased venous pres­
sure in the deep system of veins 
(the post-DVT syndrome), until fi­
nally physiologic disruption of the 
valves in the perforator veins occurs 
with flow from the deep system to 
the superficial system and resulting 
subcutaneous venous hyperten­
sion.18
Evidence is accumulating, howev­
er, that another mechanism can 
cause incompetent perforators. Val­
vular incompetence of superficial 
veins, whether due to congenital 
valvular problems, intrinsically 
weak vein wall or metabolic vein- 
wall disturbance, leads to superficial 
venous stasis, venous hypertension 
and superficial venous volume in­
crease. The flow is from the superfi­
cial to the deep system through the 
perforators, but over time the in­
creased flow destroys the valves in 
the perforating system, and reflux 
occurs.19
Chronic Venous Insufficiency (CVI)
Table II sets forth a pathological 
classification of chronic venous in­
sufficiency. In 10% to 20% of cases 
of venous stasis, reflux can occur in 
the superficial system alone, due to 
gross, often-complete GSV or LSV 
valve incompetence.20 These prob-Table I. Six Points to Observe in Relation to Venous Anatomy
1. The greater saphenous vein is duplicated 10% of the time.
2. Three perforators in the upper calf and inner thigh (above the Cockett perforators) are 
important causes of primary varicose veins in these specific areas and must be dealt with for 
long-term good results.
3. Calf perforators do not join the greater saphenous vein (GSV) directly and are not altered by 
GSV stripping. They join the posterior arch vein, a tributary of the GSV.
4. Tributaries of the GSV and the lesser saphenous vein (LSV) may be varicose with no disease 
of the main trunks.
5. The location of the LSV popliteal junction differs widely. If the LSV is to be used in arterial 
bypass surgery it should be remembered that it may be longer than anticipated.
6. A reasonable concept in the management of superficial venous reflux is to think of the calf 
perforators, the thigh perforators and the saphenofemoral and saphenopopliteal junctions as 
potential sources of reflux of venous blood from deep to superficial. This reversal of flow can 
often be detected with clinical examination, Doppler examination and duplex scanning, and 
management plans can be formulated.
Table II. Classification of Chronic Venous 
Insufficiency
Reflux (90% of cases)
Superficial, secondary to superficial 
venous valvular incompetence 
Deep
Post DVT with recanalization 
Primary valvular incompetence 
Congenital valvular atresia (rare) 
Obstructive (10% of cases)
Iliofemoral vein area 
Superficial femoral vein area 
Varied locations
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lems are corrected with ablation or 
removal of the superficial vein.21
Deep valve reflux, which occurs 
in 90% of cases of CVI, is due to 
the following three entities:
•  Post-DVT recanalization and 
valve destruction.
•  Primary valvular incompe­
tence (PVI) as described first by 
Kistner in 1980.16 This entity has 
not been described pathologically 
but is definitely not post DVT, 
because there is no evidence of 
valvular fibrosis. The valves are lax, 
crinkled, elongated and incompe­
tent.
•  Congenital valvular atresia, 
which is rare and is added for 
completeness.
Obstruction, which is found in 
10% of cases of CVI, can occur 
when veins fail to recanalize follow­
ing DVT. Two distinct clinical situa­
tions exist —• iliac or femoral vein 
thrombosis, leading to classic syn­
dromes, which potentially can be 
managed by venous bypass. Howev­
er, some patients have patchy 
thrombosis involving wide areas of 
the lower extremity, which is ex­
tremely difficult to treat if the pa­
tient has significant symptoms.
In nonthrombotic venous occlu­
sion causing CVI, intrinsic left iliac 
vein webs or the left iliac vein 
compression syndrome, in which 
the vein passes under the right 
common iliac artery, has been impli­
cated, causing venous hypertension 
of the left lower limb.
Chronic Venous Stasis
Macrovascular changes. The re­
sult of venous stasis is increased 
venous pressure in the subcutane­
ous space in the “gaiter” area of 
the leg from the ankle joint to the 
fat part of the calf. Current data 
suggest that the highest hydrostat­
ic and ambulatory venous pressures 
are in the gaiter area.22 This abnor­
mally high venous pressure is trans­
mitted from the macrocirculation to 
the microcirculation and is a causa­
tive factor in the development of 
lipodermatosclerosis, with or with­
out ulcer.
Microvascular changes. Two cur­
rent theories exist as to the cause 
of the microvascular changes that 
occur in the subcutaneous tissue of 
the gaiter area. Browse and associ­
ates23 implicated transudation of 
fluid, fibrinogen and hemosiderin 
from the capillaries into the subcu­
taneous tissue, accompanied by a 
decrease in fibrinolytic capability in 
the tissue. In addition to subcutane­
ous and cutaneous fibrotic changes, 
pericapillary fibrin cuffs are formed 
with resultant lipodermatosclerosis. 
It is postulated that the pericapil­
lary fibrous rings prevent or impede 
oxygen transport to the tissue, with 
resultant anoxia and skin break­
down. This theory has been disput­
ed as it has been shown that the 
pericapillary rings do not impede 
the passage of oxygen.24 The most 
recent theory, based partially on 
intravital microscopy and fluores­
cence video microscopy, indicated 
leukocyte trapping, stasis, obstruc­
tion to flow, anoxia, exudation of 
toxic materials, subcutaneous in­
flammation and tissue necrosis.24
These macro and microvascular 
changes would lead to therapeutic 
regimens to lower venous hyperten­
sion, to increase the level of fibrino­
lytic activity in the tissue and to 
enhance tissue oxygenation.
Noninvasive Investigations
History and Physical Examination
Telangiectasia (spider veins) and 
reticular veins (veins feeding the 
spider veins). These are usually 
obvious and may present with itch­
ing, fullness, bursting and burning, 
especially at the time of menstrua­
tion in females. Sometimes patients
describe nocturnal discomfort in the 
areas of these veins, not relieved by 
rest. The symptoms seem to be 
relieved by ablation with scleroth­
erapy. Often cosmetic distress is the 
sole reason for seeking medical at­
tention.
Varicose veins. Classic causative 
factors may be elicited — pregnan­
cy, ascites, constipation, venereal 
disease, previous groin surgery, 
constrictive garments, trauma,25 
heart failure and cirrhosis, abdomi­
nal tumours and long hours of 
standing. A history of DVT may 
also be elicited. Often no cause is 
present other than a familial histo­
ry, and even this may not be pres­
ent, leaving no reason for the ve­
nous abnormality. Symptoms of 
heaviness, itching, bursting, noctur­
nal cramps and occasionally pain 
are described.
All the symptoms of varicose 
veins, which are due to venous 
hypertension, are relieved by leg 
elevation. If the patient states that 
symptoms are unrelieved by leg 
elevation, especially overnight in 
bed. the diagnosis should be ques­
tioned.
For physical examination, the pa­
tient should stand motionless, al­
lowing the veins to fill. The varicose 
veins are often seen and more often 
felt. The Trendelenburg test may be 
used to elicit saphenofemoral in­
competence, and double tourniquet 
tests will show incompetence of the 
perforators, especially in the thigh. 
Calf perforators are often difficult 
to demonstrate because of the ac­
companying brawny dermatolipo- 
sclerosis. Manual milking of the 
swollen calf with the leg elevated 
will often disclose the calf veins and 
perforators.26 These tests, although 
worthwhile, are often inaccurate, 
especially in obese patients.
Venous stasis. Of patients with 
venous stasis, 50% describe a histo­
ry of DVT. They tell of a period 
after the DVT when the lower ex-
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tremity began to feel heavy, as if 
they were dragging it and by the 
end of the day as if it was going to 
burst. This sensation is accompa­
nied by varying degrees of swelling, 
and once again the patient will state 
emphatically that the symptoms are 
relieved by rest. Often there is little 
to see in the early stage because 
subcutaneous venous hypertension 
has not developed, probably be­
cause the valves of the perforating 
veins are competent.
Confirmation can be obtained by 
investigation of the previous DVT 
and its sequelae with appropriate 
tests. Once subcutaneous venous 
hypertension occurs with brawny 
induration, lipodermatosclerosis 
and ulcers, the diagnosis is much 
more straightforward. Occasionally 
a patient may be seen who has only 
superficial venous hypertension in 
the long saphenous system with 
pigmentation at the ankle. These 
patients make up 10% to 15% of all 
those with venous ulcers,21 but the 
diagnosis is easy because the veins 
are often huge and completely in­
competent from groin to ankle, 
with associated ankle skin pigment.
Chronic venous obstruction. 
This is often caused by thrombosis 
with little or no recanalization. 
When venous obstruction is caused 
by thrombosis of the inferior vena 
cava or the iliac or femoral system, 
patients complain of heaviness, 
swelling and discomfort in the 
lower extremity but exhibit ankle 
lipodermatosclerosis only rarely.
Venous claudication (i.e., a feel­
ing of bursting and pain when walk­
ing, relieved by rest and limb eleva­
tion) is an identifying symptom. 
This is owing to increased arterial 
inflow with exercise and an inability 
to drain blood from the limb be­
cause of the venous obstruction.
Hand-held Doppler Examination
This investigation is often helpful
as an adjunct to office examination 
in verifying incompetence in the 
superficial venous system, especial­
ly at the saphenofemoral and sa- 
phenopopliteal junctions and in the 
GSV and LSV. Physicians who see 
many cases of lower extremity ve­
nous problems should probably add 
this to their office diagnostic proce­
dures. The results are operator de­
pendent and alone are not accurate 
enough to use in making manage­
ment decisions.7
A ir Plethysmography
This test, devised by Chris- 
topoulos, Nicolaides and Szendro,11 
will determine calf vein reflux, ejec­
tion efficacy of the calf muscle 
pump and residual volume of ve­
nous blood in the calf. The investi­
gation is easily performed, repeat- 
able and an excellent tool for the 
primary investigation of patients 
suffering from chronic venous dis­
ease and in the follow-up of patients 
treated with various modalities.27
A simple tourniquet around the 
lower thigh in conjunction with 
evaluation of APG tracings will help 
differentiate deep from superficial 
causes of venous hypertension. This 
test adds to the overall investigation 
of chronic venous disease; it ap­
pears to offer a great deal of physio­
logic information about the veins. 
However, good or poor surgical 
results are not always reflected in 
the findings of APG.11-27
Colour-Flow Duplex Scanning
Duplex scanning combines B- 
mode echo imaging and a pulsed 
Doppler analysis. The examination 
is highly operator dependent, and 
there is a marked learning curve. 
Despite early frustrations that inevi­
tably occur, duplex scanning is a 
diagnostic tool of the future and 
may be the investigation of choice 
for diagnosing DVT and chronic
venous insufficiency. Associated 
with the duplex scanning, rapid cuff 
inflators are used to affect the di­
rection of flow of the venous co­
lumn of blood, and reflux is noted. 
With duplex scanning and rapid 
cuff inflators, incompetent veins in 
the deep and superficial systems 
can be analysed.28 This is expensive 
but is the state of the art in venous 
investigation. Two specific areas in 
which duplex scanning is invalu­
able, in addition to the detection of 
valvular reflux, are in the detection 
of recurrent incompetent superficial 
veins in thickened legs and in the 
preoperative mapping of the LSV- 
popliteal junction, especially if the 
saphenous vein is being considered 
for use in arterial reconstructive 
surgery. It is important to note that 
recurrent or missed superficial vari­
cosities are most important in the 
etiology of refractory venous stasis, 
which must be corrected before any 
esoteric deep valve surgery is con­
templated. This has not been fully 
appreciated because more effort has 
been concentrated on repair of the 
deep venous valvular system.
Invasive Investigations
Ascending Venography
The benchmark of venous inves­
tigation has been ascending venog­
raphy. This test shows not only 
anatomic aspects of the venous sys­
tem but also reflux in perforating 
veins of the calf and thigh. Dye is 
injected into a small vein in the 
dorsum of the foot, and often a 
small tourniquet around the ankle 
forces the dye into the deep sys­
tem.29 Excellent ascending views 
are usually obtained of the calf 
veins, the popliteal and the superfi­
cial femoral veins; the deep femoral 
vein, however, is not usually 
shown, and often radiographs of 
the iliac vein and vena cava are
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faint. Incompetent perforating veins 
in the calf are detected as the dye, 
driven into the deep system by the 
tourniquet, fills the perforators 
from deep to superficial indicating 
incompetence. There is some ques­
tion of the validity of this test 
because the proportion of normal 
legs that would show no reflux at 
all with this examination has not 
been determined.30 No doubt exists, 
however, that the dilated, short­
ened, incompetent perforator rapid­
ly fills the superficial system to 
which it connects. O’Donnell indi­
cated that ascending venography is 
a reliable test as he compared pre- 
operatively delineated incompetent 
perforating veins with operative de­
monstration of reversal of flow in 
the perforator.7 Ascending venogra­
phy less often shows incompetence 
of the thigh perforators. This test 
has excellent specificity and sensi­
tivity30 and will continue to be the 
primary invasive investigation test 
for venous disease, especially in the 
diagnosis of DVT and its sequelae. 
However, noninvasive colour-flow 
bidirectional duplex scanning may 
succeed this test because good or 
better anatomical information and 
far better physiologic information 
are obtained.
Descending Venography
This is a rejuvenated invasive test 
that is easily performed. The patient 
is elevated 60°. Contrast material is 
usually injected into the common 
femoral vein. The patient is asked 
to do the Valsalva manoeuvre and 
pictures are taken to detect distal 
reflux and visualize its extent. Nor­
mal valves will allow minimal reflux 
(a trickle of dye); with gross reflux 
there is a cascade of dye distally. 
Kistner and associates31 developed a 
working classification of reflux: 0 is 
no reflux; grades 1 and 2 are reflux 
into the thigh; grade 3 is reflux 
past the knee and grade 4 indicates
reflux to the ankle. Descending 
venography helps the surgeon 
graphically. Probably, only patients 
with grade 3 or 4 reflux, together 
with significant physical findings 
(i.e., lipodermatosclerosis with or 
without ulcer at the ankle) should 
be considered for deep valvular sur­
gery.32
Strain-gauge plethysmography, 
light reflection rheography and 
photoplethysmography are other 
tests that may be used in CVI 
investigation.
Conservative Management
One must always keep in mind 
the three anatomical necessities for 
good venous flow: an open outflow 
tract, competent valves and a good 
muscle pump. The conservative 
management of venous problems 
except for cosmetic distress, con­
sists of weight reduction, elevation 
of the foot of the bed (not pillows), 
elevation of the legs whenever pos­
sible during the day, considerable 
walking to enhance the efficacy of 
the muscle pump and use of sup­
port stockings. Compression stock­
ings remain the primary treatment 
of lower extremity venous dis­
ease.3334 They range from the 
low-pressure support hose and plain 
elastic stockings to pressurized 
stockings and pressure-gradient 
stockings and are prescribed ac­
cording to the classification of the 
pressures at the ankle (class 1, 
under 25 mm Hg; class 2, 25 to 35 
mm Hg; class 3, 35 to 45 mm Hg; 
and class 4, more than 45 mm Hg). 
The physician should not prescribe 
too heavy-duty stockings because 
compliance will be minimal owing 
to the difficulties of putting them 
on and an uncomfortable tightness 
when they are on. This occurs 
especially in the elderly with diffuse 
arthritis. Ulcer healing is greatly 
reduced in noncompliant patients.35
Inexpensive, metal, expanding 
devices are available comercially 
that allow the stocking to be 
opened up and put on.31 Also pa­
tients should put the stockings on 
before getting out of bed in the 
morning, not an hour or so later 
when edema has formed. The mech­
anism of benefit of compression 
stockings is unknown.33 Below- 
knee stockings are well tolerated, 
and despite some above-knee symp­
toms and mild swelling, patients 
should be treated first with below- 
knee stockings. If more or higher 
compression is needed, panty-hose- 
type stockings are available, al­
though these are expensive. Our 
suggestion would be to start with 
class 1 below-knee stockings and 
adjust the degree of compression 
and length of stocking according to 
the patient’s degree of comfort and 
symptom relief.
Viscopaste boots (Unna boots, a 
moist paste bandage impregnated 
with zinc oxide, calamine lotion and 
glycerin), an older method of com­
pression, are still favoured by ma- 
ny_36,37 The principle is sound (i.e., 
constant compression, soothing 
ointment [zinc oxide] and patient 
compliance), and the method has 
received wide acceptance in the 
management of CVI and venous 
ulcers36 as the ulcer heals under the 
constant compression.
Occlusive hydrocolloid dressings 
(Duoderm) changed intermittently 
are available. They contain gelatin, 
pectin, carboxymethyl cellulose and 
polyisobutylene. The dressing ab­
sorbs wound moisture, forming a 
gel. This dressing does not seem to 
be as efficacious as Unna boots, 
probably because of lack of com­
pression.3738 However, it seems to 
relieve the pain associated with 
ulcer compression, and it may be 
that venous ulcers could be ma­
naged with a Duoderm pad, covered 
by a compression bandage or stock­
ings.38
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Pharmacologic Manipulation
As already noted there is in­
creased fibrin, decreased fibrinolytic 
activity and decreased tissue oxy­
genation in the subcutaneous tissue 
of patients with CVI. This has led 
to investigation and proposed drug 
therapy. Stanozolol, an androgenic 
steroid with fibrinolytic activity, has 
been investigated and used exten­
sively in the United Kingdom. Re­
sults are equivocal.39 Pentoxifylline 
has been used in an attempt to alter 
the leukocyte trapping in the tis­
sues. This drug reduces leukocyte 
adhesiveness and the release of oxy­
gen free radicals, and it appears 
effective in early trials.40 These 
studies have reported good success 
with a combination of compression 
therapy and pentoxifylline.
I recommend ulcer care with soap 
and water. Care must be taken with 
topical antibiotics as a great many 
patients with CVI exhibit sensitivi­
ty. Early studies of Ketanserin salve 
(Janssen Pharmaceutica Inc., Mis­
sissauga, Ont.), a serotinin-2 antag­
onist, have shown it to be effica­
cious in ulcer healing.41
Invasive Management
Sclerotherapy was developed in 
Europe and the United Kingdom, 
especially as a result of the work of 
Fegan in Dublin.42 The principle of 
sclerotherapy is to irritate the endo­
thelial lining of the vein and then 
use compression until the walls are 
permanently fused. Various sub­
stances are available for injection, 
as is excellent reference material 
that describes in detail office set­
tings, sclerosing agents, technique, 
post-injection compression and ex­
pected results.43
Sclerotherapy offers a reliable 
way to treat telangiectasia, reticular 
veins and incompetent tributaries of 
the GSV and LSV; telangiectasia
may need no compression or com­
pression for only 3 to 4 days.44 
Controversy exists, however, as to 
the treatment of the main trunk of 
the GSV and of the LSV.
There is no doubt that if the 
saphenofemoral junction or sa- 
phenopopliteal junction is incompe­
tent, sclerotherapy of the GSV or 
LSV will probably not work. This 
has been demonstrated conclusively 
with the aid of duplex scannning to 
show recurrence of varicose veins 
after injection alone in patients with 
an incompetent saphenofemoral 
junction.45 This finding led to the 
suggestion of ligation of the sa­
phenofemoral junction followed by 
sclerotherapy.46 Recent investiga­
tive work with duplex scanning 
indicates that if the GSV is in­
competent at the groin and also 
incompetent in the mid-thigh with 
an incompetent Hunterian, Boyd’s 
or Dodd’s perforator, the GSV prob­
ably should be stripped from just 
below the knee to the thigh with 
subsequent sclerotherapy or sur­
gery of the remaining veins.47 Ve­
nous ulcers and chronic venous 
stasis can be treated with scleroth­
erapy by careful detection, marking 
and injection of the offending su­
perficial incompetent calf perforat­
ing veins. Sclerotherapy plays an 
important role in overall manage­
ment and should form part of the 
armamentarium of all physicians 
managing venous diseases.48
Surgical Management
The management of varicose 
veins of the lower extremity should 
not include removal of all the main 
trunks and tributaries by countless 
incisions and avulsion. Although 
this method has given satisfactory 
clinical results for years, cosmetical­
ly it is unnecessary and may be 
associated with long-saphenous 
nerve injury. The main trunk (GSV
and LSV) should remain untouched 
if it is competent, and only the 
tributaries should be sclerosed or 
removed. Huge varicose veins 
should be removed surgically. The 
“stab technique” of vein removal 
advocated by Goren49 is the accept­
ed method, fulfilling criteria of vein 
removal and acceptable cosmetic re­
sults. Venous investigation will 
show the position of all areas of 
varicosities and reflux, superficial 
or deep, above or below the knee or 
combinations thereof. If there are 
varicosities and incompetence the 
superficial veins, with normal perfo­
rating veins and a normal deep 
system, the superficial veins only 
should be treated. If there is super­
ficial incompetence and perforator 
incompetence, the superficial veins 
should be managed either by scle­
rotherapy or surgery. Linton’s pro­
cedure — subfascial ligation of in­
competent perforators — using the 
posterior seam incision50 has been 
used. Long-term follow-up of 60 
patients managed by this technique 
indicated an 80% ulcer-free period 
despite poor compliance with post­
operative compression stockings.51
Recently, sclerotherapy of the 
perforators has given promising re­
sults.26 The number of Linton pro­
cedures performed has been falling 
rapidly. In the 20% of patients who 
fail the above regimen, that is, 
those who have recurrent ulcer de­
spite the use of compression hose 
and have superficial and perforating 
vein obliteration, deep venous sur­
gery should be considered. Howev­
er, it is important that no signifi­
cant superficial veins are missed.52 
Hand-held Doppler examination and 
duplex scanning are invaluable in 
these patients because these re­
maining superficial veins can be 
heard and seen.
Patients with no incompetent su­
perficial veins but severe reflux on 
duplex scanning and descending ve­
nography, that is, Kistner grade 3
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or 4, can be divided into two 
groups: a post-thrombophlebitic
group with recanalization and a 
primary venous insufficiency group, 
based on the findings of descending 
venography.
For patients in the post-DVT 
group, if symptoms warrant and if 
the condition is refractory to com­
pression hose and conservative 
measures, a vein transplant accord­
ing to the technique of O'Donnell 
and Shepard53 is indicated. The axil­
lary vein with the predetermined 
valve is transplanted to the popliteal 
vein on the involved side (the “gate­
keeper” position). Postoperatively, 
these patients receive anticoagula­
tion with heparin, bed rest for 2 to 
3 days and sequential venous pump­
ing on the extremity until they are 
completely ambulatory. The heparin 
is replaced by warfarin for 3 
months. Long-term results of this 
operation are of concern. There is 
some worry relating to valve dilata­
tion, sclerosis and incompetence. 
Surgeons interested in this opera­
tion should be aware of current 
follow-up results and modifications 
suggested in the current litera­
ture.54
For patients with PVI, a single, 
double or triple closed external val­
vuloplasty may be done in the su­
perficial or deep femoral vein ac­
cording the technique of Kistner.55 
Closed valvuloplasties can be aided 
by the angioscope placed through a 
side vein as advocated by Gloviczki, 
Merrell and Bower.56 These patients 
receive anticoagulation, are mobi­
lized on the 2nd postoperative day 
and have sequential venous pump­
ing. Results with this technique in 
the Division of Vascular Surgery at 
the University of Western Ontario 
have been encouraging, with some 
significant clinical failures: 80% (4 
of 5) of the valve transplants are 
good clinically and on APG and 
duplex scanning; 75% (9 of 12) of 
the valvuloplasties have improved
the patient’s condition. However, 
the follow-up is short, less than 2.5 
years, and specific comments can­
not be made.
Obstruction
Iliac vein obstruction can be by­
passed with the contralateral saphe­
nous vein, that is femorofemoral 
bypass (Dale-Palma procedure).57’58 
A blocked femoral vein can be by­
passed with a saphenous vein on 
the same side (the May-Husnie pro­
cedure).59 A reasonable alternative 
to the Dale-Palma saphenous vein 
crossover femoral graft is to use a 
ringed polytetrofluoroethylene graft 
(6 mm or 8 mm) from the femoral 
vein to femoral vein or iliac vein60 
with an accompanying arteriove­
nous fistula. These procedures 
should only be used for obstructive 
disease that is long term in a se­
verely disabled patient.61
Conclusions
Complete venous investigation is 
possible with history taking, physi­
cal examination, tourniquet testing, 
hand-held Doppler examination, 
APG, duplex scanning and ascend­
ing and descending venography.
With respect to telangiectasia 
(spider veins) and reticular veins 
(feeding venules), sclerotherapy 
provides excellent results.
Uncomplicated varicose veins 
(tributaries of the CSV and the 
LSV) should probably be managed 
by sclerotherapy because the results 
are excellent and long lasting. If the 
saphenofemoral junction is in­
competent, the CSV, along with the 
groin tributaries, should be ligated 
under local anesthesia and scleroth­
erapy of the remaining varicose 
veins carried out later. Recent evi­
dence indicates, however, that if the 
saphenofemoral junction is in­
competent and the thigh and juxta- 
knee perforators are incompetent, 
the patient would benefit from long 
saphenous stripping from the groin 
to just below the knee with scle­
rotherapy or stab avulsion of the 
rest of the veins.
Chronic venous insufficiency 
with lipodermatosclerosis and ul­
cers should be investigated to deter­
mine which veins are incompetent. 
If only the superficial veins are 
incompetent, sclerotherapy or sur­
gery, or both, and compression 
hose are used. If superficial veins 
and perforating veins are incompe­
tent, the trend is toward stripping 
of the upper CSV, occasionally the 
LSV, with sclerotherapy of the per­
forators. Our management philoso­
phy for venous ulcers refractory to 
previous treatment attempts (con­
servative and surgical) is, first, to 
make sure all superficial veins are 
removed. Careful physical examina­
tion associated with hand-held 
Doppler evaluation is often diagnos­
tic, but occasionally in the large 
limb, especially when there is lipo­
dermatosclerosis, ascending and de­
scending venography and duplex 
scanning are helpful and often diag­
nostic.
If no superficial or perforator 
veins are detected, attention is fo­
cused on the deep system. If severe 
reflux is noted on duplex scanning 
or descending venography (Kistner 
grade 3 or 4 reflux), deep venous 
reconstruction is considered. Valve 
transplantation (i.e., axillary vein 
valve to popliteal vein) is performed 
for post-DVT patients with valve 
destruction in the deep system. Val­
vuloplasty is done for PVI in the 
superficial and deep femoral vein. I 
have no experience with valve 
transposition in which a vein, such 
as the superficial femoral vein with 
no competent valves, is transected 
and anastomosed to the deep femo­
ral vein which has a high competent 
valve.57
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Remarkable gains have been 
made in the last few years in the 
overall philosophy and management 
of venous disease of, the lower ex­
tremities. I have attempted to syn­
thesize the up-to-date thoughts and 
suggest a possible management 
protocol for all eventualities in the 
management of lower extremity ve­
nous disease. We do not have all 
the answers regarding the investi­
gation and management of venous 
disease. Suggested management of 
identical cases can range from the 
use of compression stockings to 
sophisticated deep valve reconstruc­
tion. The venous renaissance is 
here, and a period in which a more 
complete understanding of venous 
physiology exists is anticipated. 
This would ideally lead to a stan­
dardized management protocol for 
complicated venous disease.
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Th e Case of Canadian General Surgeons: 
Getting the Message Heard
R.H. Railton, MD, FRCSC; William G. Tholl, MA; Claudia A. Sanmartin, MSc
The problem of physician resources is at the top of the health care policy agenda, 
and physicians are faced with the challenge of change. General surgeons, like 
others, must address the changes in health care needs and demands, technology, 
information and funding. This paper begins with a demographic and workload 
profile of general surgery based on data provided by the Canadian Medical 
Association’s Physician Resource Questionnaire (PRQ). The findings indicate the 
following: the supply of general surgical procedures has been declining; general 
surgeons are older than other specialists; and the proportion of women in general 
surgery is lower than that of the profession as a whole. The practice profile of 
general surgery is also changing because of advances in technology and information 
and the changing practice of subspecialists.
Changes affecting general surgery raise important questions regarding future 
physician resource policies. The medical profession’s involvement in the area of 
physician resources at the national level is outlined, with a particular focus on the 
role of the Canadian Medical Association. It is important that general surgeons 
become involved in the discussion, since the policy decisions made today will affect 
the future practice of general surgery.
Les effectifs medicaux viennent au premier rang des priorites en matiere de 
politiques sur les soins de sante et les medecins se voient confrontes au defi du 
changement. Les chirurgiens generaux, comme plusieurs autres groupes de 
medecins, doivent trouver des reponses aux questions liees aux changements qui 
touchent les besoins et la demande en soins de sante, la technologie, 1’information et 
le financement. Cet article debute par un profil demographique et une description de 
la tache du chirurgien general correspondant aux donnees recueillies a l’aide du 
Questionnaire sur les effectifs medicaux (QEM) de l’Association medicale 
canadienne. Ces donnees indiquent que: le nombre d’interventions de chirurgie 
generale a diminue; les chirurgiens generaux sont plus ages que les autres 
specialistes; et la proportion des femmes en chirugie generale est inferieure a celle 
de l’ensemble de la profession. Le profil de pratique du chirurgien general change 
egalement a cause des progres de la technologie et de [’information, et de la pratique 
changeante des sous-specialistes.
Les changements affectant la chirurgie generale soulevent d’importantes 
questions concernant les politiques futures en matiere d’effectifs medicaux. On 
souligne l’implication de la profession medicale au niveau national dans le domaine 
des effectifs medicaux; une attention particuliere est accordee au role joue par 
l’Association medicale canadienne. II est important que les chirurgiens generaux 
s’impliquent dans la discussion, puisque les decisions politiques d’aujourd’hui vont 
affecter la pratique future de cette specialite.
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S ince the Barer-Stoddart Report was released in June 1991,1 the 
challenges facing physician re­
sources continue to be debated by 
the medical profession and by gov­
ernments. Given the changes in 
health care delivery and funding, 
many specialty groups are facing 
the challenge of change, particular­
ly in the areas of specialist supply 
and practice patterns.
The issues of physician resources 
are not new to general surgery. 
Previous reports2-5 have addressed 
the undersupply of general sur­
geons, the changes in scope of 
practice and the need to redefine 
general surgery. This paper focuses 
on physician resource management 
pertaining to general surgery.
Supply and Distribution of 
General Surgeons
The Canadian Medical Associa­
tion (CMA) and the Department of 
National Health and Welfare have 
developed extensive databases for 
the supply and distribution of physi­
cians in Canada. The number of 
certified general surgeons in active 
practice has been declining steadily 
over the past 15 years whereas the 
overall supply of physicians has 
continued to increase (Fig. 1). Be­
tween 1975 and 1990, the total 
supply of physicians increased by 
59% and the supply of general 
surgeons decreased by 7.8%. The 
Atlantic region had the largest de­
crease in general surgeons — 
23.4%.
General surgeons, unlike sur- 
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geons in most other specialties, are 
an older group. The proportion of 
general surgeons 55 years of age 
and older increased from 38.8% in 
1982 to 49.2% in 1990 (Table 1). 
Conversely, the proportion of gen­
eral surgeons younger than 45 
years decreased from 31.8% in 
1982 to 26.3% in 1990, leading 
many to predict a future shortage 
of general surgeons.
The proportion of women in gen­
eral surgery has increased slightly 
but remains well below the national 
average for all physicians. Accord­
ing to the findings of the CMA's 
Physician Resource Questionnaire 
(PRQ), the proportion of female 
general surgeons increased from 
1.9% in 1982 to 3.8% in 1990.
Overall, women constitute 20% of 
all active physicians and 14.4% of 
all certified specialists.
General surgeons outnumber all 
other specialists in rural communi­
ties (those with a population of less 
than 10 000): 8.6% versus 3.8% 
respectively (Table II). The Atlantic 
provinces have the highest propor­
tion of rural general surgeons 
(17.5%).
General surgeons work more 
hours per week than their specialist 
and family physician colleagues. 
The mean hours worked per week 
by general surgeons decreased by
6.4 between 1982 and 1990 (Table 
III) compared with 4.6 and 6.7 for 
other specialists and family physi­
cians respectively. The percentage
of time spent in direct patient care 
by general surgeons (82%) did not 
change between 1982 and 1990.
General surgeons in urban prac­
tice worked more total hours per 
week than those in rural practice:
50.4 compared with 46.0 (Table 
IV). Rural surgeons spent 93% of 
that time in direct patient care 
compared with 81% for urban sur­
geons, who spent 12.5% of their 
working hours in research, adminis­
tration and teaching. Rural sur­
geons spent on average 77.9 hours 
per week on call compared with
59.5 hours per week for those in 
urban practice.
Data on the number of physicians 
in “post-MD” training provide in­
sight on future supply. According 
to the Canadian Post-MD Education 
Registry annual census,6 there were 
503 physicians in post-MD 
general-surgery training during 
1992/1993. This represented 6.4% 
of all postgraduate trainees and
Table II. Percentage of Active Specialists 
Rural Practice by Region
Region
General
surgeons
All
specialists
Atlantic 17.5 8.8
Quebec 8.0 4.1
Ontario 7.1 3.4
Prairies 8.8 2.8
BC and
territories 6.9 2.9
All of Canada 8.6 3.8
Source: Department of Health Policy and 
Economics: Canadian Medical Association, 
Physician Resource Questionnaire, 1982, 
1990
20
-5
1975-1980 1980-1985 1985-1990
Period, yr
FIG. 1. Changes in physician supply, 1975 to 1990 (source: Department of National 
Health and Welfare, Health Information Division). Solid bars =  general surgery, 
hatched bars = all physicians.
Table I. Age Distribution of Active General Surgeons and all Specialists Responding to the 1982 and 1990 Physician Resource Questionnaires
General surgeons All specialists
1982 1990 1982 1990
Age, yr No. % No. % No. % No. %
< 35 145 8.8 104 7.6 2 406 13.5 1 823 10.9
3 5 - 4 4 378 23.0 258 18.7 5 366 30.0 4 838 29.0
4 5 - 5 4 482 29.3 338 24.5 5 051 28.3 4 556 27.3
5 5 - 6 4 436 26.5 406 29.5 3 676 20.6 3 709 22.2
> 64 203 12.3 271 19.7 1 376 7.6 1 754 10.6
Total 1 644 100.0 1 377 100.0 17 875 100.0 16 680 100.0
Source: Department of Health Policy and Economics: Canadian Medical Association, Physician Resource Questionnaire, 1982,1990
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30% of trainees in all surgical pro­
grams. Only 22% of residents in 
general surgery were women com­
pared with 40% in all post-MD 
training programs. In 1992, 79 
trainees exited general surgery 
training programs; 16 of them exit­
ed before their 4th year. However, 
fewer than half the trainees will 
actually practise general surgery 
since most will take subspecialty 
training.3'7
Demand for General Surgeons
To address the issues of resource 
management, supply and demand 
must be considered simultaneously. 
The changing demographic pattern 
of the population and the increasing 
proportion of elderly patients is 
expected to increase the demand for 
general surgery. In the United 
States, surgical services are expect­
ed to increase by 16% to 19% 
between 1985 and 2000.7
Advances in science and tech­
nology have contributed to the 
changes in specialty profiles. Specif­
ic services traditionally provided by 
general surgeons have decreased 
because of such advances. For ex­
ample, surgery for peptic ulceration 
has almost disappeared; imaging 
technology has reduced the need 
for surgical biopsies; and endoscop­
ic retrograde cholangiopancreatog­
raphy has reduced the need for 
common duct stone operations.7 8
The scope of general surgery is 
affected by a proliferation of 
subspecialists performing in areas 
that were once the domain of gener­
al surgeons. For example, plastic 
surgeons and otolaryngologists are 
involved in the treatment of head 
and neck cancers, and orthopedic 
surgeons are now performing many 
hand operations.57
Changes in surgery raise impor­
tant resource questions; Do we need 
more general surgeons? Do we need 
to change post-MD training to re­
flect differences in rural versus 
urban practice? Do we need to re­
define the purpose and scope of 
general surgery? These are impor­
tant resource management ques­
tions for the future.
Future Policy Directions
Provincial and federal health min­
isters are meeting regularly to ad­
dress current structural and fund­
ing problems within the health care 
system. A new era in health policy 
is emerging, marked by increased 
joint action in a fiscal environment 
where there are no additional re­
sources. This has led to a unique 
process in health care policy devel­
opment: for the first time federal, 
provincial and territorial health 
ministers have agreed on a specific 
set of policy initiatives, including a 
plan to reduce enrolment and resi­
dency training by 10%; also, the 
medical profession is being chal­
lenged as never before to speak 
with a unified voice. Over the past 2 
years, the profession has had the 
opportunity to influence health care 
policy development and at the na­
tional level has been successful in 
influencing government policy.
The CMA’s involvement began in 
October 1990 with a presentation 
to the provincial and territorial 
health ministers in Charlottetown. 
This meeting represented the first 
opportunity the CMA and the medi­
cal profession had to discuss with 
the health ministers issues of mutu­
al concern regarding the health care 
system. The CMA emphasized that 
effective physician resource plan-
Table III. Workload Profile of Certified General Surgeons, Specialists and Family Physicians,
1982 and 1990
Total workload, h/wk Direct care, h/wk
Group No. Mean (SD) No. Mean (SD)
General surgeons
1982 1 628 56.5 (19.7) 1 552 46.2 (16.9)
1990 1 285 50.1 (17.5) 1 228 40.9 (17.1)
All specialists
1982 17 827 53.1 (17.6) 16 979 41.1 (15.7)
1990 15 997 48.5 (14.7) 15 247 37.4 (15.5)
Family physicians
1982 17 049 51.5 (17.6) 16 072 43.5 (15.7)
1990 16 091 44.8 (14.3) 15 554 38.9 (14.9)
Source: Department of Health Policy and Economics: Canadian Medical Association, Physician 
Resource Questionnaire, 1982,1990
Table IV. Workload Profile of Certified General Surgeons by Location, 1990
Research,
Total workload, administration and
h/wk Direct care, h/wk On call, h/wk training, h/wk
Surgeon
location No. Mean (SD) No. Mean (SD) No. Mean (SD) No. Mean (SD)
Rural 106 46.0 (16.7) 103 42.7 (20.3) 84 77.9 (44.7) 297 2.5 ( 7.2)
Urban 1 179 50.4 (17.5) 1 125 40.8 (16.7) 962 59.5 (42.7) 3 390 6.3 (10.4)
Source: Department of Health Policy and Economics: Canadian Medical Association, Physician Resource Questionnaire, 1982,1990
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ning must take a broad view and 
address a range of complex issues 
including physician supply, special­
ty and geographic distribution, 
training and certification. The CMA 
also recognized that the medical 
profession must deal with the issues 
that affect all physicians.
In November 1990, the CMA, the 
Royal College of Physicians and 
Surgeons of Canada (RCPSC) and 
the College of Family Physicians of 
Canada (CFPC) hosted a workshop 
to address the issues of physician 
resource planning. The workshop 
was attended by representatives 
from various national medical asso­
ciations, including the Canadian As­
sociation of General Surgeons 
(CAGS) for the purpose of consulta­
tion regarding long- and short-term 
work plans for resource manage­
ment, including geographic distri­
bution, professional substitution, 
resource allocation and remunera­
tion.
Following the release of the Ba- 
rer-Stoddart Report, the RCPSC 
placed that report at the forefront 
of their Biennial Conference of Spe­
cialties in January 1992. The con­
ference provided a unique opportu­
nity to inform the specialty societies 
of the responses of national medical 
organizations and to seek input on 
those aspects of the the report that 
have particular implications for the 
specialty groups.
Also, in January 1992, the CMA 
released its response to the Barer- 
Stoddart Report.9 The CMA out­
lined three policy packages to ad­
dress the issues of physician re­
source management with a broad 
and comprehensive approach. The 
brief addressed the issue of special­
ty mix, recognizing that any poli­
cies developed must consider the
need for specialty services, geo­
graphic distribution and the impact 
of demographic trends on specialty 
groups, in particular general sur­
gery. The primary role of the CMA 
has been that of a facilitator and 
information broker to bring togeth­
er various groups within the medi­
cal profession in order to present a 
unified voice to government.
Recently, the focus has shifted 
from a broad-based approach to 
specific issues (i.e., specialty mix, 
postgraduate medical training, in­
ternational medical graduates). This 
is the critical time for specialty 
societies like the CAGS to become 
involved and work to influence poli­
cy that in turn will affect physician 
supply and practice patterns.
Involvement may be initiated 
through various channels: the CMA 
ensures that member concerns and 
views are heard by the various 
national committees struck to ad­
dress specific aspects of physician 
resource planning. One such com­
mittee is the National Coordinating 
Committee for Postgraduate Medi­
cal Training. The terms of reference 
of this committee include rational­
ization, redistribution and ongoing 
adjustments to the specialty mix 
and location of residency positions; 
recommendations on the coordina­
tion of all residency salary funding; 
monitoring of trends in training; 
and development of implementation 
plans at the request of the Confer­
ence of Deputy Ministers of Health. 
The committee is co-chaired by a 
physician, Dr. A. Cox, and is repre­
sented by the CMA, the RCPSC, the 
CFPC, the Canadian Association of 
Internes and Residents and the As­
sociation of Canadian Medical Col­
leges.
It is imperative that physicians
become involved in planning pro­
cesses from the bottom up and that 
they communicate their concerns 
and views to representatives of their 
respective specialty associations, 
like the CAGS, the RCPSC and 
deans and department heads of the 
medical schools. All general sur­
geons are urged to become involved 
in addressing the issues of manpow­
er and practice, resident training 
and specialist distribution. It is criti­
cal that clinicians have a voice in 
the policy decisions of today that 
will affect the practice of general 
surgery in the future.
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A Perspective on Tumour Progression
During their natural history, tumours may acquire new phenotypic traits. This 
process, tumour progression, becomes clinically important when tumours acquire 
the ability to invade and metastasize or when they develop drug resistance. An 
acquired genetic instability modulated by selection likely contributes to this 
progression. More than one genetic mechanism is probably involved, a small number 
of point mutations being complemented by karyotypic events, gene amplification and 
altered gene expression. More complicated traits, such as the ability to invade and 
metastasize, may be acquired through the inappropriate and disorganized 
reexpression of genetic programs suppressed during embryologic development.
Au cours de son histoire naturelle, une tumeur peut acquerir de nouvelles 
caracteristiques phenotypiques. Ce processus, 1’evolution tumorale, devient 
cliniquement important quand la tumeur acquiert la capacite d’envahir et de se 
metastaser, ou quand elle developpe une resistance a la chimiotherapie. Une 
instability genetique acquise modulee par la selection participe probablement a 
revolution tumorale. II y a probablement plus d’un mecanisme genetique impliques, 
un petit nombre de mutations ponctuelles etant complete par des evenements 
karyotypiques, une amplification genique et l’expression de genes modifies. Les 
caracteristiques plus compliquees, telles que la capacite d’envahir et de se 
metastaser, peuvent etre acquises par la reexpression inopportune et desorganisee 
de progammes genetiques reprimes durant le developpement embryonnaire.
Wayne S. Kendal, MD, PhD, FRCSC
T o a clinician, tumour progres­sion means that a tumour has 
grown or spread; to a biologist it 
means that one or more of the 
tumour’s phenotypic traits has 
changed. Foulds, who pioneered 
this biologic viewpoint, suggested 
that new traits were acquired in a 
stepwise manner, thus fostering 
neoplastic development.1 Conse­
quent to these stepwise changes, 
for example, a benign tumour 
might acquire the ability to invade 
and metastasize. Since invasion and
metastasis are the definitive pro­
cesses of malignancy, the mecha­
nisms underlying progression would 
necessarily be fundamental to neo­
plasia.
Should surgeons be interested in 
tumour progression? The surgical 
craft provides more cancer cures 
than any other modality,2 yet im­
provements in surgical technique 
and therapeutics will not likely pro­
vide further improvements in cure 
rates. The reasons for this should 
be clear to surgeons. Frequently,
metastases have occurred by the 
time of initial surgery. These metas­
tases, which are often clinically and 
histologically occult, only become 
manifest later. When we make a 
last attempt to control them by 
conventional systemic means, they 
acquire drug resistance. To devise a 
means to cure advanced cancer we 
will have to learn more about the 
biologic mechanisms responsible for 
the development of these problems.
Surgeons will be familiar with 
many examples of tumour progres­
sion, such as when a common 
nevus develops dysplasia then radial 
melanotic growth, later to invade 
deeply and eventually to metasta­
size;3 or when an adenomatous co­
lonic polyp develops focal carcino­
ma in situ, which eventually be­
comes invasive.4 Despite familiarity 
with such examples, the underlying 
process remains obscure to both 
clinicians and biologists.
The Clonal Selection 
Hypothesis
One contemporary model for pro­
gression resembles Darwin’s theory 
of evolution. A tumour is viewed as 
an evolving population of cells that 
reproduce, mutate and selectively 
prosper within their local environ­
ment. In keeping with these ideas, 
Nowell postulated5 that tumour 
cells possessed an acquired genetic 
instability that permitted a stepwise 
selection of variant clones, leading 
to increasingly abnormal genetic
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and biologic properties. In this evo­
lutionary model, random genetic 
change modulated by environmental 
selection drives tumour progres­
sion. Nowell’s model has come to 
dominate modern cancer biology.
Since Nowell’s work was pub­
lished we have come to realize that 
progression involves a large number 
of somatically heritable changes.6 
For instance, metastatically compe­
tent cells will have acquired a com­
plex series of alterations involving 
cell surface glycoproteins, plas­
minogen activators, collagenases, 
cathepsins, glycosidases, proteases, 
angiogenesis factors and so on.7 
Within the same tumour, individual 
clones will express these changes at 
quantitatively different levels, lead­
ing to a remarkable degree of heter­
ogeneity.8 Individual clones may, as 
a result, differ in their abilities to 
invade, implant, disseminate and 
proliferate.
Presumably the multiple changes 
associated with progression result 
from underlying genetic changes
that have accumulated within so­
matic cells. Fearon and Vogelstein9 
proposed a model for the progres­
sion of colorectal tumours that im­
plicated at least four sequential mu­
tations. It is likely that additional 
genotypic changes will also be im­
plicated in colorectal tumorigenesis. 
Moreover, such multiple and se­
quential genetic changes probably 
are a consistent feature of all forms 
of tumour progression.
Genetic Instability in Tumour 
Progression
It had been mentioned that these 
changes could accumulate conse­
quent to an acquired genetic insta­
bility. Nowell further suggested 
that this instability should increase 
as a neoplasm became more malig­
nant.5 He based this assertion on 
numerous observations that an in­
creased prevalence and heterogen­
eity of cytogenetic abnormalities 
correlated with more advanced
states of malignancy. His hypothe­
sis seemed to be confirmed when 
Cifone and Fidler observed an in­
creased rate of somatic point muta­
tion in highly metastatic cells rela­
tive to poorly metastatic cells.10 
Unfortunately subsequent ex­
periments11-15 did not corroborate 
Cifone and Fidler’s work.
When these subsequent experi­
ments were considered, it seemed 
that the cytogenetic observations 
were at variance with those from 
the work on point mutations. How­
ever, the earlier cytogenetic obser­
vations were not based on rate 
measurements, and when the rates 
of major karyotypic changes were 
finally measured no correlation was 
found with increased metastatic ca­
pacity. 14 The increased prevalence 
and heterogeneity of cytogenetic 
abnormalities could simply be attri­
buted to their accumulation within 
malignant cells. 15 Thus, it was not 
necessary to postulate increasing 
instability with more advanced 
stages of progression. Nevertheless,
Table 1. Glossary of Terms Used in This Paper
Term Explanation
Angiogenesis factors
Cathepsins 
Cell surface 
glycoproteins 
Conformational folding 
Epiphenomenon 
Gene amplification
Gene expression 
Genetic instability
Genotype
Glycosidases
Histones
Karyotype
Phenotype
Plasminogen activators
Point mutation 
Proteases 
Transacting protein 
factors 
Transcription 
Transcription factors 
Translation
Soluble compounds that incite the formation of new blood vessels. Tumours must elaborate such factors in order to 
develop their vascular supply.
Proteolytic enzymes that are thought to degrade extracellular substrates and possibly facilitate invasion and metastasis
Membrane-associated proteins that contain abundant carbohydrate residues. These proteins may be involved in 
intercellular recognition.
The three-dimensional arrangement of linear molecules like DNA and protein
An occurence that is accessory or coincidental to another, more fundamental, process
The production of additional copies of a DNA sequence within a genome. Such amplification increases the expression of 
certain genes.
The manifestation of traits encoded by DNA
Infidelity in the transmission of heritable information from one cell generation to the next. Increased genetic instability is 
thought to underlie tumour progression.
The genetic constitution of a cell or organism
A group of enzymes that hydrolyse glycoside moieties and are thereby thought to aid the ability of cancer cells to invade 
and metastasize
A group of basic proteins that bind DNA to form the principal structure of chromosomes and that may influence gene 
expression
The display of a cell’s constituent chromosomes seen in the metaphase of mitosis
Properties of a cell or organism resulting from the interaction of genotype with the environment
Proteolytic enzymes that form plasmin, an important fibrinolytic enzyme. Their elaboration could help cancer cells to 
metastasize.
A change in the base-pair sequence of DNA affecting a single base pair
Enzymes that hydrolyse proteins, some of which may facilitate metastasis
Any protein that acts on DNA after diffusing through the nucleoplasm. These proteins can influence gene expression.
Synthesis of messenger RNA from a DNA template
A group of DNA-binding proteins that regulate the transcription of protein-coding genes
Synthesis of protein from a messenger RNA template
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some genetic instability, relative to 
normal cells, seemed necessary to 
drive tumour progression.
Was somatic point mutation the 
source of the increased genetic in­
stability postulated in tumour pro­
gression? Point-mutation rates in 
malignant cells are generally of the 
same order as in normal cells.10-13 
Also, given typical rates of about 
10-7 mutations per cell generation, 
the chances that five or more se­
quential point mutations would ac­
cumulate (within any single clone) 
during a tumour’s natural history 
were impossibly small.16 Even if 
effects like cell loss or somatic 
hypermutation were accounted for, 
at most, only a few point mutations 
could be expected. The role of point 
mutation seemed to be limited to a 
small number of lesions that were 
insufficient to directly cause the 
large number of phenotypic 
changes observed.
If point mutation was not the 
major source of genetic instability, 
then what genetic mechanism(s) 
could directly cause the multiplicity 
of phenotypic changes? On further 
estimation the necessary rate for 
genetic change in progression was 
at least 10~3 events per cell genera­
tion.16 A number of genetic mecha­
nisms can produce changes at such 
high rates. Gene amplification, in 
particular, occurs at rates up to 3 X 
10-2 events per cell generation.17 In 
fact amplification has been implicat­
ed in specific cases of progression, 
as with the development of drug 
resistance18 and the increased ex­
pression of certain oncogenes.19 Re­
cently, Tlsty, Margolin and Lum20 
correlated increased amplification 
rates with more highly malignant 
states, in support of Nowell’s hy­
pothesis. However, gene amplifica­
tion has been demonstrated at only 
a relatively few loci in neoplasms, 
and further experiments with addi­
tional loci and tumour lines will be 
required before Tlsty’s observations
can be considered a general phe­
nomenon.
If point mutation does not occur 
at sufficiently high rates and gene 
amplification only affects a minority 
of loci, then other mechanisms 
probably are involved in progres­
sion. Since karyotypic changes are 
extremely rare in normal somatic 
cells yet are quite common in most 
neoplastic cells, a level of increased 
karyotypic instability apparently ex­
ists within neoplastic cells. In fact, 
chromosomal gains and losses may 
occur at rates up to 10-2 events per 
cell generation.14 Since a chromo­
some may contain 8% of the ge­
nome,21 a single event could have 
far-reaching effects. These events 
could lead to the loss of tumour 
suppressor genes, altered gene dos­
ages and altered amounts of trans­
acting protein factors. Certain non- 
random chromosomal changes have 
been strongly implicated in neo­
plasia;22 however, it remains uncer­
tain whether the large majority of 
random karyotypic changes associ­
ated with progression are biologi­
cally significant or are simply epi- 
phenomena.
One other potential mechanism 
deserves mention — altered gene 
regulation. In higher organisms an 
elaborate mechanism has evolved to 
control the expression of multiple 
genes during embryonal develop­
ment and differentiation.23 These 
controls occur at the level of tran­
scription, where DNA is transcribed 
to RNA. Gene transcription is regu­
lated by the binding of specific 
proteins to DNA segments adjacent 
to the affected genes. Generally 
several regulatory proteins will af­
fect a single gene and through the 
conformational folding of DNA 
these proteins can interact with 
each other.24 A relatively small 
number of proteins can thus, by 
combining, combinatorically, con­
trol a large number of genes.23-25 
These proteins include a diverse
group of histones and transcription 
factors. If these regulatory mecha­
nisms were perturbed they possibly 
could lead to a spectrum of labile 
(yet somatically heritable) changes 
in gene expression, possibly having 
a major influence on progression.
Progression As a Disorder of 
Embryologic Development
We have come full circle back to 
the ideas of Foulds. He suggested1 
that tumour progression resulted 
from the disorderly regulation of 
the genetic mechanisms responsible 
for embryonal development. This 
concept lost favour to the evolu­
tionary model when experiments in­
dicated that metastatic capacity de­
veloped with the random appear­
ance of variant cells within tu­
mours.26 It is difficult to conceive, 
however, how complex processes 
like invasion and metastasis could 
be orchestrated solely through ran­
dom mutation as the evolutionary 
model would predict. More likely, 
both models contain some truth. A 
small number of random mutations 
could lead to an inappropriate re­
expression of latent genetic pro­
grams, thereby fostering malignant 
traits. The mechanisms for gene 
re-expression may be quite labile, 
contributing to the phenotypic in­
stability and heterogeneity noted in 
tumours.
The way in which different genet­
ic mechanisms, such as point muta­
tion, gene amplification, chromo­
somal changes and altered gene 
regulation might become involved 
in progression is unclear. Recent 
experiments indicated that a small 
number of molecular changes (i.e., 
the activation of oncogenes or the 
loss of tumour suppressor genes) 
may strongly influence tumorigeni- 
city and metastatic capacity.27-28 
These major changes may occur at 
rates typical for spontaneous muta-
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tion in normal cells and might incite 
minor changes at higher rates. The 
minor changes may result from an 
increased lability of gene regulation 
along with increased rates of gene 
amplification and karyotypic 
changes. What seems probable is 
that in any one tumour more than 
one mechanism will be involved and 
that there is more than one way for 
the tumour to progress.
These concepts of tumour pro­
gression, mutation, gene amplifica­
tion and gene regulation may seem 
far removed from the clinical world 
of surgery. However, the interests 
of surgeons should not be limited to 
problems amenable to the scalpel. 
Historically, surgeons have made 
considerable contributions in di­
verse areas of basic research, such 
as endocrinology, nutrition and im­
munology. If surgeons are to main­
tain their important role in onco­
logy, these diverse interests must be 
encouraged and maintained. It is 
hoped that an improved under­
standing of tumour biology will 
contribute to the development of 
more effective cancer therapies.
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Pin-Site Radioulnar Synostosis 
After External Fixation of a Distal Radial 
Fracture: Two Case Reports
James H. Roth, MD, FRCSC, FACS; Ronald Vandersluis, MD
Complications of distal radial fracture and external fixation are common, but the 
authors report, in two patients, a previously unrecognized complication, that of 
radioulnar synostosis. In both cases the proximally placed pins extended across the 
interosseous region, and the distal ends were adjacent to the ulna. Hematoma and 
osseous debris were introduced into the interosseous region. Several weeks after the 
external fixator was removed, the patients were noted to have a restricted range of 
pronation and supination. A radioulnar synostosis had formed across the 
interosseous region. Resection of the synostosis restored pronation and supination. 
With careful pin placement this complication will be avoided.
Les complications des fractures distales du radius et de leur fixation externe sont 
frequentes, mais les auteurs decrivent deux cas d’une complication inconnue jusqu’a 
maintenant, une synostose radio-cubitale. Dans les deux cas, la broche situee en 
position proximale passait a travers la region interosseuse et les parties distales 
etaient adjacentes au cubitus. Un hematome et des debris osseux furent introduits 
dans l’espace interosseux. Plusieurs semaines apres le retrait du dispositif de 
fixation externe, on observa chez les patients, une diminution de l’amplitude de 
pronation et de supination. Une synostose radio-cubitale s’etait formee a travers 
l’espace interosseux. La resection de la synostose retablit la pronation et la 
supination. Cette complication peut etre evitee en choisissant soigneusement le 
positionnement de la broche.
A lthough complications of distal radial fractures and external 
fixation are not uncommon, radioul­
nar synostosis occurring at the 
proximal pin site as a complication 
of external fixation of the radius 
has not previously been reported. 
The purpose of this paper is to 
report two such cases.
Accepted fo r publication June 11, 1992
Case Reports
Case 1
A 78-year-old, right-hand-domi­
nant woman tripped while shop­
ping. She fell onto her outstretched 
left hand, sustaining an open frac­
ture of her distal radius and ulna
(Fig. 1). She was operated on the 
same day. The 1-cm wound on the 
radial aspect of the wrist, which 
communicated with the fracture of 
the distal radius, was debrided and 
left open. A Hoffman half frame 
was applied to the forearm. A longi­
tudinal incision 3 cm in length was 
made along the radial aspect of the 
middle of the left forearm, care 
being taken not to damage the 
superficial branch of the radial 
nerve. Two 4-mm Hoffman half pins 
were inserted into the radius, and 
two 3-mm Hoffman half pins were 
inserted through the base of the 
index metacarpal. The external fixa­
tor was removed 6 weeks later (Fig. 
2). Some calcification was noted at 
the pin sites. Over the next 6 
months a solid synostosis developed 
(Fig. 3). The synostosis was resect­
ed 13 months after the initial frac­
ture. One year after the resection 
the patient’s supination was 50° 
and pronation was 65°.
Case 2
A 22-year-old, right-hand-domi­
nant woman was involved in a high­
speed motor vehicle accident. She 
sustained a fracture-dislocation of 
C7, which resulted in quadriplegia. 
Her only other injury was a closed 
fracture of the right distal radius 
(Fig. 4). After two unsuccessful
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attempts at closed reduction, an 
external fixator was applied 1 week 
after injury. Two 4-mra half pins 
were inserted into the middle part 
of the radius. Two 5-mm half pins 
were inserted into the index and 
long-finger metacarpal shafts. A de­
pressed intra-articular fragment was 
elevated and internally fixed with 
two K wires. Subsequent x-ray films 
showed that the pins in the radius 
protruded through the radius and 
were in close approximation to the 
ulna (Fig. 5). The external fixator 
was removed after 6 weeks. Three 
months postoperatively the pa­
tient’s range of pronation and supi­
nation was markedly restricted. Ra­
diographs demonstrated a radioul­
nar synostosis at the proximal pin 
sites (Fig. 6). We are waiting for the 
synostosis to mature before excis­
ing it surgically.
Discussion
Synostosis of the radius and ulna 
may be congenital1 or occur after 
trauma.2 It has been recognized 
after closed or open reduction of 
fractures of both bones of the fore­
arm,3 after distal biceps tendon re­
pair4 and after removal of forearm 
plates.2 Reported complications of 
external fixation of distal radial
FIG. 1. Case 1: (left) anteroposterior and (right) lateral views of left wrist of 
78-year-old woman who fell onto her outstretched left hand. Radiographs show 
comminuted fractures of distal radius and ulna.
fractures include pin-tract infection, 
pin loosening, injury to the superfi­
cial branch of the radial nerve,
FIG. 2. Case 1: (top) anteroposterior 
view of left wrist 6 weeks after applica­
tion of external fixator; (bottom) calci­
fication is seen at proximal pin sites.
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injury to tendons and reflex sym­
pathetic dystrophy.5^ 11 Radioulnar 
synostosis at the proximal pin site 
after external fixation of a distal 
radial fracture has not been report­
ed.
These two cases illustrate the 
importance of proper pin placement. 
In both cases the pins extended 
beyond the ulnar cortex of the 
radius, thus allowing bony debris 
and hematoma into the interosseous 
space between the radius and ulna. 
This led to the development of a 
bony synostosis.
In patients with a marked restric­
tion of pronation and supination
FIG. 3. Case 1: anteroposterior view of 
left wrist 6 months after initial frac­
ture. Synostosis has developed at 
proximal pin sites.
following external fixation of a dis­
tal radial fracture, a synostosis at 
the proximal pin site should be 
considered.
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Alzheimer Disease affects over 300,000 Canadians. 
And that’s not including the people who love them. 
Alzheimer Disease is a degenerative brain disorder that 
destroys vital brain cells. It often occurs in people over 
65, but can strike at any age, slowly stealing away the 
ability to think, understand, remember, communicate, or 
perform the simplest tasks. Eventually, it leaves them 
completely dependent.
There is no known cause, nor is there a cure. Today.
The Alzheimer Society of Canada is a national organiza 
tion dedicated to helping those affected by the disease, 
as well as their caregivers. We also conduct research into 
possible causes, treatments and a cure, so that we can put 
an end to the devastation A l l  •
of this killer disease. / \  I
Tomorrow A A I  /  I O I  I C
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Initial Nonfunction in Cadaveric Renal 
Transplantation
Francis R. Sutherland, MD, FRCSC;* Wendy Bloembergen, MD, FRCPC;t Mahms Mohamed;* 
Truls Ostbye, PhD;$ Neil Klar, MSc;J Andrew I. Lazarovits, MD, FRCPCf
Patients who receive a kidney transplant that does not function immediately have 
more complications and decreased graft survival than patients whose allografts 
function immediately. To determine the causes of initial nonfunction (INF), the 
authors reviewed 188 consecutive cadaveric kidney transplants performed between 
1985 and 1988 at the University Hospital, London, Ont. Data were collected on 16 
putative risk factors for INF, which were divided into three categories: donor, 
recipient and technical. INF was defined as the need for dialysis within 7 days of 
transplantation. Forty-eight (26%) of the 188 allografts had INF, 6 of which never 
functioned. Univariate analysis identified five variables associated with increased 
risk of INF: no donor dopamine use, back-table flush, single-organ retrieval, 
exchanged kidney and prolonged cold ischemic time. Multivariate analysis, however, 
identified only three variables associated with INF: cerebrovascular accident as the 
cause of donor death, no donor dopamine use and single-organ retrieval. The 
authors recommend (a) low-dose dopamine therapy for all donors and (b) multiorgan 
retrieval to produce quality kidneys for transplantation.
Les patients qui refoivent une greffe renale qui ne fonctionne pas immediatement, 
subissent plus de complications et ont un survie du greffon reduite par rapport aux 
patients dont l’allogreffe fonctionne immediatement. Afin d’identifier les cause de 
non fonctionnement initial (NFI), les auteurs ont etudie 188 transplantations de 
reins cadaveriques effectuees entre 1985 et 1988, a l’Hopital universitaire de 
London, Ont. Des donnees ont ete recueillies sur 16 facteurs de risque putatifs de 
NFI, lesquels ont ete regroupes en trois categories: ceux qui etaient relies au 
donneur, au receveur ou a la technique. Le NFI a ete defini par le besoin de dialyse 
dans la semaine qui suivit la greffe. Quarante-huit allogreffes (26 %) eurent un NFI, 
6 d’entre-elles ne devenant jamais fonctionnelles. Une analyse unifactorielle a 
identifie cinq variables reliees a un risque accru de NFI : l’absence d’emploi de 
dopamine par le donneur, l’irrigation externe, le retrait d’un seul organe, l’echange 
de rein et le temps prolonge d’ischemie froide. L’analyse multifactorielle, toutefois 
n’a revele que trois variables reliees au NFI : accidents vasculaires cerebraux comme 
cause de deces du donneur, l’absence d’emploi de dopamine par le donneur et le 
retrait d'un seul organe. Les auteurs recommandent a) l'emploi de dopamine a faible 
dose pour tous les donneurs et b) le retrait de plusieurs organes afin de produire 
des reins de qualite pour la transplantation.
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Accepted for publication Mar. 9. 1992
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Initial nonfunction (INF) of kid­ney allografts is a major cause of 
morbidity and is associated with 
decreased graft survival.1-5 INF pro­
longs hospital stay and increases 
expense.6 Problems associated with 
INF include the need for dialysis 
postoperatively, difficulty in diag­
nosing acute rejection, increased 
use of invasive diagnostic proce­
dures and adverse psychologic ef­
fects. The frequency of INF after 
cadaveric renal transplantation var­
ies from 2% to 60%, with most 
centres reporting approximately 
30%.7-9 Pathological examination of 
kidney allografts with INF usually 
reveals acute tubular necrosis; how­
ever, occasionally, arterial thrombo­
sis or hyperacute rejection may be 
present.
INF is most likely caused by 
multiple interrelated factors. Some 
factors, found by univariate analy­
ses to increase the risk of INF, are 
prolonged warm and cold isch­
emia,4710 increased donor age11 and 
poor hemodynamic status of the 
donor.1 Most studies investigating 
the causes of INF have used 
univariate analysis. This does not 
allow the assessment of the in­
dependent impact of one of many 
covariates on outcome; for this, 
multivariate analysis is preferred.
We conducted a review of kidney 
transplant patients and used multi­
ple logistic regression to determine 
which factors were associated with 
an increased risk of INF.
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Methods
We reviewed 198 cadaveric renal 
transplants performed at University 
Hospital in London, Ont., between 
July 1985 and November 1988. All 
kidneys were flushed and stored in 
Eurocollins solution at 0°C and 
were transplanted within 43 hours. 
Every patient underwent volume ex­
pansion intraoperatively to a central 
venous pressure of approximately 5 
to 10 mm Hg, and mannitol (0.5 to 
1.0 g /kg) was given just before 
revascularization of the graft. All 
patients received cyclosporine (CsA) 
and prednisone maintenance im­
munosuppression, and in 75% im­
munosuppression was induced with 
Minnesota antilymphocyte globulin 
(10 m g/kg daily for 7 days) with 
CsA starting on day 6.
Patient information was collected 
prospectively and entered into a 
computerized database at the Cen­
tre for Transplant Studies in Lon­
don, Ont. A retrospective review of 
the patient’s hospital chart or the 
donor’s chart was done if data were 
missing. Data on eight patients 
were incomplete, and they were 
therefore excluded from the analy­
sis. Two patients with obvious tech­
nical failure at the time of surgery 
were also excluded, leaving 188 
patients (kidneys) for the analysis.
INF (the dependent variable) was 
defined as the need for dialysis 
within 7 days of transplantation. 
Patients who had grafts that never 
functioned were included. Independ­
ent variables possibly associated 
with INF were divided into three 
categories: donor, recipient and 
technical. Their definition, frequen­
cy of occurrence and rate of INF 
are listed in Table I. There were two 
categories of flush: back table if the 
kidneys were removed and flushed 
in a basin and in situ if the kidneys 
were flushed through a cannula 
inserted in the aorta or iliac vessel. 
Donor instability was defined as an
episode of hypotension in which a 
blood pressure of less than 80 
mm Hg systolic or 50 mm Hg dia­
stolic was recorded. Current cyto­
toxicity was determined on the 
most recently available sera using 
T-cell-panel reactivity by standard 
microcytotoxicity assays (panel size 
= 15).
The association between the 16
putative risk factors and INF was 
examined with logistic regression in 
both univariate and multivariate 
analyses. Separate models were fit 
for each variable in the univariate 
analysis, although one model, in­
cluding all 16 variables, was used in 
the multivariate analysis. Additional 
parsimonious models were used but 
are not included in this report be-
Table I. Variables, Definitions and Frequency of Occurrence of Kidney Transplant Initial 
Nonfunction (INF) Among 188 Patients
Variable/definition No. of patients No. (%) with INF
Donor 
Age, yr 
> 5 0
< 50
Cause of death 
Cerebrovascular accident 
Other
Dopamine use 
Yes 
No
Creatinine level, mitioI/L  
> 120
< 120
Hemodynamic Instability 
Yes 
No
Hospitalization, d
> 4 
< 4
Recipient 
Age, yr 
> 5 0
< 50 
Diabetes
Yes
No
Current cytotoxicity, %
> 3 0
< 3 0
No. of transplants
> 1 
1
Induction therapy 
Antilymphocyte globulin 
Cyclosporine 
Technical 
Type of flush 
Back table 
In situ
Type of retrieval 
Multiorgan 
Single organ 
Exchanged kidney 
Yes 
No
Cold ischemic time, h 
> 2 4
< 24
Anastomosis time, min 
> 45 
< 4 5
34 8(24)
154 40 (26)
75 25 (33)
113 23 (20)
159 35 (22)
29 13(45)
32 7(22)
156 41 (26)
107 26 (24)
81 22 (27)
70 17(24)
118 31 (26)
66 15(23)
122 33 (27)
36 10 (28)
152 38 (25)
35 12(34)
153 36 (24)
23 6(26)
165 41 (25)
141 37 (26)
47 11 (23)
58 22 (38)
130 26 (20)
118 20(17)
70 28 (40)
34 14(41)
154 34 (22)
57 21 (37)
131 27 (21)
47 16(34)
141 32 (23)
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cause they did not add any informa­
tion. All models were fit with the 
logistic-regression program of 
BMDP.12 Tests of the null hypothe­
sis of no association were calculated 
with Wald’s x2 statistics, and 95% 
confidence ii trvals were construct­
ed as described by Hosmer and 
Lemshow.13
Results
Forty-eight (26%) patients had 
INF. Six allografts with INF never 
functioned. Table I demonstrates 
the differences in rates of INF for 
each dichotomous variable. The 
greatest difference (23%) occurred 
in the donor dopamine variable 
(45% INF without donor dopamine 
use versus 22% with dopamine use) 
and type of retrieval (40% INF with 
single-organ retrieval versus 17% 
with multiorgan retrieval). As 
shown in Table II, donor dopamine 
use and type of retrieval were also 
the only variables to have a statisti­
cally significant association with 
INF in both the univariate and 
multivariate analyses. In the mul­
tivariate model the odds of INF 
were reduced by a factor of five 
when dopamine was used and by a 
factor of three when multiorgan 
retrieval was done. The statistical 
evidence of an association with INF 
is strongest for these two variables.
Results from four other variables 
are worth considering: cause of 
donor death, type of flush, ex­
changed kidney and cold ischemic 
time. Of these, cause of donor death 
(cerebrovascular accident versus 
other causes) is the most interest­
ing. Although cause of donor death 
was marginally associated with INF 
in the univariate analysis (the lower 
limit of the 95% confidence interval 
included but was not more than 1) 
the association became statistically 
significant after adjusting for all 
other variables. The association be­
tween INF and the other three 
variables (type of flush, exchanged 
kidney and cold ischemic time) was 
statistically significant only in the 
univariate analysis. The lack of 
multivariate association is indicated 
both by confidence intervals includ­
ing 1 and, perhaps more important­
ly, by the odds ratios being close 
to 1.
Discussion
Our data suggest that the inci­
dence of INF is increased in kidneys 
from donors who suffered a cere­
brovascular accident and decreased 
when donors were supported with 
dopamine or when multiorgan re­
trieval was done. We were unable to 
identify any recipient factors associ­
ated with INF.
Kidneys from donors suffering a 
cerebrovascular accident have been 
reported previously to have a poor­
er outcome. Both Sinclair and col­
leagues14 and Cecka and Cook15 
found that these kidneys were at 
risk of early graft failure. More 
recently, Troppmann and associ­
ates16 demonstrated reduced 1-year 
graft survival from donors who suf­
fered a cerebrovascular accident and
Table II. Univariate Analysis and Multivariate Analysis: 
Odds Ratios of INF
Univariate Multivariate
Odds Odds
Variable ratios (95% Cl) ratios (95% Cl)
Donor
Age, yr
> 50 v. < 50 0.9 (0.4, 2.1) 0.6 (0.2, 1.6)
Cause of death 
Cerebrovascular 
accident v. other 2.0 (1.0, 3.8) 3.2 (1.4, 7.5)
Dopamine use 
Yes v. no 0.3 (0.2, 0.8) 0.2 (0.1, 0.6)
Creatinine level, Mmol/L 
> 120 v. < 1 2 0 0.8 (0.3, 1.9) 1.0 (0.3, 2.8)
Instability 
Yes v. no 0.9 (0.4, 1.7) 1.2 (0.5, 2.7)
Hospitalization, d 
>  4 v. <  4 0.9 (0.5,1.8) 0.7 (0.3, 1.6)
Recipient 
Age, yr 
>  50 v. <  50 0.8 (0.4, 1.6) 0.7 (0.3, 1.6)
Diabetes 
Yes v. no 1.2 (0.5, 2.6) 1.0 (0.4, 2.7)
Current cytotoxicity, % 
>  30 v. <  30 1.7 (0.8, 3.7) 3.0 (1.0, 8.9)
No. of transplants 
>  1 v. 1 1.0 (0.4, 2.8) 0.4 (0.1, 1.6)
Induction therapy 
Antilymphocyte globulin 
v. cyclosporine 1.2 (0.5, 2.5) 0.7 (0.3, 1.9)
Technical 
Type of flush 
Back table v. in situ 2.4 (1.2, 4.8) 1.4 (0.6, 3.2)
Type of retrieval 
Multiple v. single 0.3 (0.2, 0.6) 0.3 (0.1, 0.7)
Exchanged kidney 
Yes v. no 2.5 (1.1, 5.4) 1.7 (0.6, 5.0)
Cold ischemic time, h 
>  24 v. <  24 2.2 (1.1, 4.5) 1.3 (0.5, 3.3)
Anastomosis time, min 
>  45 v. <  45 1.8 (0.9, 3.6) 1.9 (0.8, 4.5)
Cl =  confidence intervals
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stroke but not from donors who 
suffered a cerebrovascular accident 
with subarachnoid hemorrhage. 
Our study indicates that this poor 
graft survival may occur because of 
a higher rate of INF in kidneys 
from donors suffering a cerebrovas­
cular accident. These donors may 
have an increased incidence of un­
derlying systemic diseases such as 
atherosclerosis and hypertension. 
Unrecognized nephrosclerosis may 
be present. Patients with cere­
brovascular accidents often have 
dramatic hemodynamic instability 
and diabetes insipidus, which may 
cause ischemic damage to the kid­
ney before retrieval. Furthermore, 
patients with primary intracerebral 
events often are dehydrated inten­
tionally to reduce cerebral edema. 
This may have resulted in relative 
hypovolemia before retrieval com­
pared with other donors who were 
involved in polytrauma.
In this analysis, the use of dopa­
mine in donors was found to de­
crease the risk of INF. This same 
association has been confirmed re­
cently by the Toronto group.17 Low- 
dose dopamine is known to increase 
renal blood flow and to stabilize 
blood pressure.18 The pre-retrieval 
use of dopamine may also prevent 
vasospasm after revascularization. 
Dhabuwala, Bird and Salaman19 
demonstrated that low-dose dopa­
mine prevented renal vasospasm in 
hypotensive rats. In our study, the 
beneficial effects of dopamine do 
not seem to be related to reduced 
hemodynamic instability, because 
there was no association with INF 
and this variable. In an animal 
study, Pienaar and colleagues20 
demonstrated reduced survival of 
kidney allografts from hypotensive 
donors treated with dopamine. In 
humans, Schneider and associates21 
found an increased incidence of 
acute tubular necrosis in kidneys 
from donors treated with dopamine. 
This discrepancy may be related to
the dose of dopamine and the he­
modynamic stability of the donor. 
Although low-dose dopamine (less 
than 10 Mg/kg-min J) may dilate 
the renal vessels, higher doses may 
cause vasoconstriction.18 The use of 
high-dose dopamine (more than 10 
Mg/kg-mirr') to increase blood 
pressure in an unstable donor may 
not improve renal blood flow and 
may actually decrease perfusion. If 
dopamine is used in only the very 
unstable donor, its use may just be 
an indicator of ischemic end-organ 
damage from hypotension. A pro­
spective trial comparing the use of 
low-dose dopamine therapy to no 
therapy would clarify this issue.
The effect of multiorgan retrieval 
on kidney allograft function is con­
troversial, with some concern that it 
leads to a higher incidence of INF.22 
In our study, multiorgan retrieval 
was associated with reduced INF. 
Kidneys from a multiorgan retrieval 
are usually removed en bloc without 
a formal dissection. This technique 
prevents damage and spasm of the 
renal vessels and may account for 
the decreased INF compared with 
single-organ retrieval in which a 
formal dissection is often per­
formed. The in-situ flush technique, 
used in all multiorgan retrievals, 
might be expected to prevent INF 
by eliminating warm ischemic time. 
However, in the multivariate analy­
sis its association with INF was no 
longer significant. Multiorgan do­
nors may be higher “quality” do­
nors, hence producing grafts with 
better function. However, we were 
unable to demonstrate that INF is 
associated with factors found in 
better donors, such as lower donor 
age, less donor instability or shorter 
hospital stay.
We could not demonstrate any 
association between recipient varia­
bles and INF. Other studies have 
suggested that high current cyto­
toxicity,5 CsA induction23 and a 
previous transplant2 were associated
with greater risk of INF. This dif­
ference may relate to the high inci­
dence of antilymphocyte antibody 
induction therapy (75%) and our 
policy of aggressive hydration in 
the perioperative period.
Conclusions
Kidneys from donors suffering a 
cerebrovascular accident should be 
recognized as being at higher risk 
for INF. In view of the shortage of 
organs for transplantation the use 
of these kidneys is necessary, and a 
higher rate of INF and graft loss 
must be accepted. Optimizing donor 
care with faster retrieval and trans­
plantation may alleviate this prob­
lem.
Low-dose dopamine therapy may 
be beneficial for all donors regard­
less of their hemodynamic stability. 
A prospective trial is required to 
answer this question definitively.
Multiorgan retrieval is the har­
vesting method of choice, produc­
ing quality kidneys for transplanta­
tion and satisfying the ever-increas­
ing demand for extrarenal organs.
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SESAP VII Question /  Question SESAP VII
Items 309 to 313
(A) Heparin
(B) Warfarin
(C) Both
(D) Neither
309. Effective prophylaxis for deep venous thrombosis
310. Immediate anticoagulant therapy for acute deep venous thrombosis
311. Antagonizes action of vitamin K
312. Monitored by determination of partial thromboplastin time
313. Produces lysis of thrombi
For each of the numbered items select the appropriate lettered heading.
For the critique of Items 309 to 313 see page 159.
(Reproduced by permission from SESAP ’9 2 - ’93 Syllabus; Surgical Education and Self-Assessment Program 
No. 7. For enrolment in the Surgical Education and Self-Assessment No. 7, please apply to the American College 
of Surgeons, 55 E Erie St., Chicago, IL 60611.)
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Verrucous Carcinoma of the Genital 
Tract: Is It a Distinct Entity?
Donald I. Robertson, MD, FRCPC; Raymond Maung, MD, FRCPC;* Maire A. Duggan, MB, FRCPC
Between 1974 and 1985, 16 patients (7 men, 9 women) with a diagnosis of genital 
verrucous carcinoma were identified from the cancer registry of the Tom Baker 
Cancer Centre in Calgary. All the men had lesions on the penis. In the women, five 
lesions were on the vulva, four were on the cervix and two were on the vagina (two 
women each had two involved sites). The histologic slides from the surgically 
excised specimens were reviewed, and, by applying strict criteria, all cases could be 
reclassified as giant condyloma (five cases), intraepithelial neoplasia with or without 
condylomatous features (eight cases) or invasive squamous cell carcinoma (five 
cases). The authors believe that, in genital lesions associated with the human
Entre 1974 et 1985, 16 patients (7 hommes et 9 femmes) presentant un diagnostic 
de tumeur verruqueuse genitale maligne avaient ete inscrits a la liste du Tom Baker 
Cancer Centre, de Calgary. Tous les hommes etaient porteurs de lesions sur le 
penis. Chez les femmes, cinq lesions touchaient la vulve, quatre le col et deux le 
vagin (deux femmes avaient une double atteinte). Les coupes histologiques des 
echantillons excises ont ete revues et, a l’aide de criteres stricts, toutes les tumeurs 
ont pu etre reclassifiees en tant que condylomes geants (cinq cas), neoplasies 
intraepitheliales avec ou sans caracteristiques condylomateuses (huit cas), ou 
epitheliomas epidermoi'des envahissants (cinq cas). Les auteurs croient que, dans les 
cas de lesions genitales reliees au papillomavirus humain, le diagnostic de cancer 
verruqueux est non specifique et peut conduire au mauvais traitement clinique.
** >v..v
inappropriate clinical management.
V errucous carcinoma was first described in the oral cavity by 
Ackerman in 1948.1 Similar lesions 
in the genital tract were described 
in 1965 by Dawson and associates2 
and in 1966 by Kraus and Perez- 
Mesa.3
Despite numerous reports of gen­
ital verrucous carcinoma subse­
quently, the precise nature of this
lesion remains undetermined. Some 
believe that it represents a giant 
condyloma,3-6 whereas others sug­
gest that it is a distinctive form of 
cancer that rarely metastasizes.7-11 
Verrucous carcinoma was classified 
as a distinctive variant of squamous 
cell carcinoma (SCC).12
Within the genital tract there is a 
morphologic continuum of epitheli­
al changes ranging from condyloma 
at the one end to invasive SCC at 
the other.213-15 Between these two 
extremes there are various degrees 
of intraepithelial neoplasia, often 
with condylomatous features that 
tend to disappear as the degree of 
dysplasia or intraepithelial neoplasia
molecular hybridization studies has 
implicated different types or strains 
of the human papillomavirus (HPV) 
in the genesis of some or all of 
these lesions.16 HPV types 6 and 11 
are most frequently associated with 
condyloma and low-grade dys­
plasias,16-18 whereas types 16 and 
18 are associated with high-grade 
dysplasias and invasive cancers.19-21 
Other more recently discovered 
HPV subtypes may also play a 
role.1315 Because verrucous carcino­
ma histologically and clinically re­
sembles a giant condyloma, we 
questioned the need to regard this 
lesion as a variant of SCC. This 
study presents a review of genital 
lesions previously diagnosed as ver­
rucous carcinoma to determine if 
they could be reclassified as condy­
loma, intraepithelial neoplasia or 
invasive SCC on the basis of accept­
ed histologic criteria.
Patients and Methods
A search of the population-based 
cancer registry of the Tom Baker 
Cancer Centre from 1974 to 1985 
identified 16 cases of verrucous 
carcinoma of the genital tract.
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The original pathology slides of 
the surgical specimens from all pa­
tients were reviewed. The criteria 
used in the reclassification included 
those of Ackerman1 for verrucous 
carcinoma and Meisels, Fortin and 
Roy22 for condyloma. Koilocytes 
were regarded as pathognomonic of 
an HPV infection.13 Standard crit­
eria for diagnosing intraepithelial 
neoplasia were applied, including 
loss of basal polarity, architectural 
disorganization, nuclear atypia, mi­
toses not confined to the basal layer 
and abnormal mitotic figures. All 
lesions with invasion of the underly­
ing stroma were classified as carci­
noma. The diagnoses after review 
are presented in Table I.
Results
The mean age for the seven men 
was 54 years (range from 42 to 78 
years) and for the nine women was 
56 years (range from 29 to 76 
years).
As a result of the review of the 
original pathology specimens, all 
cases could be reclassified as giant 
condyloma, intraepithelial neoplasia 
with or without condylomatous fea­
tures or invasive SCC. Those le­
sions accepted as condylomas 
showed acanthosis, multifocal pa­
rakeratosis and hyperkeratosis, and 
koilocytosis with only minimal raisi- 
noid nuclear changes. They fre­
quently had a flat or pushing epi­
thelial-stromal interface, formed in 
part by apparent fusion of blunt 
rete pegs (Figs. 1 and 2). Hybrid 
lesions were common: one penile, 
three vulvar and two vaginal lesions 
had features of intraepithelial neo­
plasia with koilocytosis of an asso­
ciated HPV infection. One patient 
(no. 14) had a typical flat wart 
adjacent to an area of vulvar intra­
epithelial neoplasia with koilocyto­
sis.
Four men each had one recur­
rence within 1 year at which time a 
diagnosis of verrucous carcinoma 
was made. Three women had recur­
rent lesions before a diagnosis of 
verrucous carcinoma was reached. 
Patient no. 15 had six recurrences 
over 4 years, patient no. 14 had one 
recurrence in 4 months and patient 
no. 16 had two vulvar recurrences 
in 8 months before her cervical 
condition was detected, leading to 
the decision to proceed with radical 
surgery for verrucous carcinoma of 
both vulva and cervix.
Discussion
The diagnosis of verrucous carci­
noma as originally described for 
lesions of the oral cavity by Acker­
man1 was applied subsequently to 
histologically similar lesions in the 
genital tract. However, a morpho­
logically similar lesion of the genital 
tract had been described previously 
by Buschke and Loewenstein23 as a 
giant condyloma. These differences 
in diagnostic formulation from car­
cinoma on the one hand to a benign 
infective process on the other, re-
Table I. Clinical Features and Review Diagnosis
Patient
no.
Location 
of tumour
Age,
yr Treatment Outcome Follow-up
Review
diagnosis
1 Penis 78 Penile amputation Died Ml, NED 1 yr PIN stage III, HPV
2 Penis 50 Penile amputation Alive, NED 11 yr Invasive SCC
3 Penis 43 Circumcision Unknown Lost Condyloma
4 Penis 45 Partial amputation Alive, NED 18 mo Condyloma
5 Penis 74 Partial amputation Alive, NED 2 yr Condyloma
6 Penis 42 Circumcision/
radiotherapy
Alive, NED 3 yr Invasive SCC
7 Penis 48 Radical penectomy Died CHF, NED 10 yr Invasive SCC
8 Cervix 41 Radiotherapy DOD 4 yr
5 mo
Invasive SCC
9 Vulva 63 Radical vulvectomy Alive, NED 3 yr Condyloma
10 Cervix 29 Total abdominal 
hysterectomy
Alive, NED 26 mo CIN stage III
11 Vulva 75 Simple vulvectomy/ 
cautery
Alive, NED 8 mo Condyloma
12 Vagina 65 Simple excision Alive, NED 16 mo VAIN stage II, HPV
13 Vulva 76 Radical vulvectomy Died, lung 
cancer, NED
5 yr VIN stage III, HPV
14 Vulva 54 Simple excision Alive, NED 14 mo VIN stage III, HPV
15 Vagina/
cervix
67 Upper vaginectomy Alive, NED 16 mo VAIN stage III,
HPV. CIN stage III
16 Vulva/
cervix
35 Radical vulvectomy/ 
radical hysterectomy
Alive, NED 4 yr VIN stage III,
HPV. Invasive SCC
Ml =  myocardial infarction, NED =  no evidence of disease, CHF =  congestive heart failure, DOD =  dead of disease, PIN =  penile intraepithelial 
neoplasia, HPV =  human papillomavirus, SCC =  sguamous cell carcinoma, CIN =  cervical intraepithelial neoplasia, VAIN =  vaginal intraepithelial 
neoplasia, VIN =  vulvar intraepithelial neoplasia
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fleet the historical disagreement be­
tween authors as to the relationship 
of these two entities.
The application of newer diag­
nostic techniques implicates various 
HPV types in a spectrum of lesions 
affecting genital squamous epitheli­
um from condyloma to invasive 
SCC. Electron microscopy has re­
vealed HPV particles in con­
dyloma24' 26 as well as in lesions 
diagnosed as verrucous carcino­
ma.5'27'28 Similarly, immunocyto- 
chemistry has revealed HPV anti­
gens in condyloma,24'29 intraepitheli­
al neoplasia,14'30-32 and invasive 
SCC.14 As the degree of intraepi­
thelial neoplasia advances, detection 
of HPV becomes progressively more 
difficult by either electron microsco­
py or immunocytochemistry14 be­
cause viral DNA is integrated into 
the host genome.1533 Molecular hy­
bridization, a sensitive technology 
for detecting the DNA of HPV, is 
positive in condyloma, intraepitheli­
al neoplasia and invasive SCC30'34 as
FIG. 1. Giant condyloma (patient no. 
4), showing hyperkeratosis (thick 
white line) and acanthosis (thin white 
line) with broad, club-shaped rete pegs 
(dotted line) (hematoxylin-eosin, origi­
nal magnification X 25).
well as in some reported examples 
of verrucous carcinoma.34' 36
In this study, the multiple genital 
lesions originally diagnosed as ver­
rucous carcinoma on review formed 
a continuum from condyloma 
through intraepithelial neoplasia 
with or without associated condylo- 
matous features to invasive SCC. 
The concept of a continuous spec­
trum from condyloma to verrucous 
carcinoma has also been proposed 
by others, including Bogomoletz, 
Potet and Molas37 and Okagaki.38
Only three penile and two vulvar 
lesions fulfilled Ackerman’s criteria1 
of a verrucous carcinoma, yet they 
also had features of condyloma, 
including both koilocytosis and 
multifocal parakeratosis with only 
minimal associated dysplasia. Al­
though the size of the original 
lesions was seldom known in this 
retrospective study, the only dis­
tinctive feature of these five lesions 
was their relatively large size micro­
scopically, i.e., present in multiple 
tissue blocks from the resected 
specimen. We therefore reclassified 
these lesions as giant condylomas.
Although morphologic criteria
have been proposed to differentiate 
verrucous carcinoma from SCC, 
squamous papilloma and mucosal 
HPV infections,71011'39 they are dif­
ficult to apply in a precise and 
consistent fashion in genital tract 
lesions. This study emphasizes that 
diagnostic imprecision. Of the 18 
original lesions diagnosed as verru­
cous carcinoma, only 5 (3 penile 
and 2 vulvar) were acceptable on 
review as (giant) condyloma. Five 
were reclassified as invasive SCC 
because of stromal invasion, and 
eight lesions revealed intraepithelial 
neoplasia.
It is apparent that the morpho­
logic criteria applied by different 
pathologists in diagnosing HPV- 
related genital lesions are not uni­
form, a finding noted previously.8 
This lack of inter-pathologist con­
sistency reduces the clinical signifi­
cance of a diagnosis of verrucous 
carcinoma. For example, despite a 
pathological diagnosis of verrucous 
carcinoma, the mass in patient no. 
8 was clinically defined as stage IIB 
cervical carcinoma and was treated 
with radiotherapy. The patient died 
of widespread metastatic disease 4
FIG. 2. Giant condyloma (patient no. 4), showing broad-based epithelial-stromal 
interface without invasive characteristics, and lack of epithelial dysplasia (hematox­
ylin-eosin, original magnification X 235).
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years and 5 months from the time 
of diagnosis.
It there is confusion regarding 
the pathological criteria for verru­
cous carcinoma, it is not surprising 
that there is equal confusion re­
garding the appropriate treatment 
for such lesions. This was particu­
larly apparent in the current study. 
The treatment for the penile lesions 
varied from circumcision to radical 
penectomy or radiotherapy, and for 
the women therapy ranged from 
simple excision and cautery to radi­
cal surgery or radiotherapy.
The clinical behaviour of lesions 
diagnosed as verrucous carcinoma 
does not seem sufficiently distinc­
tive to warrant separate designa­
tion. The known tendency for “gi­
ant” condylomas to recur after 
what seems to be adequate therapy 
can now be explained by the find­
ings from recent DNA hybridization 
studies. Persistent HPV has been 
found in surrounding, seemingly 
normal mucosa up to 5 cm from the 
apparent lesion.40'41 Re-epithelializa- 
tion from the lateral margins by 
HPV-infected epithelium might be 
expected to result in recurrence of 
disease. If the surgical treatment 
should result in a fistula or sinus- 
tract formation, its re-epithelializa- 
tion with HPV-infected mucosa may 
result in recurrent disease in the 
fistula or sinus.
Although a series of misdiag­
noses of verrucous carcinoma does 
not disprove its existence, we doubt 
there exists sufficient reason to 
retain the diagnostic formulation of 
verrucous carcinoma in modern gy­
necologic or urologic pathology. As 
shown in this study, there exists 
sufficient imprecision in the applica­
tion of pathological criteria to ren­
der the term “verrucous carcino­
ma” almost useless, leading, at 
least in part, to clinical confusion as 
to appropriate treatment. The clini­
cal behaviour of such lesions does 
not appear distinctive, and newer
diagnostic techniques, especially 
DNA hybridization, emphasize the 
concept of a continuum from con­
dyloma through intraepithelial neo­
plasia to invasive SCC. Further di­
agnostic fragmentation by the use 
of terms such as verrucous carcino­
ma or condylomatous carcinoma38 
seems unwarranted. In any event, 
the clinical behaviour of the lesion 
appears more related to the specific 
infecting type of HPV than to 
subtle or peculiar morphologic fea­
tures, which may not be recognized 
by different pathologists. If the gen­
ital lesion is remarkable because of 
its large size, we suggest that the 
diagnosis of “giant” condyloma in­
stead of verrucous carcinoma is less 
likely to lead to excessively radical 
treatment than would a diagnosis 
indicating cancer.
For these HPV genital lesions, 
the crucial histopathological feature 
affecting subsequent treatment in­
volves the presence or absence of 
stromal invasion. Those lesions 
with stromal invasion should be 
classified as SCC and treated appro­
priately, according to the stage of 
the disease. Management of con­
dylomas, with or without associated 
intraepithelial neoplasia, should in­
clude wide ablation of the abnormal 
epithelium by the preferred clinical 
method, recognizing that both con­
dyloma and intraepithelial neoplasia 
are prone to recurrence. In this 
manner, radical therapy for benign 
genital tract lesions may be avoided.
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NOTICES
AVIS
Progress in Gastrointestinal 
Surgery
A course entitled “Progress in Gastroin­
testinal Surgery’’ will be presented as 
the major topic of the 57th Annual 
Surgery Course, to be held from June 
16 to 19. 1993, at the University of 
Minnesota. The course is presented by 
the Department of Surgery of the Uni­
versity of Minnesota Medical School. 
For more information contact: Office of 
Continuing Medical Education, Univer­
sity of Minnesota, Radisson Hotel Met- 
rodome, Suite 107. 615 Washington 
Ave. SE, Minneapolis, MN 55414; 
phone: 1-800-776-8636; fax: (612) 
626-7766
International Surgical Week
The 35th World Congress of Surgery of 
the International Society of Surgery 
with its integrated societies presents 
International Surgical Week from Aug.
37. Bocomoletz WV. Potet F, Molas G: 
Condylomata acuminata, giant condylo­
ma acuminatum, (Buschke-Loewenstein 
tumour) and verrucous squamous carci­
noma of the perianal and anorectal 
region: a continuous precancerous spec­
trum? Histopathology 1985; 9: 1155— 
1169
38. Okacaki T: Female genital tumors asso­
ciated with the human papillomavirus 
infection, and the concept of genital 
neoplasm-papilloma syndrome (GENPS). 
Pathol Annu 1984; 19 (2): 31-62
39. Japaze H, Dinh TV, Woodruff JD: Ver­
rucous carcinoma of the vulva: study of 
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40. Ferenczy A, Mitao M, Nacai N et al: 
Latent papillomavirus and recurring 
genital warts. N Engl J Med 1985; 313: 
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er JW et al: Human papillomavirus in 
clinically and histologically normal tis­
sue of patients with genital cancer. N  
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22 to 27, 1993, in Hong Kong. For 
more information contact: Congress 
Secretariat, ISW Hong Kong, Depart­
ment of Surgery, University of Hong 
Kong, Queen Mary Hospital, Hong 
Kong; phone: (852) 819-2235; fax; 
(852) 855-1897.
Digestive Disease Week
Digestive Disease Week, to be held in 
Boston from May 15 to 21, 1993, is 
one of the largest medical meetings in 
the country, featuring over 3000 pre­
sentations of original research. The 
sponsoring societies include the Ameri­
can Association for the Study of Liver 
Diseases, the American Gastroentero­
logical Association, the American Soci­
ety for Gastrointestinal Endoscopy and 
the Society for Surgery of the Alimenta­
ry Tract. For more information contact: 
Melanie Haney, DDW press room man­
ager, Boasberg Valentine-Radford, 
4600 Madison, Kansas City, MO 64112; 
phone; (816) 531-2100.
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N o  Stent, No Diversion” Mathieu 
Hypospadias Repair
Michael McCormack, MD, FRCSC; Yves Homsy, MD, FRCSC; Yvan Laberge, MD, FRCSC
The Mathieu procedure is a surgical technique for anterior hypospadias repair. The 
disadvantage of this technique is the prolonged hospital stay associated with 
postoperative urinary diversion. In an effort to reduce the length of hospital stay the 
authors carried out a prospective study to determine the usefulness of urethral 
stents and urinary diversion after Mathieu repair. Seventeen boys (mean age 4.1 
years) formed the experimental group, and 19 boys (mean age 4.6 years) served as 
controls. Urinary diversion and urethral stents were used postoperatively in the 
control group but not in the experimental group. After a minimum of 6 months of 
observation the complications noted in both groups were found to be similar. The 
authors conclude that urinary diversion and urethral stents have no beneficial 
effects on surgical outcome but do prolong hospital stay.
L’operation de Mathieu est une technique chirurgicale qui permet la reparation de 
l’hypospadias anterieur. L’inconvenient de cette technique est qu’elle exige une 
hospitalisation prolongee due a une derivation urinaire postoperatoire. En vue de 
reduire le sejour hospitalier, les auteurs ont realise une etude prospective visant a 
mesurer l’utilite d’un manchon uretral et de la derivation urinaire apres une 
reparation de Mathieu. Dix-sept garpons (age moyen de 4,1 ans) ont constitue le 
groupe experimental, alors que 19 garcons (age moyen de 4,6 ans) formaient le 
groupe temoin. Chez les garcons du groupe temoin, on eut recours, en periode 
postoperatoire, au manchon uretral et a la derivation urinaire main non pas chez les 
garcons du groupe experimental. Apres un minimum de 6 mois de surveillance, les 
complications observees dans les deux groupes ont ete jugees similaires. Les 
auteurs concluent que la derivation urinaire et les manchons uretraux n’ont aucun 
effet benefique sur les resultats chirurgicaux, alors qu’ils prolongent le sejour a 
I’hopital.
H ypospadias, a congenital defect of the penis that results in the 
incomplete development of the ante­
rior urethra, occurs with varying 
degrees of severity in approximately 
8.2 per 1000 live male births.1 The 
classification of hypospadias is 
based on meatal location after cor­
rection of penile curvature. Most 
patients (65%) have anterior (distal) 
hypospadias.
The Mathieu procedure2 is a well- 
established surgical technique used
Accepted fo r publication July 30, 1992
to repair anterior hypospadias if 
two conditions are met: there must 
be no chordee by artificial erection, 
and the ventral skin of the penis 
must provide a viable meatal-based 
flap to reconstruct the distal ure­
thra. Because the results of the 
Mathieu procedure are quite suc­
cessful and the complication rate is 
low, this surgical technique has 
gained widespread acceptance.3 The 
only drawback to this procedure is 
the prolonged hospital stay associ­
ated with postoperative urinary di­
version. Most surgeons perform uri­
nary diversion for 5 to 10 days 
postoperatively, and many prefer to 
insert a urethral stent for 1 to 3 
days or a “splent” for 1 week.
In an effort to diminish morbidity 
and length of hospital stay, Rabino- 
witz4 recently reported on the ac­
ceptable morbidity associated with a 
modified Mathieu hypospadias re­
pair without urinary diversion or 
urethral stenting.
Because the study reported by 
Rabinowitz was not controlled, we 
undertook a prospective random­
ized study to determine the useful­
ness of urethral stents and urinary 
diversion after Mathieu hypospadias 
repair.
Patients and Method
Thirty-six boys with anterior hy­
pospadias had surgical repair by the 
Mathieu technique.3' 5 They were 
randomized to either an experimen­
tal (“no stent, no diversion”) group 
(17 boys) or a control group (19 
boys) on the basis of their date of 
admission to hospital. The mean 
age of boys in the experimental 
group was 4.1 years and in the 
control group was 4.6 years. No 
child had been operated on for this 
condition previously.
In the control group a meatal- 
based flap was created, measuring 
one and a half times the length 
between the meatus and the tip of 
the fossa navicularis. The flap was 
flipped over and sutured to the 
medial edges of two parallel glandu­
lar incisions. Glandular flaps were 
developed laterally and reapprox-
From the Department o f Urology, Hopital du Haut-Richelieu, Saint-Jean-sur-Richeiieu, Que., and 
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imated over the neourethra (Fig. 1). 
A circumcision was also performed. 
Vicryl suture material (5-0) was 
used in all repairs. A no. 8 French 
silicone urethral stent was inserted 
and removed 24 hours after the 
operation. Urinary diversion by peri­
neal urethrostomy was carried out 
for 10 days postoperatively.
Boys in the experimental (“no 
stent, no diversion”) group under­
went the same Mathieu repair as 
boys in the contol group but had no 
urethral catheter -inserted postoper­
atively. As a precautionary measure, 
during the surgical intervention we 
installed a cystostomy tube percuta-
neously (no. 12 French silicone). 
However, the suprapubic tube was 
clamped as soon as it was inserted 
and remained clamped postopera­
tively. Patients were thus able to 
void in the immediate postoperative 
period through their neourethra. 
The cystostomy tube was used only 
to measure residual urine volume 
after micturition and otherwise re­
mained clamped and nonfunctional.
The boys were assessed clinically 
with respect to morbidity and com­
plications in the immediate postop­
erative period and after a minimum 
follow-up of 6 months (range from 
6 to 18 months).
Results
The complications for the two 
groups are shown in Table I. In the 
control group there were 14 compli­
cations compared with 8 complica­
tions in the “no stent, no diversion” 
group. Every child in the experi­
mental group was able to void 
through his neourethra. Initial void­
ing through the neourethra oc­
curred most often in the recovery 
room. Thus, the precautionary cys­
tostomy tube inserted during the 
operation remained clamped and 
nonfunctional in every case.
The length of hospital stay dif­
fered markedly in the two groups. 
Because our standard approach in 
the control group included a 10-day 
urinary diversion, boys in this 
group had a mean length of hospi­
talization of 12 days (range from 10 
to 18 days). In contrast, the mean 
length of hospitalization for boys in 
the experimental group was only 
3.8 days (range from 2 to 7 days).
Discussion
Because the anterior form of hy­
pospadias is the most frequent, the 
Mathieu procedure has become 
widely accepted. Efforts to minimize 
length of hospital stay were pio­
neered by Rabinowitz,4 who pro­
posed a modified Mathieu hypos­
padias repair done on an outpatient
Table 1. C o m p lic a t io n s  in  C o n tro l and 
E x p e rim e n ta l G ro u p s
Group
Control Experimental
Complication ( n = 1 7 ) ( / r = 1 9 )
F e ve r (te m p e ra tu re
>  3 8 ° C ) 3 2
F is tu la 3 2
B la d d e r s p a s m s 4 3
A b n o rm a l u r in a ry
s tre a m 1 1
M e a ta l s te n o s is 2 0
H e m a to m a 1 0
T o ta l 14 8
FIG. 1. Mathieu procedure. (A) Dotted lines outline skin flaps. (B) Proximal flap is 
rotated, and lateral glans flaps are developed. (C) Gians flaps cover neourethra, and 
preputial skin is moved if necessary. (D) Completed repair. (Reproduced by 
permission from Walsh PC, Retik AB, Stamey TA [eds]: Campbell’s Urology, 6th 
ed, Saunders, Philadelphia, 1992: 1905.)
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basis. Our prospective study of 36 
boys with anterior hypospadias was 
designed to compare the morbidity 
between the standard Mathieu re­
pair, which includes urinary diver­
sion and the use of a urethral stent, 
to a "no stent, no diversion" experi­
mental approach.
We noted 14 complications in the 
control group and 8 complications 
in the experimental group after 6 
months of observation. Complica­
tions included fever, urinary fistula, 
bladder spasm, meatal stenosis, ab­
normal stream and hematoma.
Because the types of complica­
tions were similar in both groups, it 
appears that urethral stents have no 
obvious beneficial effects on surgi­
cal outcome after Mathieu hypos­
BOOK REVIEWS 
CRITIQUES DE LIVRES
The following books are also re­
viewed in this issue: Pediatric Sur­
gery of the Liver, Pancreas and 
Spleen (page 177); Atlas of Surgi­
cal Pathology (page 183); Tech­
niques in Therapeutic Endoscopy, 
2nd edition (page 190).
KNEE SURGERY: CURRENT PRAC­
TICE. Edited by Paul M. Aichroth and 
W. Dilworth Cannon, Jr. 822 pp. II- 
lust. Raven Press Ltd., New York. 
1992. $250 (US). ISBN 0 -8 8 1 6 7 - 
9 3 4 -8
This large text provides a comprehen­
sive reference for every aspect of ortho­
pedic practice as it relates to the knee.
The book is divided into 21 sections 
and is well organized, beginning with 
investigation in the first section and 
ending with documentation and evalua­
tion in the last section.
Individual sections that appear to be 
particularly well done relate to the 
controversial topics of acute and chron­
padias repair. They may even be 
related to a higher complication 
rate.
The results of this study suggest 
that urinary diversion is not associ­
ated with better surgical results but 
prolongs hospital stay, as evidenced 
by the mean hospital stay of 3.8 
days for boys who did not have 
urinary diversion or stenting com­
pared with 12 days for boys who 
had urinary diversion. The “no 
stent, no diversion” Mathieu hypos­
padias repair significantly reduces 
hospital stay. Psychologic advan­
tages are evident for both the par­
ents and the child. Medical costs are 
also greatly reduced.
From our data we conclude that 
a “no stent, no diversion" Mathieu
procedure is the procedure of
choice to treat many cases of anteri­
or hypospadias.
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ic deficiency of the anterior cruciate 
ligament, patellofemoral disorders, 
problems related to children's knees 
and total knee replacement. In each of 
these sections, recognized authorities in 
the field give a clear and concise expla­
nation of their theory with regard to 
pathogenesis and treatment. In all cases 
these short sections tend to be compre­
hensive and are edited in such a way as 
to provide a uniform style of presenta­
tion. The illustrations are variable, 
being excellent in some chapters but 
lamentably deficient in others. This defi­
ciency is particularly felt in chapters 
that try to describe surgical technique 
by the written word alone, without any 
accompanying illustration.
The section on osteotomy is disap­
pointing in that it does not address the 
issue of femoral osteotomy and its role 
in the management of osteoarthritis; in 
comparison, the section on total knee 
replacement for the management of 
osteoarthritis is comprehensive, and the 
chapters on design and total knee re­
placement by Peter Walker and on 
adjustments necessary during knee ar­
throplasty by Lauren and Zukor are 
particularly good. However, the section 
on revision total knee replacement, an 
area of increasing interest and concern 
for all orthopedic surgeons, is deficient 
in discussion of planning, selection of 
implants and anticipated results.
Despite these criticisms, the areas of 
primary concern to most orthopedic 
surgeons are well covered — manage­
ment of acute and chronic anterior 
cruciate insufficiency and the planning 
and successful execution of total knee 
arthroplasty. This book would be of 
value in the libraries of those hospitals 
in which a significant amount of trau­
matic and reconstructive knee surgery 
is performed. It will not be useful in the 
libraries of most general orthopedic 
surgeons.
James P. Waddell, MD, FRCSC
Division of Orthopedics 
St. Michael’s Hospital 
30 Bond St.
Toronto. ON 
M5B 1W8
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ORIGINAL ARTICLES
T h e  Morbidity of Abdominal 
Hysterectomy
Mark E. Boyd, MD;* Patti A. Groome, BFAt
Objective: To determine the morbidity of abdominal hysterectomy.
Design: Descriptive. Physician billings to the Quebec Health Care Plan in the 
1-month period after abdominal hysterectomy were examined.
Setting: Operations performed in 102 hospitals in the Province of Quebec between 
Jan. 1, 1989, and Mar. 31, 1989, were selected.
Patients: The study group included 3322 patients who had abdominal hysterectomy. 
Patients who had vaginal or abdominal hysterectomy for invasive cancer or 
pregnancy-related complications were excluded. A patient was considered to be 
morbid if the physician’s intervention indicated concern for the patient's well-being. 
Main outcome measures: Multiple logistic regression analysis to determine the 
adjusted rate ratio for inclusion in a categorical list of morbid patients among 
different subsets of surgeons, hospitals and patients.
Results: Postoperative morbidity occurred in 646 patients (19.5%), who spent an 
average of 1.7 days longer in the hospital than patients with no postoperative 
morbidity. There were two postoperative deaths (0.1%). Forty-nine patients (1.5%) 
had postoperative surgical intervention. On 119 occasions (3.6%), patients were 
treated in the intensive care unit. A consultation was given by a medical specialist in 
303 cases (9.1%). The rate ratio for postoperative morbidity was not significantly 
affected by years in practice or specialty of the surgeon but was increased for 
operations performed in mid-sized hospitals. The strongest predictor of 
postoperative morbidity was a pre-existing medical disorder (RR).
Conclusion: The major causes of morbidity in patients who undergo abdominal 
hysterectomies are medical rather than surgical.
Objectif: Definir la morbidity reliee a l'hysterectomie abdominale.
Conception : Description, par etude de la facturation des medecins a la Regie de 
l'assurance maladie du Quebec, dans le mois qui a suivi l’hysterectomie abdominale. 
Cadre: Les operations effectuees dans 102 hopitaux de la province de Quebec, entre 
le l er janvier 1989 et le 31 mars 1989.
Population : L’etude a porte sur 3322 patientes qui ont subi une hysterectomie 
abdominale. Les patientes qui avaient eu une hysterectomie vaginale ou celles qui 
avaient eu une hysterectomie abdominale pour un cancer invasif ou des 
complications de la grossesse ont ete exclues. L’on estimait qu’une patiente souffrait 
d’un etat morbide si Tintervention du medecin indiquait une crainte pour le bien-etre 
de la malade.
Principales mesures des resultats : Analyse de regression logistique multiple afin 
d’etablir le rapport de taux ajuste pour l'inclusion d’une patiente dans une classe de 
morbidite parmi differents sous-groupes de chirurgiens, d'hopitaux et de patientes. 
Resultats : Une morbidite postoperatoire est survenue chez 646 patientes (19,5 %) 
dont le sejour hospitalier s’est prolonge de 1,7 jours par rapport aux patientes sans 
morbidite postoperatoire. On a enregistre deux deces postoperatoires (0,1 %). 
Quarante-neuf patientes (1,5 %) ont du subir une deuxieme operation. A 119 
occasions (3,6 %), les patientes ont transite par le service de soins intensifs. Un 
specialiste fut appele en consultation dans 303 occasions (9,1 %). Le rapport de taux 
de la morbidite postoperatoire n’a pas ete influence de fa?on significative par le 
nombre d’annees de pratique ou la specialite du chirurgien, mais il etait augmente si 
l’intervention avait ete pratiquee dans un hopital de moyenne importance. Une 
maladie preexistante constituait le facteur previsionnel le plus important de 
morbidite postoperatoire.
Conclusion : Les principales causes de morbidite chez les patientes qui subissent 
une hyterectomie abdominale sont d’ordre medical plutot que chirurgical.
The morbidity associated with abdominal hysterectomies that 
are performed in community hospi­
tals has never been satisfactorily 
determined. The purpose of this 
study was to ascertain this morbidi­
ty and to assess the contribution of 
different surgeons, hospitals and 
patients to it.
Methods
The Federation des Medecins 
Specialistes du Quebec and the Fed­
eration des Omnipraticiens du Que­
bec provided information from their 
claim forms for all hysterectomies 
performed between Jan. 1, 1989, 
and Mar. 31, 1989, and the sub­
sequent claims of these patients 
over the next 3 months. The file 
contained anonymous patient and 
physician identification numbers, 
the date of intervention, the age of 
the patient, a description of the 
intervention as indicated by a proce­
dure code, the physician’s specialty, 
the number of years since the physi­
cian first registered with the Que­
bec Health Insurance Plan and an 
identifying hospital code number. 
There was a total of 27 505 such 
records. The length of hospital stay 
and the principal and secondary 
discharge diagnoses were obtained 
from the Ministere de la Sante and 
the Services Sociaux of the Prov-
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ince of Quebec. The latter informa­
tion was available for 82% of the 
patients.
The presence of invasive cancer 
was determined, and if postopera­
tive chemotherapy or radiotherapy 
had been given or if radical hyster­
ectomy or staged biopsy of periaort­
ic and pelvic lymph nodes had been 
done the patient was excluded. If 
hysterectomy had been performed 
on the same day as a vaginal deliv­
ery, cesarean section or abortion, 
the hysterectomy was classified as 
pregnancy related and the patient 
was excluded from the study. Pa­
tients who had undergone a vaginal 
hysterectomy were also excluded 
(Table I). Surgical experience was 
judged by the number of abdominal 
hysterectomies the practitioner had 
performed in the 3-month study 
period. The number of years in 
practice was inferred from the num­
ber of years that the physician had 
been registered with the Quebec 
Health Insurance Plan. In ordinary 
circumstances, registration occurs 
soon after internship. The hospital 
code was used to determine the 
number of beds, and university affil­
iation was assigned as accredited by 
the Royal College of Physicians and 
Surgeons of Canada.
The patient’s postoperative 
course was inferred from analysis of 
the postoperative claims. Patients
T a b le  1. H ys te re c to m ie s  in P ro v inc e  o f 
Q u e b e c , Jan. 1 ,1 9 8 9  to  M ar. 3 1 ,1 9 8 9
H ysterectom ies ,
G roups no. (% )
S tu d y  g ro u p 3 3 2 2  ( 7 8 .2 )
A b d o m in a l
h y s te re c to m y  
M a rs h a ll—M arche tti
3 0 4 4
o p e ra tio n
S u b to ta l
270
h y s te re c to m y 8
E x c lu s io n s
P re gn a n cy -re la te d  
h ys te re c to m y  
H y s te re c to m y  fo r
3  ( 0 .0 7 )
in v a s iv e  cancer 1 5 8  ( 3 .7 )
V a g in a l h ys te re c to m y 7 6 5  ( 1 8 .0 )
T o ta l 4 2 4 8  (1 0 0 .0 )
were included in a categorical list of 
women with postoperative morbidi­
ty if the physician performed any 
act within 1 month after surgery 
that indicated concern for the pa­
tient's well-being (Table II). The 
adjusted rate ratio (RR) for being 
included in the categorical list was 
calculated for the various types of 
physician training, experience and 
years of practice (Table III), for 
hospital size and university affilia­
tion (Table IV) and for patient age, 
the indication for hysterectomy and 
the presence of pre-existing medical 
disease (Table V).
The adjusted RR for each sub­
group was determined against all 
other members of the study popula­
tion. Multiple logistic regression 
analysis was used to compute the
RR and the 95% confidence interval 
(Cl). Data for use in multiple regres­
sion analysis were complete for 74% 
to 82% of the study population, 
depending on the model. Each was 
computed while controlling for pa­
tient’s age, reason for hysterectomy 
and any underlying medical disorder 
(Tables III to V). The reference 
patient in the model was someone 
with no underlying medical disease 
whose indication for hysterectomy 
was a fibroid uterus (age was a 
continuous variable). Comparison 
was made between the mean length 
of hospital stay among patients who 
had and did not have postoperative 
intervention. The relationship of pa­
tient age to average length of hospi­
tal stay was examined by analysis of 
variance.
T a b le  II. In d ica tio n s  fo r  P o s to p e ra tive  M o rb id ity  (N  = 3 3 2 2 )
Act In d ic a tio n /p ro ced u re
P atien ts, 
no. (% )
Genera l su rg ica l p rocedu re 33  ( 1 .0 )
A b d o m in a l w a ll a b s c e s s /h e m a to m a 18
L a p a ro to m y 11
In te s tin a l la ce ra tio n 4
U ro lo g ic  o p e ra tio n 13 ( 0 .4 )
U re te ra l in ju rie s 7
V es ico va g in a l f is tu la 2
B ladder la c e ra tio n s 4
G y n e co lo g ic  o p e ra tio n 3 ( 0 .1 )
R esu tu re  o f va g ina 2
C o lp o to m y 1
C a rd io p u lm o n a ry  p rocedu re
(in te n s ive  care  u n it) 119 ( 3 .6 )
In se rtio n  o f ce n tra l lin e  a n d /o r  ( >  2 ) 
b lood  gas d e te rm in a tio n s 51
U ltra s o n o g ra p h y  o f hea rt 25
P u lm o n a ry  fu n c t io n  te s tin g 24
P ro longed  re s p ira to ry  su p p o rt 7
A d m is s io n  to  c a rd ia c  care u n it 4
S pec ia l e le c tro c a rd io g ra p h ic  s tu d ies 4
O ther 4
N e u ro lo g ic  in v e s tig a tio n N e u ro m u s cu la r tra n s m is s io n  s tu d ies 7 ( 0 .2 )
R ad io lo g ic  in v e s tig a tio n 159 ( 4 .8 )
U ltra s o n o g ra p h y  o f a b d o m e n  o r p e lv is 138
C om pu ted  to m o g ra p h y  o r ra d io g ra p h y 10
O ther 11
E nd o sco p ic  e xa m in a tio n 79  ( 2 .4 )
C ys tos co p y 66
G a s tro sco p y 11
B ro n c h o sco p y 2
C o n su lta tion s 3 0 3  ( 9 .1 )
E m ergency  v is it  a t
w ee k-e n d  o r la te  n ig h t 12 ( 0 .4 )
T o ta l no. w ith  one o r  m ore
in te rve n tio n s 6 4 6  (1 9 .5 )
N o. o f dea ths 2 ( 0 .1 )
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T a b le  II I .  P hys ic ia n  V aria b le s  and P o s to p e ra tive  M o rb id ity
V ariab le
P hysic ians ,
no.
H ysterectom ies,
no.
M orb id  
ep isodes, 
no. (% )
A djusted
ra te
ratio Cl
S pe c ia lty
G y n e c o lo g is t 3 1 3 2 7 1 7 5 2 6  (1 9 .4 ) 1 .1 8 0 . 7 4 - 1 . 8 8
Genera l su rg e o n 43 172 2 5 ( 1 4 .5 ) 0 .8 3 0 . 5 2 - 1 . 3 4
Genera l p ra c tit io n e r 12 9 6 1 5 (1 5 .6 ) — —
O ther 4 4 1 (2 5 .0 ) — —
U nassigned 3 3 3 7 9  (2 3 .7 ) — —
H ys te re c to m ie s , no.
1 - 6 183 6 5 8 150  (2 2 .8 ) 1 .2 2 0 . 9 7 - 1 . 5 6
7 - 8 48 3 8 7 6 6 (1 7 .1 ) 0 .6 7 0.48  -  0 .9 4
9 - 1 5 93 116 5 2 1 4 (1 8 .4 ) 0 .9 8 0 . 7 9 - 1 . 2 0
1 6 - 4 4 4 6 111 2 2 1 6 (1 9 .4 ) 1 .0 4 0 . 8 5 - 1 . 2 9
Y ears o f p ra c tice , no.
<  5 8 38 1 0 (2 6 .3 ) 1 .1 0 0 .47  -  2 .5 7
6 - 1 0 59 3 8 8 88  (2 2 .7 ) 1 .2 6 0 . 9 3 - 1 . 7 0
1 1 - 1 5 74 6 7 4 1 2 6 (1 8 .7 ) 0 .9 6 0 . 7 5 - 1 . 2 3
>  16 2 2 9 2 2 2 2 4 2 2  (1 9 .0 ) 0 .9 2 0 . 7 5 - 1 . 1 3
Cl =  co n fid e n c e  in te rv a l
T a b le  IV . H o sp ita l V ariab les and P o s to p e ra tive  M o rb id ity
V ariab le
P hysic ians ,
no.
H ysterec tom ies ,
no.
M orb id  
ep isodes, 
no. (•/»)
A djusted
ra te
ratio Cl
H osp ita l beds, no.
<  2 0 0 3 5 5 5 5 94  (1 6 .9 ) 0 .8 6 0 . 6 5 - 1 . 1 3
2 0 0  -  4 0 0 38 1 4 7 4 3 0 8  (2 0 .9 ) 1 .4 2 1 . 1 7 - 1 . 7 3
>  4 0 0 24 1 2 4 7 2 2 8  (1 8 .3 ) 0 .71 0 .57  -  0 .8 7
U nass igned 4 6 9 ( 1 9 .6 ) — —
U n iv e rs ity  a ff il ia t io n
T each ing 19 8 3 3 1 7 8  (2 1 .4 ) 1 .0 6 0 . 8 4 - 1 . 3 2
N o n te a ch in g 81 2 4 4 8 4 5 2  (1 8 .5 ) — —
U nass igned 2 41 1 6 (3 9 .0 ) — —
Cl =  c o n fid e n c e  in te rv a l
T a b le  V. P a tie n t V ariab les and P o s to p e ra tive  M o rb id ity  Rate
V ariab le
Patients,
no.
M orb id  
ep isodes, 
no. (°/o)
A djusted  
ra te  ratio Cl
Age, y r  ( fo r  each  10  y e a rs ) 1 .05 0.94 -  1 .17
In d ica tio n  fo r  h y s te re c to m y
C ancer 123 4 3  (3 5 .0 ) 2.31 1.48 -  3 .6 0
M en s tru a l d is o rd e r 617 143  (2 3 .2 ) 1 .54 1.18 -  2 .01
P e lv ic  in f la m m a to ry  d isease 152 28  (1 8 .4 ) 1 .14 0.72 -  1 .80
E n d o m e trio s is 349 56  (1 6 .0 ) 1 .10 0.77 -  1 .55
U te rin e  le io m y o m a 876 147  (1 6 .8 ) 1 .00
O ther 612 1 1 5 (1 8 .8 ) 1 .12 0.84 -  1 .48
M ed ica l d is o rd e r
H eart d isease 80 54  (6 7 .5 ) 9 .4 9 5.50 -  1 6 .3 8
P u lm o n a ry  d isease 58 3 0  (5 1 .7 ) 6 .4 9 3.67 - 1 1 . 4 9
H yp e rte n s io n 108 37  (3 4 .3 ) 2 .6 6 1.71 -  4 .1 2
D iabe tes m e llitu s 42 1 4 (3 3 .3 ) 2 .3 2 1.15 -  4 .71
A nem ia 227 50  (2 2 .0 ) 1 .36 0.96 -  1 .92
Cl =  c o n fid e n c e  in te rv a l
In te rce p t fo r  lo g is t ic  re g re ss io n  a n a lys is  =  - 2 .0 3 0 4
Results
There were two postoperative 
deaths (1 per 1661 patients), in 
both instances caused by cardiopul­
monary arrest. The average length 
of stay in the hospital for women 
with postoperative morbidity was 
9.8 days (Cl =  9.19 to 10.36). This 
is in contrast to an average length 
of stay for the control population of 
8.1 days (Cl =  7.95 to 8.17).
There was substantially less 
chance of being included in the list 
of women with postoperative mor­
bidity if the physician performed 
seven to eight hysterectomies dur­
ing the study period (Table III) or if 
the hysterectomy occurred in a 
large hospital (i.e., more than 400 
beds) (Table IV).
The most important factor in­
creasing the risk of postoperative 
medical intervention was the pres­
ence of certain concurrent medical 
disorders. Heart disease increased 
the risk by a factor of 9.49 and 
pulmonary disease by a factor of 
6.49. Cancer, as an indication for 
hysterectomy, doubled the risk, but 
diabetes and hypertension as coex­
isting disorders were equally impor­
tant (Table V). Age was not signifi­
cant when consideration was given 
to concurrent medical disorders and 
the indication for hysterectomy. 
Laparotomy was done on 11 occa­
sions; in more than half of the cases 
(60%) the surgery was performed by 
the gynecologist. A claim form was 
submitted for intestinal suture on 
four occasions, each time by a gen­
eral surgeon. No claim for the con­
trol of hemorrhage, at the time of 
hysterectomy, was submitted by a 
general surgeon.
Discussion
This study is unique in that it 
includes detailed information relat­
ed to all hysterectomies performed
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in a large area over a short period 
of time. Previously published 
studies of the morbidity of abdomi­
nal hysterectomy were concerned 
mainly with national statistics of 
age-specific and region-specific 
rates of hysterectomy or their distri­
bution by surgical approach,12 or 
data were collected over a period of 
years.3 In other instances, the litera­
ture related to a single complica­
tion,4 the experience of accom­
plished surgeons5’6 or selected aca­
demic units.78 Separate consider­
ation was not always given to hys­
terectomies done as a result of 
malignant disease or complications 
of pregnancy.9 This study and all 
others are limited in the sense that 
control groups of patients, those 
who had comparable gynecologic 
and medical disease and were not 
operated on, were unavailable.
The standard means of analysing 
postoperative gynecologic morbidity 
is through use of the American 
College of Obstetricians and Gyne­
cologists’ indicators,10 which in­
clude a large proportion of the 
patients.11 We determined the post­
operative course by analysis of indi­
vidual financial records, a method 
that has been used in the past.612 
The reliability of physicians’ claims 
to provincial fee-for-service systems 
has been established.13 An indica­
tion of the validity of our methodol­
ogy is the comparison of the length 
of hospital stay in the study and 
control groups (9.8 versus 8.1 days 
respectively).
Abdominal hysterectomy for be­
nign or minimally invasive disease is 
a common operation that consti­
tutes a large portion of all major 
gynecologic surgery. Generally, the 
operation is safe. There is no cate­
gorical manifestation of physician 
concern after 81% of hysterecto­
mies (Table II).
The current death rate for ab­
dominal hysterectomy in Quebec, as 
noted in our study, is 1 in 1661
cases. In a comparable group of 
patients studied in 1965, the death 
rate after abdominal hysterectomy 
in a single institution was 1 in 1150 
cases.14 A recent study of Danish 
national figures reported 1 death in 
739 cases.15 Multicentre reports of 
the mortality of hysterectomy may 
not have had selective inclusion 
criteria. The small subset, 8%, of 
hysterectomies in pregnant patients 
and those with cancer were associ­
ated with 61% of the hysterectomy- 
related deaths.9 Patients with local­
ized malignant disease were includ­
ed in our study. The minimal extent 
of disease and operation was such 
that the overall aim of the study 
was unaffected.
This study showed that much of 
the morbidity after abdominal hys­
terectomy related to medical rather 
than to surgical disability. A num­
ber of patients who underwent ab­
dominal hysterectomy became 
acutely ill in the early postoperative 
period. On 119 occasions investiga­
tion or management was carried out 
in the intensive care unit. Almost all 
of the 303 (9%) patients who had a 
consultation were referred to medi­
cal rather than to surgical special­
ists. Because only postoperative 
consultations were considered, the 
number of consultations is under­
stated. Usually a medical consulta­
tion for pre-existing disease is car­
ried out before surgery. The non- 
surgical risk of operation has been 
documented in other instances. 
Mangano and colleagues16 showed 
that adverse cardiac events are par­
ticularly likely to occur in the peri­
operative period. Most deaths (81%) 
that follow hysterectomy are due to 
medical disease; only 11% are 
caused by surgical complications.15
There is indirect evidence that a 
number of patients had a fever 
postoperatively. Postoperative ul­
trasonography of the pelvis or ab­
domen for possible abscess or he­
matoma was commonly performed
(138 [4.2%] of our patients). Surgi­
cal operation to drain an abscess 
was done 10 times, and infection 
may have been responsible for a 
number of the 11 postoperative 
laparotomies. In all probability the 
single colpotomy was related to a 
pelvic infection.
Intraoperative complications of 
abdominal hysterectomy are few. 
The safety of the operation is not 
strongly influenced by the operat­
ing surgeon (Table III). We were 
able to show a reduction in the 
relative risk of the operation if the 
number of hysterectomies the sur­
geon performed in the 3-month pe­
riod was neither excessively small 
nor large. Nongynecologists per­
formed a relatively small number of 
the hysterectomies, and their effect 
on postoperative morbidity has not 
been determined.
The size of the hospital in which 
abdominal hysterectomy is per­
formed is important. There was a 
significant increase in morbidity if 
the operation was performed in a 
200- to 400-bed hospital (RR = 
1.42) (Table IV). There was an 
equally significant decrease in mor­
bidity when the operation was done 
in a large hospital (RR = 0.71). The 
RR was not increased in teaching 
hospitals.
The most important predictor of 
postoperative morbidity is pre-exist­
ing disease. The described increases 
that occur in 200- to 400-bed hos­
pitals must be compared with those 
resulting from pre-existing disease. 
Heart disease was six times as im­
portant (RR = 9.49 versus 1.42); 
hypertension (RR = 2.66) was com­
parable; cancer, as an indication for 
hysterectomy, caused postoperative 
morbidity to more than double (RR 
= 2.31). It is of interest that when 
the indications for hysterectomy 
and for any concurrent medical dis­
ease were controlled, age was no 
longer a risk factor for postopera­
tive medical intervention. (Table V).
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Conclusions
The major morbidity of abdomi­
nal hysterectomy relates to postop­
erative medical complications. The 
operating surgeon and the place of 
surgery are less important predic­
tors of morbidity than pre-existing 
patient disease.
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SESAP VII Critique /  Critique SESAP VII
Items 309 to 313
Heparin and warfarin are anticoagulants used extensively in the management of patients with deep vein 
thrombosis (DVT). Both are used for prophylaxis of DVT. Heparin for prophylaxis is usually administered 
subcutaneously. Warfarin is probably the most effective form of pharmacologic prophylaxis in patients at high 
risk for DVT. Heparin has a rapid onset of action and short half-life (60 -90  minutes), whereas warfarin has a 
slow onset and long half-life (96 hours).
Warfarin should not be used as the sole agent to initiate anticoagulation for a patient with recently proven 
DVT because of the delay in achieving therapeutic anticoagulation. Warfarin inhibits the production of vitamin 
K dependent clotting factors (VII, IX, X, and II). The effects of warfarin can be reversed by administration o f 
vitamin K, but this effect is not rapid. The adequacy of warfarin anticoagulation can be monitored by 
measurement of the prothrombin time (PT) or more recently by the international normalized ratio (INR), which 
minimizes laboratory variability by using a ratio of the patient’s time to a laboratory standard rather than a 
patient population. Heparin’s effect is measured by determination of the partial thromboplastin time (PTT). 
Neither functions directly as a thrombolytic agent, but merely prevent propagation of established thrombi.
3 0 9 0  3 1 0 0  311[b] 3 1 2 0  3 1 3 0
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VASOTEC
(enalapril maleate, Frosst Std.) 
Tablets 2.5, 5,10, 20 mg"VASOTEC■ m i
(enalaprilat)
1.25 mg/mL
Angiotensin Converting Enzyme Inhibitor
INDICATIONS AND CLINICAL USE
VASOTEC® is indica ted in the trea tm ent of 
essential or renovascular hypertension; usually 
adm inistered in association with other drugs, 
particularly thiazide diuretics. Consider the risk of 
angioedema (see WARNINGS). Normally used 
when a diuretic or beta-blocker was ineffective or 
associated with unacceptable adverse effects. 
Can also be tried as initial agent where a diuretic 
and/or beta-blocker is contraindicated or could 
cause serious adverse effects.
Oral enalapril is also indicated in the treatment of 
congestive heart failure, as adjunctive therapy in 
patients not responding adequately to digitalis and 
diuretics.
Use of ACE inhibitors during the second and 
third trimesters of pregnancy can cause injury 
or death of a developing fetus. When pregnancy 
is detected, discontinue VASOTEC® as soon as 
possible (see WARNINGS; Use in Pregnancy).
VASOTEC® I.V. (enalaprilat) is an active meta­
bolite of enalapril; the onset of action after admin­
istration occurs within 15 minutes, with the maximum 
effect within 1 to 4 hours.
VASOTEC® I.V. is indicated for the treatment of 
hypertension when oral therapy is not practical. 
VASOTEC® I.V. has been studied with only one 
other antihypertensive agent, furosemide, which 
showed additive effects on blood pressure. Due to 
insufficient experience in the treatment of acceler­
ated or malignant hypertension, VASOTEC® I.V. is 
no t recom m ended in such s itu a tio n s  (see 
DOSAGE and ADMINISTRATION).
CONTRAINDICATIONS
Hypersensitiv ity to any component; history of 
angioneurotic edema related to ACE inhib itor 
therapy.
WARNINGS
Angioedema, with laryngeal edema and/or shock, 
have been reported and may be fatal. In such 
cases, discontinue drug promptly and observe 
patient until swelling subsides. Swelling confined 
to  the face, lips, and mouth usually resolves 
without treatment, although antihistamines may be 
useful in relieving symptoms. However, where 
there is involvement of the tongue, glottis and 
larynx, likely to cause airway obstruction, prompt 
administration of subcutaneous adrenaline (0.5 mL 
1:1000) may be indicated. Patients with a history of 
angioedema, unrelated to ACE inhibitor use, may 
be at increased risk (see CONTRAINDICATIONS). 
Symptomatic hypotension has occurred, usually 
du ring  in itia l therapy or when the dose was 
increased, and is more likely in patients who are 
vo lu m e -d e p le te d . In pa tien ts  w ith severe 
congestive heart failure, excessive hypotension 
m ay be associated w ith  oliguria and/or p ro ­
gress ive  azotemia. For patients in whom the 
excessive hypotension could result in severe or 
fa ta l com p lica tion s , i.e . those w ith seve re  
co n g e s tive  heart fa ilu re , ischem ic heart or 
cerebrovascular disease -  start therapy under 
close medical supervision, usually in a hospital. 
Such patients should be followed closely for the 
potential fall in blood pressure during first two 
weeks of therapy or when enalapril or a diuretic is 
increased. If hypotension occurs, place patient in 
sup ine position and if needed, adm inister IV 
infusion of normal saline. A transient hypotensive 
response is not a contraindication to further doses 
of enalapril or enalaprilat.
®Trademark Merck & Co., Inc. 
Merck Frosst Canada Inc., R.U.
Neutropenia/agranulocytosis and bone marrow 
depression have been caused by ACE inhibitors. 
Current experience with enalapril shows incidence 
to be rare. Consider periodic monitoring of white 
blood cell counts in patients with collagen vascular 
disease and renal disease.
Use of ACE inhibitors in pregnancy can cause 
fetal and neonatal morbidity and mortality. When 
pregnancy is detected, discontinue VASOTEC® 
as soon as possible. Rarely, no alternatives to an 
ACE inhibitor will be found and mothers should be 
apprised to the potential hazards to the fetus. 
Ultrasound should be performed to assess fetal 
development, well-being and volume of amniotic 
fluid. If oligohydramnios is observed, discontinue 
VASOTEC® unless lifesaving for the mother. 
A non-stress test and/or a biophysical profiling 
may be appropriate however, if concerns persist, a 
contraction stress testing should be considered. 
Oligohydramnios may only appear after fetus has 
sustained irreversible injury.
Closely observe infants exposed in utero to ACE 
inhibitors for hypotension, oliguria and hyper­
ka lem ia, and in itia te  appropria te  corrective 
medical procedures.
Human Data: Exposure to ACE inhibitors during 
second and third trimesters has been associated 
with hypotension, neonatal skull hypoplasia, 
anuria, reversible or irreversible renal failure and 
death of the fetus. Oligohydramnios, associated 
with fetal limb contractures, craniofacial defor­
mation, and hypoplastic lung development also 
has been reported. Prematurity and patent ductus 
arteriosus also reported but unknown if due to 
ACE inhibitor use. It is not known whether expo­
sure limited to the first trimester can adversely 
affect fetal outcome.
PRECAUTIONS
Impaired renal function: Renal function should 
be assessed before initiating therapy with enalapril 
or enalaprilat. Patients with renal insufficiency may 
require reduced or less frequent doses, and their 
renal function must be monitored appropriately (see 
DOSAGE). Renal failure, which has been reported 
mainly in patients with severe congestive heart failure 
or underlying renal disease including renal artery 
stenosis, is usually reversible when treated promptly. 
Some hypertensive patients with no apparent 
renal disease have developed increases in BUN 
and creatin ine w hile on concurrent d iu re tic / 
enalapril therapy. Dosage reduction or discontin­
uation of one or both drugs may be required. 
Hyperkalemia: In clinical trials, hyperkalemia 
(>5.7 mmol/L) was observed in approximately 1% 
of hypertensive patients, and caused discontin­
uation of therapy in 0.28% of such patients. Risk 
factors for hyperkalemia development may include 
renal insufficiency, diabetes mellitus, and con­
comitant use of agents to treat hypokalemia (see 
ADVERSE REACTIONS).
Valvular Stenosis: Theoretically, patients with 
aortic stenosis, who do not develop as much 
afterload reduction, might be at risk o f  decreased 
coronary perfusion when treated with vasodilators. 
Surgery/Anaesthesia: During major surgery or 
anaesthesia with hypotensive agents, enalapril 
b locks angiotensin II formation secondary to 
compensatory renin release. Hypotension that 
develops due to this mechanism can be corrected 
by volume expansion.
Im paired liver function: Hepatitis, jaundice 
(hepatocellular and/or cholestatic),elevation of 
liver enzymes and/or serum bilirubin, which have 
occurred in patients with or without pre-existing 
liver abnormalities, were usually reversed on 
discontinuation of enalapril or enalaprilat. For any 
unexplained symptoms, particularly within the first 
months of treatment, a full set of liver function tests 
and other necessary investigations are recom­
mended. Consider discontinuation of enalapril or 
ena lap rila t when appropriate . Use enalapril 
or enalaprilat with particular caution in patients with 
pre-existing liver abnormalities. Obtain baseline 
liver function tests before in itiating drug and 
monitor response and metabolic effects closely. 
Cough: A dry, persistent cough has been report­
ed, which usually disappears after withdrawal or 
lowering the dose of enalapril or enalaprilat. 
Nursing mothers: Enalapril and enalaprilat are 
secre ted  in human m ilk  in tra ce  am ounts 
therefore, nursing should be interrupted.
Pediatric use: This use is not recommended 
because enalapril and enalaprilat have not been 
studied in children.
Hemodialysis patients: Anaphylactoid reactions 
have been reported with high-flux membranes (eg.
polyacrylonitrile [PAN]) and treated concomitantly 
w ith an ACE inhib itor. If symptoms such as 
nausea, abdominal cramps, burning, angioedema, 
shortness of breath and severe hypotension 
occur, stop dialysis immediately. The symptoms 
are not relieved by antihistamines and the use of a 
different type of dialysis membrane or class of 
antihypertensive agent should be considered. 
Drug Interactions
Hypotension - Patients on Diuretic Therapy:
Particu larly when diuretics recently initiated, 
patients occasionally experience hypotension 
after initiating therapy with enalapril or enalaprilat. 
To minimize the hypotensive effects, discontinue 
the diuretic or increase the salt intake prior to 
starting the drug. If the diuretic cannot be dis­
continued, patients should be placed under close 
medical supervision for at least one hour after the 
initial dose of enalaprilat (see WARNINGS).
Agents Increasing Serum Potassium: Since 
enalapril and enalaprilat decrease aldosterone 
production, elevation of serum potassium may 
occu r. D iu re tics  such as sp irono lac tone , 
triamterene or amiloride, or potassium supple­
ments should be given cautiously for documented 
hypokalem ia only and should be m onitored 
frequently. Potassium containing salt substitutes 
should be used with caution.
Agents Causing Renin Release: Diuretics, for 
example, augment the antihypertensive effect of 
enalapril and enalaprilat.
A gents A ffecting Sym pathetic A ctiv ity :
Ganglionic blocking agents or adrenergic neuron 
blocking agents, for example, may be used with 
caution. Beta-adrenergic blockers add some 
further antihypertensive effect to enalapril.
Lith ium  S alts : Lith ium  clearance may be 
reduced; therefore, monitor serum lithium levels 
carefully if they are administered.
ADVERSE REACTIONS
VASOTEC®: In controlled clinical trials involving 
2314 hypertensive patients and 363 heart failure 
patients, the most severe adverse reactions were: 
angioedema (0.2%), hypotension (2.3%) and renal 
fa ilu re  (5 cases). In hypertensive pa tients, 
hypotension occurred in 0.9% and syncope in 
0.5%, with a discontinuation rate of 0.1%. In heart 
failure patients, hypotension occurred in 4.4% and 
syncope in 0.8%, with a discontinuation rate of 
2.5%. The most frequent clinical adverse reactions 
in controlled clinical trials were: headache (4.8%), 
dizziness (4.6%) and fatigue (2.8%). Discontin­
uation of therapy was required in 6.0% of the 
2677 patients.
H y p e rte n s io n H e a r t  F a ilu r e
% %
(2 3 1 4  P a tie n ts ) (3 6 3  P a t ie n ts )
C A R D IO V A S C U L A R
Hypotension 0.9 4.4
Chest Pain 0.9 1.7
Palpitations 0.6 0.3
Myocardial Infarction,
Acute 0.2 0.6
Myocardial Infarction,
Recurrent — 0.3
G A S T R O IN T E S T IN A L
Nausea 1.4 1.1
Vomiting 0.8 1.7
Dysphagia 0.1 —
Diarrhea 1.4 3.0
Abdominal pain 0.7 1.4
R E N A L
Renal failure 0.1 0.6
Oliguria 1 case
Proteinuriat 0.1 —
D E R M A T O L O G IC
Rash 1.4 1.9
Pruritus 0.4 1.4
N E R V O U S  S Y S T E M
Headache 5.2 2.2
Dizziness 4.3 6.6
Insomnia 0.5 0.3
Nervousness 0.6
Somnolence 0.6 _
Paresthesia 0.6 —
A L L E R G IC
Cough 1.3 1.4
Angioedema 0.2 —
H E M A T O L O G IC
Anemia 0.1 _
Leukopenia 1 case —
M IS C E L L A N E O U S
Muscle cramps 0.6 0.3
Dyspnea 0.6 1.1
Hyperhidrosis 0.7 —
Impotence 0.4 0.3
Fatigue 3.0 1.4
Taste disturbance 0.4 0.3
t  Defined as >1g/24h or >0.5g/12h on two consecutive 
measurements, at least one month apart.
ABNORMAL LABORATORY FINDINGS 
Hyperkalemia: (see PRECAUTIONS).
Creatinine, Blood Urea Nitrogen: Increases were 
reported in about 20% of patients with renovascular 
hypertension and about 0.2% of patients with 
essential hypertension on enalapril alone. In­
creases, which usually were reversible upon 
discontinuation of enalapril or concomitant therapy, 
were reported in 9.7% of heart failure patients who 
were receiving diuretics and/or digitalis.
Hemoglobin and Hematocrit: Decreases (mean 
approximately 0.34 g% and 1.0 vol%, respectively) 
occurred frequently, but were rarely of clinical 
importance. In clinical trials, less than 0.1% of 
patients discontinued therapy due to anemia.
Hepatic: Elevations of liver enzymes and/or serum 
bilirubin have occurred (see PRECAUTIONS). 
ADVERSE REACTIONS REPORTED IN UN­
CONTROLLED TRIALS AND/OR MARKETING 
EXPERIENCE
With an incidence of 0.5 to 1%: Insomnia, im 
potence, renal dysfunction, renal failure and 
oliguria.
With an incidence < 0.5%:
Cardiovascular: Myocardial infarction or 
cerebrovascular accident, possibly secondary to 
excessive hypotension in high risk patients (see 
WARNINGS); cardiac arrest; pulmonary em­
bolism; rhythm disturbances; angina pectoris. 
Gastrointestinal: Anorexia; ileus; pancreatitis; 
dyspepsia; constipation. Hemopoeitic: Neutro­
penia; thrombocytopenia; bone marrow depres­
sion. Hepatic: Liver function abnormalities; 
hepatitis; jaundice (hepatocellular and/or 
cholestatic). Nervous System/Psychiatric: Vertigo; 
depression; confusion; ataxia. Respiratory: 
Bronchospasm/asthma; rhinorrhea. Other: Ery­
thema multiforme; exfoliative dermatitis; Stevens- 
Johnson syndrome; toxic epidermal necrosis; 
urticaria; photosensitivity; alopecia; flushing; tin­
nitus; hearing impairment; glossitis; blurred vision. 
A symptom complex has been reported which may 
include fever, serositis, vasculitis, myalgia, 
arthralgia/arthritis, a positive ANA, elevated 
erythrocyte sedimentation rate, eosinophilia and 
leukocytosis. Rash, photosensitivity or other 
dermatologic manifestations may occur. These 
symptoms have disappeared after discontinuation 
of therapy.
LABORATORY TEST FINDINGS: Hyponatremia
VASOTEC® I.V.: Since enalapril is converted to 
enalaprilat, those adverse reactions associated 
with VASOTEC® tablets might also be expected to 
occur with VASOTEC® I.V. The incidence of symp­
tomatic hypotension is 3.4% with VASOTEC® I.V. 
Other adverse experiences occurring in greater 
than 1% of patients were headache (2.9%) and 
nausea (1.1%). Adverse reactions occurring in 0.5 
to 1.0% of patients in controlled clinical trials 
include myocardial infarct, fatigue, dizziness, 
fever, rash and constipation.
SYMPTOMS AND TREATMENT 
OF OVERDOSAGE
Limited human data are available. The most likely 
manifestation of overdosage would be hypo­
tension, which can be treated by I.V. infusion of 
normal saline solution. Enalaprilat may be 
removed from the general circulation by 
hemodialysis.
DOSAGE AND ADMINISTRATION
VASOTEC®
FOR ORAL ADMINISTRATION ONLY
Dosage must be individualized. The absorption of 
enalapril maleate is not affected by food. 
HYPERTENSION
Initiation of enalapril requires consideration of 
extent of blood pressure elevation, salt restriction 
and recently used antihypertensive agents, the 
dosage of which may need to be adjusted.
The recommended initial dose of enalapril maleate 
in patients not on diuretics is 5 mg once a day. 
Adjust dosage according to blood pressure 
response; the usual range is 10 to 40 mg daily, in 
a single dose or divided in two doses. Some 
patients on once-daily dosage may have 
diminished antihypertensive effect toward the end 
of dosing interval and require an increase in 
dosage, or twice daily administration. If blood 
pressure is not controlled, a diuretic may be 
added. Raising the daily dose above 40 mg is not 
recommended because adverse reactions may be 
increased.
Occasionally symptomatic hypotension may occur 
following the initial dose, more likely in patients 
currently taking a diuretic. Therefore, if possible, 
discontinue the diuretic two to three days before 
initiating enalapril therapy (see WARNINGS). If 
the diuretic cannot be discontinued, use an initial 
dose of 2.5 mg.
In the absence of sufficient experience in the 
treatment of accelerated or malignant hyper­
tension, enalapril is not recommended in such 
situations.
Dosage in the Elderly (over 65 years): Start at 
2.5 mg daily. Some elderly patients may be more 
responsive than younger patients.
Dosage Adjustment in Renal Impairment: (see 
PRECAUTIONS - Hemodialysis patients)
Guidelines for reducing doses in hypertensive 
patients:
Renal Status
Creatinine
Clearance
mL/min(mL/s)
Initial Dose 
mg/day
Normal renal 
function
>80 mL/min 
(>1.33 mL/s)
5 mg
Mild impairment <80 >30 mLVmin 
(<1.33 >0.50 mL/s)
5 mg
Moderate to 
severe impairment
<30 mLVmin 
(<0.50 ml_/s)
2.5 mg
Dialysis patients — 2.5 mg on 
dialysis days*
Enalaprilat is dialysable. Dosage on nondialysis days 
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Late Anastomotic Laceration 
After Ileocolic Resection in Childhood
Craig A. Paterson, BSc(Hons), MD;* Jacob C. Langer, MD, FRCSC;* Gordon S. Cameron, MD, FRCSC;* 
Robert M. Issenman, MD, FRCPC;t Michael J. Marcaccio, MD, FRCSC*
Anastomotic ulcers are a rare late complication of ileocolic resection in children.
The authors describe the cases of two patients who presented 10 and 8 years, 
respectively, after ileocolic resection. Both had suffered from iron-deficiency anemia 
caused by an anastomotic ulcer. In one patient the anemia improved after resection 
of the ulcer; in the second patient cholestyramine and a lactose-free diet resolved the 
problems of anemia and diarrhea. Anastomotic ulceration should be suspected in any 
child who has undergone an ileocolic anastomosis and subsequently presents with 
persistent iron-deficiency anemia and occult blood in the stool.
L’ulcere anastomotique est une complication rare de la resection ileocolique chez 
l’enfant. Les auteurs decrivent les cas de deux patients qui ont ete vus, 
respectivement 10 et 8 ans apres une resection ileocolique. Les deux avaient souffert 
d’une anemie ferriprive causee par un ulcere anastomotique. Chez un patient, 
l’anemie s ’est amelioree apres resection de Tulcere; chez le second, un regime sans 
lactose et sans cholestyramine est venu a bout des problemes d’anemie et de 
diarrhee. L’ulceration anastomotique doit etre soupfonnee chez l’enfant qui a subi 
une anastomose ileocolique et qui presente par la suite une anemie ferriprive 
persistante et des traces de sang dans les selles.
I leocolic resection during child­hood may be required for a num­
ber of conditions, including necro­
tizing enterocolitis, volvulus, intus­
susception and inflammatory bowel 
disease. Complications associated 
with ileocolic resection, especially 
when accompanied by massive 
small-bowel resection, include diffi­
culty maintaining adequate nutri­
tion, diarrhea and vitamin B12 defi­
ciency.1’2 Chronic anastomotic ul­
cers have been described after 
bowel resection in adults, although 
the cause is unclear.3’4 We have
identified two cases of children who 
had anastomotic ulcers after ileocol­
ic resection. The ulcers developed 
many years after the initial surgical 
procedure.
Case Reports
Case 1
A 3-year-old boy was seen in 
December 1977 with a 16-hour his­
tory of vomiting and abdominal 
pain. Investigations revealed a mid­
gut volvulus. A Ladd procedure for 
incomplete rotation with obstruc­
tion of the duodenum by congenital 
bands was necessary together with 
resection of the gangrenous por­
tions of the terminal ileum and 
right colon. The Ladd procedure 
consists of division of the bands 
between the duodenum, proximal 
colon and lateral abdominal wall 
with subsequent appendectomy and 
placement of the cecum in the left 
lower abdominal quadrant and the 
duodenum in the right lateral por­
tion of the abdomen. The mid-ileum 
was anastomosed to the transverse 
colon with a continuous inner layer 
of 4-0 chromic catgut and a sero­
muscular layer of interrupted 4-0 
silk. One week later a further 
46-cm segment of small bowel was 
resected because of gangrene. Over 
the next 9 years the patient did 
well, exhibiting normal growth and 
energy.
In April 1987, the boy was seen 
in the emergency department with 
acute alcohol intoxication. Routine 
investigations revealed microcytic 
anemia (hemoglobin level 83 g/L). 
Serum levels of vitamin B12 and 
folate were normal. He gave no 
history of melena or hematochezia, 
abdominal pain, nosebleeds, lethar­
gy, illicit drug ingestion or previous 
drunken episodes. Findings on rec­
tal examination were normal, and 
there were no fissures. Ferrous sul­
fate therapy (300 mg three times 
daily) was started.
By July 1987, the boy’s hemoglo-
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bin level had increased to 107 g/L. 
Colonoscopy revealed an ulcer, 1 
cm in dimension, at the site of his 
previous ileocolic anastomosis. Sev­
eral biopsies showed ulceration and 
a bed of granulation tissue with 
edema and mild inflammation in 
adjacent mucosal tissue. Sucralfate 
(1 g orally, four times daily) and 
ferrous sulfate (900 mg once a day) 
therapy was started.
On this regimen the hemoglobin 
level was kept in the range of 100 
to 110 g/L. The sucralfate was 
discontinued in the summer of 
1989 and the iron supplement in 
the fall of 1989, after which time 
the boy noticed increasing fatigue. 
A decision was made to resect the 
area of the anastomosis in August 
1990. At operation, an ulcer 1 cm 
in size was found on the small-bow­
el side of the anastomosis. Histolog­
ic examination revealed chronic in­
flammation of the lamina propria in 
several small fragments with no 
suture material seen and no evi­
dence of dysplasia or malignancy.
After resection of the ulcer, the 
patient’s iron-deficiency anemia im­
proved greatly. As of March 1991 
his hemoglobin level was 124 g/L  
and the serum ferritin level was 28 
mg/L, without the use of supple­
ments. Loose stools were not a 
problem.
Case 2
An infant girl was born in Febru­
ary 1977, at 27 weeks’ gestational 
age, after premature onset of deliv­
ery and prolonged rupture of mem­
branes. Apgar scores were 2 at 1 
minute and 5 at 5 minutes. On the 
2nd day of life, necrotizing entero­
colitis developed with perforation of 
the ileum 20 cm proximal to the 
ileocecal junction. An ileal resection 
and ileostomy were performed. Dur­
ing her hospital stay the baby was 
treated for iron-deficiency anemia 
and was investigated for malabsorp­
tion. She was discharged home in 
June 1977.
The baby was readmitted in July 
1977 for failure to thrive and exces­
sive ileostomy output for which she 
was started on cholestyramine and 
hyperalimentation through a central 
line. This management resulted in 
considerable gains in weight and 
linear growth. In November 1977 
she underwent further resection of 
the cecum, appendix and proximal 
ascending colon with end-to-end 
anastomosis between the ileum and 
ascending colon. A continuous 
inner layer of 5-0 chromic catgut 
and an interrupted outer layer of 
5-0 silk were used. Histologic sec­
tions showed normal bowel at both 
resection margins. An additional je­
junal mucosal biopsy showed ab­
normal villous architecture.
Subsequently this girl had prob­
lems with recurrent bouts of diar­
rhea and anemia. Investigation of 
her anemia in 1985 revealed a 
serum ferritin level greater than 10 
Mg/L, a hemoglobin level of 85 
g /L  and an erythrocyte protopor­
phyrin level of 0.9 Mmol/L, indica­
tive of iron-deficiency anemia. Fer­
rous gluconate, 300 mg twice daily, 
was given to reverse the anemia.
In 1986 her stool tested positive 
for occult blood. Colonoscopy 
showed an ulcer, measuring 1 cm in 
diameter, at the site of the ileocolic 
anastomosis. Biopsies of this area 
showed small-bowel mucosa and in­
flammatory granulation tissue con­
sistent with a healing ulcer. There 
was no evidence of Crohn’s disease. 
She was started on a therapeutic 
trial of sucralfate, 1 g four times 
daily, which was later discontinued.
In December 1988, she was ad­
mitted for investigation of worsen­
ing diarrhea. Repeat colonoscopy 
showed the ulcer to be more super­
ficial than before. Further investiga­
tions showed normal fecal fat con­
tent and a positive lactose hydrogen 
breath test. A lactose-free diet was
prescribed and she was started on 
cholestyramine.
With the use of intermittent iron 
supplements her hemoglobin level 
has remained within the normal 
reference range. Routine investiga­
tions in November 1991 demon­
strated a hemoglobin level of 146 
g /L  and a serum ferritin level of 15 
^g /L . Although cholestyramine 
was discontinued, she remained on 
a lactose-free diet and had no fur­
ther problems with diarrhea. She 
did not undergo repeat colonoscopy 
and no occult blood was found in 
her stool.
Discussion
Anastomotic ulcers in adults have 
been well described.23'5 However, 
we could not find any systematic 
colonoscopy studies in adults on 
the frequency of ulceration after 
ileocolic anastomosis. The only re­
port of late-presenting anastomotic 
ulcers in children was that by 
Parashor and colleagues,26 who de­
scribed four patients at the Bir­
mingham Children’s Hospital over 
15 years. The age of the children at 
the time of anastomosis in their 
study ranged from 2 days to 4 
months. The age at the time ulcer­
ation was diagnosed ranged from 4 
to 13 years (mean 9.9 years) from 
the time of the original operation. 
All four children had the triad of 
iron-deficiency anemia, severe loose 
stools and occult blood in the 
stools. The diagnoses were con­
firmed by colonoscopy. Contrast 
studies with barium were negative 
in all four cases.
The time delay between ileocolic 
resection and diagnosis of the ulcer 
was similar in our two patients and 
in those from the Birmingham 
group. One of our patients had the 
triad of symptoms described by 
Parashor and colleagues, and the 
other had iron-deficiency anemia
CJS, VOL. 36, NO. 2, APRIL 1993 163
PATERSON ET AL
and fecal occult blood without loose 
stools. Both diagnoses were made 
by colonoscopy. Neither gastrosco­
py nor upper gastrointestinal series 
was performed. These tests are use­
ful in detecting proximal ulcers, 
known to occur after massive bowel 
resection, as the cause of occult 
bleeding.7
The reason for anastomotic ulcer­
ation remains unclear. One explana­
tion is that the anastomosis out­
grows an already compromised vas­
cular supply. This might explain 
the delay between the ileocolic re­
section and the diagnosis of ulcer­
ation. However, there was no histo­
logic evidence of ischemia in either 
of our patients. Another explana­
tion may be related to bile acid 
malabsorption and loss of the 
ileocecal valve, leading to bacterial 
overgrowth, with the bile acids act­
ing in an area of compromised 
mucosal defence. This would sup­
port the use of binding resins in the 
management of these patients. Both 
of the patients we have described 
were treated with cholestyramine, 
and although one eventually re­
quired surgical intervention, the 
other had improvement in the ap­
pearance of the ulcer at repeat 
colonoscopy. A third explanation 
may be peptic ulceration due to the 
hypergastrinemia often seen after 
extensive small-bowel resection.7 
However, even if hyperacidity had 
been present, it is difficult to ex­
plain why the ulcers formed at the 
previous anastomosis. Finally, no­
nabsorbable suture material may 
play a role in some cases by provid­
ing a nidus for ongoing chronic 
inflammation.
The management of the patient 
with an anastomotic ulcer remains 
controversial. Iron supplements 
may initially provide symptomatic 
benefit. Binding resins may play a 
role, especially in patients with diar­
rhea or bacterial overgrowth. Su­
cralfate may also help in healing the
ulcer. The greatest challenge re­
mains the diagnosis. An anastomot­
ic ulcer should be suspected in any 
child who has undergone ileocolic 
anastomosis and presents with per­
sistent iron-deficiency anemia and 
occult blood in the stool.
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A n  Unusual Intraoperative Complication 
of Stapled Colorectal Anastomosis: Report 
of a Case and Review of the Literature
Vitaly Bard, BA;* Zane Cohen, MD, FRCSC; Theodore Ross, MD, FRCSC
The unusual intraoperative complication of inadvertent formation of a stapled 
colovaginal anastomosis is described in a 61-year-old woman with diverticular 
disease. Intraoperative complications of linear staplers, linear cutters and circular 
end-to-end anastomotic staplers are reviewed, as are methods of prevention and 
management of such complications. The discussion focuses mainly on the 
complications that may arise in low anterior resection. They are more likely due to 
operator error than to instrument failure.
On decrit une complication peroperatoire inhabituelle, la formation par inadvertance 
d’une anastomose colovaginale brochee chez une patiente de 61 ans souffrant de 
diverticulite. Les complications peroperatoires des brocheuses lineaires, des ciseaux 
lineaires et des brocheuses circulaires pour les anastomoses bout-a-bout sont 
passees en revue, de meme que les methodes de prevention et le traitement de ces 
complications. Le commentaire porte principalement sur les complications pouvant 
survenir lors d’une resection anterieure basse. Elies sont dues, plus souvent, a une 
erreur du chirurgien qu’a un defaut de l’instrument.
A nastomotic devices were first used to perform intestinal 
anastomoses more than 100 years 
ago. In 1892, Murphy1 used a com­
pression button to perform circular 
anastomoses between various parts 
of the gastrointestinal tract. Since 
then, interest in stapling devices 
has flourished. The use of circular 
end-to-end anastomotic staplers has 
become widely accepted, particular­
ly when low rectal anastomosis is 
desired.2’3 However, the optimal use 
of an anastomotic stapler requires a 
high level of skill and familiarity
with the instrument,4 as well as 
strict attention to technical detail.5
Most of the literature deals with 
the common postoperative compli­
cations of anastomotic leaks and 
strictures.6 Intraoperative complica­
tions of stapled anastomoses in­
clude anastomotic leaks (including 
incomplete resection rings or 
doughnuts), damage to tissues 
when using too large an instru­
ment, inability to remove the instru­
ment without destroying the anas­
tomosis and technical failure of sta­
pling (operator or instrument).
In this paper we describe a 
unique intraoperative complication, 
and discuss the management of in­
traoperative problems and their pos­
sible prevention.
Case Report
A 61-year-old woman presented 
with acute diverticulitis. A divertic­
ular abscess adherent to the vagina 
and a colovaginal fistula were 
found. She had had a hysterectomy.
This woman was treated conser­
vatively for 8 days, but because her 
symptoms persisted, a Hartmann 
procedure with end colostomy was 
performed. The rectum was stapled 
closed. Five months later the colos­
tomy was closed and a reconstruc­
tive procedure was undertaken with 
use of the end-to-end anastomotic 
stapler. At the time o f surgery, the 
anastomosis was noted to be very 
low. The integrity of the anastomo­
sis was tested with a sigmoido­
scope, and there was no evidence of 
an air leak. Postoperatively, the 
patient passed all flatus and stool 
per vagina. A recurrent colovaginal 
fistula was suspected, so she was 
put on an elemental diet and antibi­
otics.
The complexity of the compli­
cation resulted in transfer o f the 
patient to another hospital for fur­
ther investigation. A contrast 
enema demonstrated a blind rectal 
remnant (Fig. 1), and a contrast 
film of the vagina showed contrast
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medium flowing freely into the 
colon through a stapled anastomo­
sis (Fig. 2). A diagnosis of inadver­
tent colovaginal anastomosis was 
made. One week later a defunction­
ing transverse loop colostomy was 
performed. Examination under an­
esthesia confirmed the stapled colo­
vaginal anastomosis.
Two months later the patient was 
readmitted for reconstruction. In- 
traoperatively a colovaginal stapled 
end-to-end anastomosis was identi­
fied. It was taken down and the 
distal colon was anastomosed to the 
rectal remnant, again with a circu­
lar stapler. A drain was placed 
through the opened vaginal vault. 
There were no intraoperative or 
postoperative complications, and 3 
months later the colostomy was 
closed without complication.
Discussion
Since the late 1950s when the 
use of mechanical suture instru­
ments was first described in the
Soviet Union, several types of pre- 
loaded, prepackaged, reusable and 
disposable instruments have been 
developed and are currently widely 
accepted instruments in surgical 
practice. Notably, these are the lin­
ear stapler, the linear anastomotic 
instrument with knife and the circu­
lar end-to-end anastomosis instru­
ment. Each instrument has its own 
characteristic potential for malfunc­
tion or misuse.
Briefly, the linear stapler is asso­
ciated with the following potential 
errors: (a) failure to lock the safety 
on the instrument, which can result 
in premature firing; (b) failure to 
fire the staples, leaving the bowel 
open after the stapler is removed; 
(c) failure to include 360° full 
thickness of bowel within the staple 
line; (d) transection of the bowel on 
the patient’s side of the instrument 
after firing; (e) removal of the in­
strument before the bowel is tran­
sected. Division of bowel must al­
ways be done along the edge of the 
instrument before its removal; and 
(f) improper reloading of cartridges.
The linear anastomotic instru­
ment with knife has its own set 
of potential complications: (a) im­
proper reloading of cartridges; 
(b) improper mating of the instru­
ment halves; and (c) tearing of 
bowel due to excessive separation 
of the instrument halves as the 
stapler is removed.7
The term “instrument failure” is 
occasionally cited as the cause of an 
intraoperative complication. In the 
past, it has included incomplete 
loading of the instrument with sta­
ples, use of faulty cartridges and 
the absence of knives or Teflon 
rings.4-8"13 The current use of pre­
packaged and preloaded instru­
ments often removes this responsi­
bility from the surgeon. Neverthe­
less, the surgeon should inspect 
every instrument for proper assem­
bly and check the cartridge and 
head before firing.14 Although it 
may be tempting to ascribe anasto­
motic failure to instrument mal­
function, the majority of mishaps 
are the result of operator error.7
The circular end-to-end anasto­
motic stapler is susceptible to a 
unique set of operator-induced com­
plications. This is true particularly 
for low anterior resection in which 
visualization of the anastomosis is
FIG. 2. Injection of water-soluble con­
trast via Foley catheter into vagina. 
Contrast flows freely from vagina into 
colon. Rectum is not visualized.
FIG. 1. Water-soluble contrast enema. There is complete obstruction to flow of 
contrast, outlining blind rectal remnant. Air is seen in vagina (arrow).
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often difficult. There have been few 
reports that deal specifically with 
intraoperative complications of low 
anterior resection when the circular 
end-to-end anastomotic stapler is 
used. Thus, we shall focus on this 
topic using a compilation from pub­
lished reports of results.
In an attempt to avoid the occur­
rence of stenosis at the anastomotic 
site, the largest possible instrument 
size is used.3 Use of an instrument 
so large that the bowel lumen has 
difficulty in accommodating it can 
lead to damage of the bowel wall 
(splitting, tearing and devasculari­
zation) , 2'9-12-15'16 necessitating manu­
al repair of the defect and possibly a 
covering ileostomy or colostomy. 
Perforation of the rectal remnant by 
the passage of the stapler has also 
been reported. 15 However, this com­
plication should be minimal now 
that the instrument is passed with­
out the shaft being exposed. It is 
suggested that sizers be used to 
assess the maximal size of instru­
ment that the bowel lumen can 
accept, 7 and it is important not to 
use the sizers as dilators. Adminis­
tration of glucagon and hyoscine 
butylbromide encourage intestinal 
relaxation in order to accommodate 
the anvil.
Several reports have described 
the occasional difficulty in extract­
ing the stapler or the anvil without 
disrupting the anastomosis.9'12-15' 18 
Others have described failure of the 
blade within the instrument to sepa­
rate the resection rings completely. 
This may lead to tearing of the 
rectum upon withdrawal.9'11'1649 
These problems may share a similar 
etiology. Incomplete firing of the 
instrument or even a faulty gap 
setting can drive the staples partial­
ly into the anastomosis with incom­
plete excision of the lumina by the 
circular knife, resulting in failure of 
the instrument to disengage. The 
proper gap setting is ensured by 
watching the appropriate vernier
marks, and a particularly firm 
squeeze of the instrument handles 
may protect against incomplete sta­
ple penetration.7 Normally, gentle 
vertical, circular or side-to-side 
movement allows the instrument to 
be removed without complication. 20 
However, when there is difficulty, a 
colotomy may have to be performed 
to extract the anvil before removing 
the instrument and cartridge. Anas­
tomotic failure due to premature 
firing of the instrument has also 
been reported.8
The most commonly reported in­
traoperative complication of circular 
end-to-end anastomosis is an anas­
tomotic leak, either seen or suspect­
ed because of incomplete resection 
rings (doughnuts) . 2,3'510'12'15-17'19 
Withdrawal of the instrument be­
fore it has been completely re­
opened pulls on the anastomosis 
and may cause leakage. Leaks can 
also result from insufficient tighten­
ing or inadequate placement of the 
pursestring suture around the anvil, 
allowing portions of bowel wall to 
escape capture by the ring of 
staples and circular knife.7 Anasto­
motic leakage is more likely in low 
anterior resection, because place­
ment of the distal pursestring su­
ture and the tying down of the 
rectal remnant around the instru­
ment shaft can be both difficult and 
time consuming. The double sta­
pling technique can avoid both the 
placement of the distal pursestring 
suture and difficulty in approximat­
ing two ends of bowel of disparate 
sizes.
Several methods of testing the 
integrity of the anastomosis have 
been used. A solution such as Beta- 
dine can be instilled into the rectum 
per anus. The pelvis can be filled 
with saline and the proximally 
clamped rectum insufflated with air 
to inspect for bubbling. Air can be 
introduced into the rectum through 
a Foley catheter or a sigmoido­
scope; however, caution must be
exercised in insufflating a Foley 
catheter balloon against a newly 
created anastomosis and in insert­
ing a sigmoidoscope for the same 
reason. A sigmoidoscope has the 
advantage of allowing intraluminal 
visualization of the anastomosis for 
bleeding or disruption. Intraopera­
tive testing with air insufflation was 
found to be useful in reducing 
postoperative leakage by allowing 
the detection and repair of defects 
in the anastomosis. 21 However, this 
method does not guarantee freedom 
from postoperative leakage, particu­
larly in low anastomoses. 22
The case presented in this paper 
undeniably fits into the category of 
operator error since the stapler was 
inserted inappropriately into the va­
gina, and a colovaginal anastomosis 
was fashioned inadvertently. Per­
haps the presence of a colovaginal 
fistula preoperatively made the sur­
gical team less suspicious of an 
intraoperative mistake in the early 
postoperative period.
Circular end-to-end anastomoses 
have certain advantages over hand- 
sewn anastomoses, notably savings 
in time and the ability to do proce­
dures deep in the pelvis with great­
er ease. It has been stated that 
successful use of the anastomotic 
stapler with low anterior sigmoid 
resections requires strict attention 
to technical detail5 and that there is 
increased risk of intraoperative 
complications that are not apparent 
with the traditional hand-sewn tech­
nique. 18 In this case, the extensive 
draping of the perineum may make 
the incautious surgeon confuse the 
anatomy. Sometimes, less experi­
enced housestaff may make similar 
mistakes only to be corrected by the 
senior surgeon who checks the po­
sition of the instrument before fir­
ing. The relative difficulty in the 
visualization of the low anastomosis 
necessitates extra caution. It has 
been noted that rapid and reliable 
techniques of stapling are decep-
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tively difficult to master and require 
extensive experience to develop pro­
ficiency.23
Conclusions
The problems encountered in the 
use of stapling instruments are 
more often caused by the operator 
error than by instrument failure. In 
the case presented here the opera­
tor mistook the anatomy, resulting 
in a technically intact anastomosis 
in the wrong location.
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Introducing a new solution for antibacterial therapy
THE FIRST AND ONLY I.V. FLU0R00UIN0L0NE
▼ Broad spectrum coverage*1 
for the treatm ent of 
nosocomial infections
• Excellent gram 
negative coverage
• Provides gram 
positive activity
▼ Indicated for a wide range 
of difficult infections1
• Respiratory tract
• Skin or skin structure
• Septicemia
• Urinary tract
• Bone
▼ Additional benefits for use 
in combination regimens1
• Excellent safety profile
• Antimicrobial streamlining- 
Cipro I.V. to Cipro oral
• Cost effective2
| PAAB | In vitro activity does not necessarily imply a correlation with in vivo results.
P R E S C R I B I N G N F O R M A T O N
C I P R O
C I P R O ®
CIPROFLOXACIN HYDROCHLORIDE 
• XI. CIPROFLOXACIN INJECTION
THERAPEUTIC CLASSIFICATION 
THERAPEUTIC CLASSIFICATION
ANTIBACTERIAL AGENT 
ANTIBACTERIAL AGENT
ACTIONS
Ciprofloxacin, a synthetic fluoroquinolone, has a bactericidal mode of action. This action is achieved through inhibition of DNA 
gyrase, an essential component of the bacterial DNA replication system. Inhibition of the alpha subunit of the DNA gyrase blocks 
the resealing of the nicks on the DNA strands induced by this alpha.subunit, leading to the degradation of the DNA by 
exonucleases. This bactericidal activity persists not only during the multiplication phase, but also during the resting phase of the 
bacterium.
Ciprofloxacin retained some of its bactericidal activity after inhibition of RNA and protein synthesis by rifampin and 
chloramphenicol, respectively. These observations suggest ciprofloxacin may possess two bactericidal mechanisms, one 
mechanism resulting from the inhibition of DNA gyrase and a second mechanism which may be independent of RNA and protein 
synthesis.
INDICATIONS AND CLINICAL USES 
A) Oral Administration
CIPRO® (Ciprofloxacin hydrochloride tablets) may be indicated for the treatment of patients with the following infections caused 
by susceptible strains of the indicated microorganisms:
Respiratory Tract Infections: Acute bronchitis and acute pneumonia caused by: £  cloacae, E coli, H. influenzae, K. pneumoniae,
P. mirabilis, P. aeruginosa, S. aureus, S. pneumoniae
Due to the nature of the underlying conditions which usually predispose patients to Pseudomonas infections of the respiratory 
tract, bacterial eradications may not be achieved in patients who display clinical improvement despite evidence of in vitro 
sensitivity. In patients requiring subsequent courses of therapy, CIPRO® should be used alternately with other antipseudomonal 
agents. Some strains of Pseudomonas aeruginosa may develop resistance during treatment. Therefore, susceptibility testing 
should be performed periodically during therapy to detect the emergence of bacterial resistance.
Urinary Tract Infections: Upper and lower urinary tract infections, such as complicated and uncomplicated cystitis, pyelonephritis, 
and pyelitis, caused by: C. diversus, C. freundii, E. cloacae, E. coli, K. pneumoniae, K. oxytoca, M. morganii, P. mirabilis,
P. aeruginosa, S. marcescens, S. aureus, S. epidermidis, S. faecalis
Skin and Soft Tissue Infections: caused by: E. cloacae, E. coli, K. pneumoniae, P. vulgaris, P. mirabilis, S. pyogenes, P. aeruginosa, 
S. aureus, S. epidermidis
Bon * and Joint Infections: caused by: S. marcescens, P. aeruginosa, S. aureus, E. cloacae
Infectious Diarrhea: (When antibacterial therapy is indicated) caused by: £  coli [enterotoxigenic strains), C. jejuni, S. flexnen,
S. sonnei
B) Intravenous Administration
CIPRO® I.V. (Ciprofloxacin injection) may be indicated for the treatment of patients with the following infections caused by 
susceptible strains of the indicated microorganisms:
Respiratory Tract Infections: acute pneumonia caused by: £  coli, K. pneumoniae, E. cloacae, P. mirabilis, P. aeruginosa,
H. influenzae, H. parainfluenzae, S. pneumoniae
Due to the nature of the underlying conditions which usually predispose patients to Pseudomonas infections of the respiratory 
tract, bacterial eradications may not be achieved in patients who display clinical improvement despite evidence of in vitro 
sensitivity. In patients requiring subsequent courses of therapy, CIPRO® should be used alternately with other antipseudomonal 
agents. Some strains of Pseudomonas aeruginosa may develop resistance during treatment. Therefore, susceptibility testing 
should be performed periodically during therapy to detect the emergence of bacterial resistance.
Urinary Tract Infections: Upper and lower complicated urinary tract infections including pyelonephritis caused by: C. diversus,
E coli, K. pneumoniae, P. mirabilis, P. aeruginosa
Skin or Skin Structure Infections: caused by: £  cloacae, E. coli, K. pneumoniae, M. morganii, P. vulgaris, P. mirabilis,
P. aeruginosa, S. aureus, S. pyogenes 
Septicemia: caused by: £  coli, S. typhi 
Bone: caused by: £  cloacae, P. aeruginosa
Appropriate culture and susceptibility tests should be performed prior to initiating treatment in order to isolate and identify 
organisms causing the infection and to determine their susceptibilities to ciprofloxacin. Therapy with CIPRO® and CIPRO® I.V. 
may be initiated before results of these tests are known. However, modification of this treatment may be required once results 
become available or if there is no clinical improvement. Culture and susceptibility testing performed periodically during therapy 
will provide information on the possible emergence of bacterial resistance. If anerobic organisms are suspected to be contibuting 
to the infection, appropriate therapy should be administered.
CONTRAINDICATIONS
CIPRO® (ciprofloxacin hydrochloride tablets) and CIPRO® I.V. (ciprofloxacin injection) are contraindicated in patients who have 
shown hypersensitivity to ciprofloxacin or other quinolone antibacterial agents.
WARNINGS
Children The safety of CIPRO® and CIPRO® I.V. (ciprofloxacin hydrochloride tablets and ciprofloxacin injection) in children has not 
yet been established. Damage to juvenile weight-bearing joints and lameness were observed both in rat and dog studies but not 
in weaned piglets (see TOXICOLOGY in Product Monograph). Histopathological examination of the weight-bearing joints in 
immature dogs revealed permanent lesions of the cartilage. Consequently, CIPRO® and CIPRO® I.V. should not be used in 
prepubertal patients. Experience in pubertal patients below 18 years of age is limited.
Pregnancy The safety of CIPRO® and CIPRO® I.V. in the treatment of infections in pregnant women has not yet been established 
(see PRECAUTIONS).
PRECAUTIONS
General Anaphylactic reactions including cardiovascular collapse have occurred rarely in patients receiving therapy with CIPRO® 
and CIPRO® I.V. (ciprofloxacin hydrochloride tablets and ciprofloxacin injection). These reactions may occur within the first 30 
minutes following the first dose and may require epinephrine and other emergency measures.
CIPRO® and CIPRO® I.V. may cause central nervous system (CNS) stimulation which may lead to  tremor, restlessness, light­
headedness, confusion, and very rarely to hallucinations or convulsive seizures. Therefore, CIPRO® and CIPRO® I.V. should be 
used with caution in patients with CNS disorders, such as severe cerebral arteriosclerosis or epilepsy. Patients with known 
convulsive seizure disorders should only be treated with CIPRO® and CIPRO® I.V. if anticonvulsant therapy has been initiated. 
SERIOUS AND FATAL REACTIONS HAVE BEEN REPORTED IN PATIENTS RECEIVING CONCURRENT ADMINISTRATION OF 
CIPRO® I.V. AND THEOPHYLLINE. These reactions include cardiac arrest, seizure, status epilepticus and respiratory failure. 
Similar serious adverse events have been noted with administration of theophylline alone, however, the possibility that 
ciprofloxacin may potentiate these reactions cannot be eliminated. If concomitant use cannot be avoided, the plasma levels of 
theophylline should be monitored and appropriate dosage adjustments should be made.
Severe hypersensitivity reactions characterized by rash, fever, eosinophilia, jaundice, and hepatic necrosis with fatal outcome 
have also been reported to occur very rarely in patients receiving ciprofloxacin in combination with other drugs. The possibility 
that these reactions were related to  ciprofloxacin cannot be excluded. Ciprofloxacin should be withdrawn at the firs t appearance 
of a skin rash or other signs of hypersensitivity.
Crystalluria related to ciprofloxacin has been reported only rarely in man because human urine is usually acidic. Crystals have 
been observed in the urine of laboratory animals, usually from alkaline urine. Patients receiving ciprofloxacin should be well
hydrated and alkalinity of the urine should be avoided. The recommended daily dose should not be exceeded.
Pseudomembranous colitis has been reported with virtually all antibacterial agents, including ciprofloxacin, and may range in 
severity from mild to  life-threatening. Therefore, it is important to consider this diagnosis in patients with diarrhoea subsequent 
to the administration of antibacterial agents.
Subsequent to diagnosis of pseudomembranous colitis, therapeutic measures should be initiated. Mild cases will usually respond 
to discontinuation of drug alone. In moderate to severe cases, consideration should be given to the management with fluids, 
electrolytes, protein supplementation and treatment with an antibacterial drug effective against C. difficile.
Prolonged use of CIPRO® and CIPRO® I.V. may result in the overgrowth of nonsusceptible organisms. Careful observation of the 
patient is therefore essential, and if superinfection should occur during therapy, appropriate measures should be taken.
Pregnancy The safety of CIPRO® and CIPRO® I.V. in pregnancy has not yet been established. CIPRO® and CIPRO® I.V. should not 
be used in pregnant women unless the likely benefits outweigh the possible risk to the fetus. CIPRO® and CIPRO® I.V. has been 
shown to be non-embryotoxic and non-teratogenic in animal studies.
Nursing Mothers Ciprofloxacin is excreted in human milk. A decision should be made to discontinue nursing o r to discontinue the 
administration of CIPRO® and CIPRO® I.V., taking into account the importance of the drug to the mother and the possible risk to 
the infant.
Drug Interactions Concurrent administration of ciprofloxacin with theophylline may lead to an elevated plasma concentration and 
prolongation of elimination half-life of theophylline. This may result in increased risk of theophylline-related adverse reactions. If 
concomitant use cannot be avoided, plasma concentrations of theophylline should be monitored and dosage adjustments made as 
appropriate.
Ciprofloxacin has been shown to interfere with the metabolism and pharmacokinetics of caffeine. Excessive caffeine intake should 
be avoided.
Some quinolones, including ciprofloxacin, have been associated with transient increases in serum creatinine levels in patients who 
are concomitantly receiving cyclosporine.
Quinolones have been reported to increase the effects of the oral anticoagulant warfarin and its derivatives. During concomitant 
administration of these drugs, the prothrombin time o r other appropriate coagulation tests should be closely monitored. 
Probenecid blocks renal tubular secretion of ciprofloxacin and has been shown to produce an increase in the level of ciprofloxacin 
in the serum.
Concomitant administration of a nonsteroidal anti-inflammatory drug (fenbufen) with a quinolone (enoxacin) has been reported to 
increase the risk of CNS stimulation and convulsive seizures.
Antacids containing aluminum o r magnesium hydroxide have been shown to reduce the absorption of ciprofloxacin. Concurrent 
administration with these agents should be avoided.
Administration of sucralfate prior to CIPRO® resulted in a 30% reduction in absorption of ciprofloxacin. Concurrent 
administration with ciprofloxacin should be avoided.
Oral ferrous sulfate at therapeutic doses decreases the bioavailability of oral ciprofloxacin, therefore concomitant therapy is not 
advised.
The use of calcium supplement reduces the absorption of ciprofloxacin. Concurrent administration should be avoided 
Renal Impairment Since ciprofloxacin is eliminated primarily by the kidney, CIPRO® and CIPRO® I.V. should be used with caution 
and at a reduced dosage in patients with impaired renal function. (See DOSAGE AND ADMINISTRATION).
Hepatic Impairment In preliminary studies in patients with stable chronic liver cirrhosis, no significant changes in ciprofloxacin 
pharmacokinetics were observed. The kinetics of ciprofloxacin in patients with acute hepatic insufficiency, however, have not been 
fully elucidated. An increased incidence of nausea, vomiting, headache and diarrhea were observed in this patient population. 
ADVERSE REACTIONS
CIPRO® (ciprofloxacin hydrochloride tablets) and CIPRO® I.V. (ciprofloxacin injection) are generally well tolerated. During 
worldwide clinical investigation, 16,580 courses of ciprofloxacin treatment were evaluated for drug safety.
Adverse events, possibly, probably or highly probably related to ciprofloxacin occurred in 1395 (8.8%) of patients. The adverse 
reactions according to treatment (oral, iv, and sequential therapy) show that the incidence of adverse reactions was 8.0% for the 
group treated orally, 17% for the group treated with CIPRO® I.V. and 15.3% for the group treated sequentially. The difference 
between the oral and iv group relates to adverse vascular reactions which are known to be associated with iv administration.
In orally treated patients enroled in clinical tria ls, the most frequently reported events, possibly,probably drug-related were: 
nausea (1.3%) and diarrhea (1.0%).
In patients treated with CIPRO® I.V., the most frequently reported events, possibly, probably drug-related were: rash (1.8%), 
diarrhea (1.0%), and injection site pain (1.0%).
Events possibly, probably drug-related occurring at a frequency of less than 1% with ciprofloxacin oral and i.v. treatment during 
clinical tria ls and subsequent post-marketing surveillance are as follows:
Gastro-lntestinal: vomiting, dyspepsia, abdominal pain, flatulence, dysphagia, enlarged abdomen, dry mouth, stomatitis, 
gastrointestinal moniliasis, anorexia, jaundice. The following have been reported very rarely: constipation, tooth discoloration, 
ulcerative stomatitis, pseudomembranous colitis, intestinal perforation, esophagitis, increased appetite, gastro-intestinal 
hemorrhage, melena, liver damage, tenesmus, ileus, toxic megacolon, hepatomegaly, glossitis.
Cardiovascular system: palpitation, tachycardia, phlebitis. The following have been reported very rarely: hypertension, hot flashes, 
cerebrovascular disorder, syncope, kidney vasculitis, vasodilation, atrial fibrillation, cardiac arrest, angina pectoris, 
electrocardiogram abnormality, myocardial infarct, substemal chest pain, pulmonary embolus, pericarditis, hypotension.
Nervous System: increased sweating, dizziness, agitation, tremor, somnolence, insomnia, confusion, hallucinations, convulsion, 
headache. The following have been reported very rarely: anxiety, depression, nervousness, apathy, depersonalization, abnormal 
dreams, hemiplegia, sleep disorder, neuritis, paresthesia, polyneuritis, diplopia, meningism, migraine, increase of intracranial 
pressure. In some instances these reactions occurred after the first administration of CIPRO®. In these instances, CIPRO® has 
to be discontinued and the doctor should be informed immediately.
Respiratory System: dyspnea. The following have been reported very rarely: hiccup, increased cough, stridor, larynx edema, voice 
alteration, lung edema, pharyngitis, hyperventilation, lung hemorrhage.
Skin and Appendages: rash, pruritus. The following have been reported very rarely: urticaria, photosensitive dermatitis, 
angioedema, alopecia.
Special Senses: tinnitus, abnormal vision, taste perversion. The following have been reported very rarely: conjunctivitis, comeal 
opacity, eye pain, colour blindness, chromatopsia, diplopia, ear pain.
Urogenital System: albuminuria, hematuria. The following have been reported rarely: leukorrhea, dysuria, urinary retention, acute 
kidney failure, abnormal kidney function, nephritis, vaginitis.
Hypersensitivity: rash. The following have been reported rarely: pruritus, drug fever, anaphylactic/anaphylactoid reactions 
including facial, vascular and laryngeal edema, serum sickness, petechiae, haemorrhagic bullae and small nodules (papules) with 
crust formation showing vascular involvement (vasculitis), Stevens-Johnson-syndrome, interstitial nephritis, hepatitis; very rarely, 
major liver disorders including hepatic necrosis, joint pain, Lyell Syndrome.
Blood and Blood constituents: eosinophilia, leukocytopenia. leukocytosis, anaemia. Very rarely: haemolytic anaemia, 
thrombocytopenia, thrombocytosis, altered prothrombin levels.
Laboratory values: increased alkaline phosphatase, Gamma - GT, transaminases, cholestatic parameters, lactic dehydrogenase, 
BUN, NPN, AST, ALT, decreased creatinine clearance, hypercholesteremia, albuminuria, bilirubinemia, hyperuricemia, increased 
sedimentation rate. The following have been reported rarely: electrolyte abnormality, hypercalcemia, hypocalcemia, acidosis, 
crystalluria and haematuria.
Other thrombophlebitis. Very rarely, asthenia, death.
Most of the adverse events reported were described as only mild or moderate in severity .There have been 54 reports of 
arthropathies with CIPRO®. Ten of these reports involved children. Arthralgia was usually the first symptom which led to rapid 
assessment and withdrawal of the drug. No irreversible arthropathies have been observed.
SYMPTOMS AND TREATMENT OF OVERDOSE
Overdose has not yet been reported with CIPRO® and CIPRO® I.V. (ciprofloxacin hydrochloride tablets and ciprofloxacin injection). 
In the event of acute overdosage, the stomach should be emptied by inducing vomiting or by gastric lavage. The patient should be 
carefully observed and given supportive treatment.
DOSAEE AND ADMINISTRATION
The determination of dosage for any particular patient must take into consideration the severity and nature of the infection, the 
susceptibility of the causative organism, the integrity of the patient's host-defense mechanisms, and the status of renal function. 
Oral Administration
CIPRO® (Ciprofloxacin hydrochloride tablets) may be taken before or after meals. Absorption is faster on an empty stomach. 
Patients should be advised to drink fluids liberally and not take antacids containing magnesium or aluminum.
A fr it  The recommended dosages of oral CIPRO® are:____________________________________________________________
Location of Infection Type/Severity Unit Dose Frequency Daily Dose
Urinary Tract Mild/Moderate
Severe/Complicated
250 mg 
500 mg
q 12h 
q 12h
500 mg 
1000 mg
Lower Respiratory Tract 
Bone & Joint 
Skin & Soft Tissue
Mild/Moderate
Severe/Complicated*
500 mg 
750 mg
q 12h 
q 12h
1000 mg 
1500 mg
Infectious Diarrhea Mild/Moderate/Severe 500 mg q 12h 1000 mg
* e.g. hospital-acquired pneumonia, osteomyelitis
Depending on the severity of the infections, as well as the clinical and bacteriological responses, the average treatment period 
should be approximately 7 to 14 days. Generally, treatment should last 3  days beyond the disappearance of clinical symptoms or 
until cultures are sterile. Patients with osteomyelitis may require treatment for a minimum of 6 to 8 weeks and up to 3  months. 
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Foot Infections in Diabetics: 
the Antibiotic Choice
The authors studied 59 diabetics with foot infections to determine the organisms 
responsible and the sensitivity to antibiotics. All infections were polymicrobial 
(aerobic and anaerobic). On average 3.2 isolates per culture were obtained from the 
depth of the infection. The commonest organisms in order of frequency were: 
Staphylococcus aureus, ^-hemolytic streptococci, Proteus sp., Bacteroides sp., 
enterococci, Klebsiella sp. and Pseudomonas aeruginosa. A combination of 
piperacillin and cloxacillin is recommended as initial therapy for foot infections in 
diabetic patients because it was found to be effective for 73% of the causative 
microorganisms.
Les auteurs ont etudie 59 patients diabetiques souffrant d’une infection du pied, 
dans le but d’etablir quels sont les organismes responsables ainsi que leur 
sensibilite aux antibiotiques. Toutes les infections etaient polymicrobiennes 
(aerobies et anaerobies). En moyenne, 3,2 isolats ont ete obtenus par culture des 
prelevements profonds de l’infection. Les organismes les plus courants ont ete, par 
ordre de frequence : Staphylococcus aureus, les streptocoques /TheACSmolytiques, 
Proteus sp., Bacteroides sp., les enterocoques, Klebsiella sp. et Pseudomonas 
aeruginosa. On recommande une association de piperacilline et de cloxacilline 
comme traitement initial d’attaque des infections du pied chez le patient diabetique, 
car celle-ci s’est averee efficace contre 73 % des germes responsables.
T he prevalence of diabetes mel- litus (DM) in Kuwait is one of 
the highest in the world1 (6.6% of 
the population compared with 1% 
to 2% in the United Kingdom and 
3.4% in the United States2).
Foot infections in diabetics, re­
ported to be the most common 
cause of hospitalization in these 
people,34 are due mostly to periph­
eral neuropathy, which leads to 
impaired sensation in the feet. This
neuropathy is compounded by the 
reduced blood supply to the area 
because of accelerated atherosclero­
sis. Consequently, minor injuries 
caused by foot wear or trivial trau­
ma pass unnoticed until infection 
sets in. The causative organisms in 
such infections are polymicrobial 
with a mixed growth of aerobic and 
anaerobic organisms.5*7 Studies ap­
plying optimal anaerobic methods 
have shown that anaerobes play an
important role in these infections.5 
Therefore, the initial choice of anti­
biotics must be empiric, covering a 
wide range of organisms both aero­
bic and anaerobic. Unfortunately, 
most combination antibiotics that 
ensure such coverage show some 
degree of toxicity in diabetics.
We undertook this study to de­
fine the organisms responsible for 
foot infections in diabetics and to 
find the most effective and least 
toxic antibiotics for use as initial 
therapy until culture-sensitivity re­
sults become available.
Patients and Methods
Fifty-nine in-hospital diabetic pa­
tients with foot infections were 
studied to determine the infecting 
organisms and antibiotic sensitivi­
ties of these organisms. All patients 
had had DM for years. They ranged 
in age from 30 to 83 years (mean 
59.8 years). None of them had been 
on antibiotics before specimens 
were taken for culture. Specimens 
were collected from the depth of the 
infected areas, usually during 
debridement.
Standard methods were used for 
aerobic and anaerobic cultures.8 An­
tibiotic sensitivity for aerobes was 
measured by a modified Kirby- 
Bauer method8 and for anaerobes 
by comparison with a control meth­
od.9 The antibiotics that were used 
for testing the isolates are listed in 
Table I.
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FOOT INFECTIONS IN DIABETICS
Initially, antibiotics were started 
on an empiric basis with a combina­
tion of a second-generation ceph­
alosporin, metronidazole and peni­
cillin until culture results became 
available.
Results
From the 59 infected feet, 192 
organisms were isolated, an average 
of 3.2 isolates per culture. Nearly 
all the cultures were of mixed aero­
bic and anaerobic organisms. Sta­
phylococcus aureus was the com­
monest organism isolated (in about 
73% of cultures), whereas /3- 
hemolytic streptococci A and B, 
Proteus sp.. Bacteroides sp. and 
enterococci each were present in 
about one-third of the cultures. 
Klebsiella sp. were present in 27% 
of the cultures, whereas Pseudomo­
nas aeruginosa and Escherichia coli 
were isolated in 24% and 22% of the 
cultures respectively.
The sensitivity results of these 
cultures (Table II) showed that 67% 
(10 of 15 species) of isolated organ­
isms were sensitive to piperacillin. 
Nearly all S. aureus isolates (92%) 
were sensitive to cloxacillin as well 
as to other antibiotics but not to 
piperacillin.
A combination of piperacillin and 
cloxacillin would cover 73% (11 of 
15 species) of the isolated organ­
isms.
Discussion
A diabetic patient is prone to 
many complications of the disease. 
Of these, foot infection is the com­
monest cause of hospitalization.3'4 
The microorganisms responsible for 
this infection have interested many 
investigators. However, Louie and 
associates5 were the first to demon­
strate the polymicrobial nature of 
foot infection in diabetics. They 
cultured aerobic and anaerobic or­
ganisms in 90% of their patients 
and found that the mean number of 
isolates per culture was 5.8 organ­
isms. More recent studies have con­
firmed these findings.6'7-10 The aver­
age number of isolates per culture
ranged between 2.5 and 4.8 organ­
isms in these reports.7'10
Our finding of 3.2 organisms per 
culture conforms with findings re­
ported in the current literature and 
emphasizes the polymicrobial mixed 
aerobic and anaerobic nature of 
these infections. No single patho­
gen or specific combination was 
found to be responsible for such 
infections.8 The initial antibiotic 
choice, therefore, has to cover a 
wide range of aerobic and anaerobic 
organisms. The therapy most com­
monly recommended in the litera­
ture combines two or more of the 
following: ampicillin, gentamicin, 
clindamycin, cephalosporin and 
metronidazole, administered until 
culture results become available. 
Such combination regimens are not 
devoid of toxicity in diabetics, most 
of whom have some degree of ne­
phropathy. Accordingly, we believe 
that antibiotic combinations for this 
category of patients should be guid­
ed by the culture sensitivity studies 
performed at individual institutions 
caring for such patients.
Our study on 59 patients showed 
that a combination of cloxacillin 
and piperacillin would cover 73% of 
the causative organisms in our pa­
tients. Although inferior to benzyl 
penicillin, piperacillin gives ade­
quate coverage of Streptococcus sp. 
as well.9 Thus, the combination of 
piperacillin and cloxacillin could en­
sure 93% (14 of 15 organisms) 
coverage for our patients.
We recommend this regimen as 
an initial therapy in diabetics with 
foot infections because it provides 
overall coverage against the causa­
tive bacteria and is safe even in 
patients with nephropathy.
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T a b le  I I .  Antibiotics With More Than 70% Sensitivity to  Organisms Isolated From Foot Infections
in Diabetics
S en sitiv ity  to
A ntib io tic A erob es A naerobes
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—
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~
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anaerobic gram 
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S. =  Staphylococcus, P. =  Pseudomonas, £  =  Escherichia
2. Bennett PH: Type II diabetes: epidemi­
ology. In Besser GM, Bodansky HJ, 
Cudworth AG (eds): C lin ica l Diabetes, 
an Illu s tra te d  Text, Gower Med Pub, 
Philadelphia, 1988: 11.1
3. W hitehouse FW: Infections that hospi­
talize the diabetic. G eriatrics 1973; 28: 
9 7 -9 9
4. Gibbsons GE, Elipoulos GM: Manage­
m ent o f  D iabetic F o o t Problems, Saun­
ders, Philadelphia, 1984: 97-102
5. Louie TJ, Bartlett JG, Tally FP et al: 
Aerobic and anaerobic bacteria in diabet­
ic foot ulcers. A nn In te rn  M ed  1976; 85: 
461-463
6. Sapico FL, Canawati HN, W itte JL et 
al: Quantitative aerobic and anaerobic 
bacteriology of infected diabetic feet. J  
C lin  M ic ro b io l 1980; 12: 413-419
7. Sapico FL, W itte JL, Canawati HN et 
al: The infected foot of the diabetic 
patient: quantitative microbiology and 
analysis of clinical features. Rev In fec t 
D is 1984; 6 (suppl 1): 5171-5176
8. Finecold SM, Martin WJ: Bailey and  
S c o tt ’s D iagnostic  M icrob io logy, 6th ed, 
Mosby, St. Louis, 1982
9. Garrod LP, Lambert HP, O’Grady F et 
al: A n tib io tic  and Chemotherapy, 5th ed, 
Churchill Livingstone, New York, 1981
10. S ims D, Keating SE, Devincentis AF: 
Bacteriology of diabetic foot ulcers. J  
F o o t S u rg  1984; 23: 140-151
172 JCC, VOL. 36, N °  2, A  V R IL  1993
ORIGINAL ARTICLES
Foreign Bodies in the Rectum
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Although infrequent, rectal foreign bodies present a challenge in management. The 
authors report on their experience with 29 patients who had rectal foreign bodies.
Emergency-department procedures included rectal examination, proctoscopy and 
abdominal radiography. Soft or low-lying objects having an edge could be grasped 
and removed safely in the emergency department, but grasping hard objects was 
potentially traumatic and occasionally resulted in upward migration toward the 
sigmoid.
Operating-room procedures included anal dilatation under general anesthesia, 
transrectal manipulation, bimanual palpation if necessary and withdrawal of the 
foreign body. In two cases, rectal mucosa was trapped — in an open deodorant 
bottle in one patient and in a curtain rod in the second patient; operative release of 
the mucosa enabled safe removal.
Two patients presented with peritonitis; both had “broomstick” injuries and 
required proximal colostomy. Five patients had perianal sepsis due to inadvertently 
ingested pieces of wood (three) and chicken bones (two). The mean hospital stay was 
3 days (range from 6 hours to 6 days). There were no deaths. Because of the 
potential complications, rectal foreign bodies should be regarded seriously and 
treated expeditiously.
Evenement rare, l’enlevement de corps etrangers du rectum constitue un defi 
therapeutique. Les auteurs decrivent une experience portant sur 29 patients 
porteurs de corps etrangers dans le rectum.
En salle d’urgence, les interventions pratiquees comprenaient l’examen rectal, la 
proctoscopie et la radiographie abdominale. Les objets mous et ceux qui etaient 
situes bas et qui presentaient des asperites pouvaient etre saisis et retires sans 
probleme en salle d’urgence, mais la saisie d’objets durs pouvait etre traumatique et 
provoquer, a l’occasion, leur migration vers le sigmoide.
Les interventions en salle d'operation comprennent la dilatation anale sous 
anesthesie generale, la manipulation transrectale, une palpation bimanuelle si 
necessaire, et le retrait du corps etranger. A deux reprises, on a constate un 
coincement de la muqueuse, dans un flacon ouvert de desodorisant chez un patient 
et dans une tringle de rideau chez un autre patient; une intervention chirurgicale a 
du etre pratiquee pour liberer la muqueuse et retirer l’objet.
Deux patients ont eu une peritonite; les deux presentaient une lesion provoquee 
par un objet de type «manche a balai» et necessiterent une colostomie proximale. 
Cinq patients souffraient d’une sepsie perianale due a l’ingestion accidentelle de 
bouts de bois (trois) ou d’os de poulet (deux). Le sejour hospitalier moyen a ete de 3 
jours (allant de 6 heures a 6 jours). II n’y a eu aucun deces. A cause des 
complications possibles, le retrait des corps etrangers du rectum devrait etre 
considere serieusement et pratique immediatement.
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A rectal foreign body is an infre­quent occurrence, but its re­
moval can present a challenge to 
the surgeon, because of the variety 
of objects that may be retained in 
the rectum. Extraction can be diffi­
cult and is associated with potential 
complications.'~7 We have compiled 
our experience over the last 15 
years with retained rectal foreign 
bodies.
Patients and Methods
In 1975, a data collection form 
was drawn up to compile informa­
tion on patients treated for rectal 
foreign bodies at St. Joseph’s 
Health Centre, Toronto. Data in­
cluded clinical presentation, investi­
gations, treatment techniques and 
complications.
Steps taken in the emergency 
department included rectal exami­
nation, proctoscopy, and an­
teroposterior and lateral radiogra­
phy if the history was vague or 
there were any abdominal signs. 
Removal of the foreign bodies in 
the emergency department was at­
tempted in most patients who had 
no definite indication for surgery. 
When the attempt failed the patient 
was operated on.
Steps taken in the operating 
room included anal dilatation under 
general anesthesia, location of the 
foreign body, careful bimanual pal­
pation if the object was large and 
application of clamps if the object 
had a grasping edge. Post-extrac­
tion sigmoidoscopy was done in all 
patients to identify any rectal tears.
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Findings
Between January 1975 and De­
cember 1990, 29 patients were 
treated for rectal foreign bodies. 
There were 28 men and 1 woman 
who ranged in age from 16 to 75 
years (mean 42.5 years). The etiolo­
gy and type of foreign bodies insert­
ed are shown in Tables I and II. 
Those inserted rectally had been 
present for 6 to 48 hours on aver­
age (median 24 hours, mode 14 
hours). Those lodged from above 
had been present from 48 hours to 
3 months (one patient with a lodged 
chicken bone had recurrent perianal 
abscesses).
Two patients presented with peri­
tonitis due to perforations. Both 
had impaled themselves on broom 
handles, and one had free air under 
the diaphragm. Both required a 
proximal colostomy. One of the two 
patients, who was schizophrenic, 
also required repair of an associated 
hole in the bladder and a suprapu­
T a b le  1. E tio log ies  o f R ecta l F o re ign  B od ies
Etio logy No. of pa tien ts
A na l e ro t ic is m 8
P assage  f ro m  above 7
P ra nks 4
A tte m p te d  re lie f of 
p e ria n a l d isease 4
A s s a u lt 2
“ A c c id e n t” 2
P s y c h ia tr ic  p rob lem 2
T o ta l 29
T a b le  II. T y p e  o f Fore ign  B od ies F ound  in 
the R ectum
O bjects No. of pa tien ts
In se rte d  f ro m  below
D ild o /v ib ra to r 7
W o o d  (ro d -sh ap e d ) 6
D o m e s tic  ob ject 6
F ru it/v e g e ta b le 2
C u rta in  rod 1
P assed  f ro m  above 
W o o d  (e .g ., large 
to o th p ic k ) 3
C h icke n  bone 2
N ail 1
R azor b la d e s 1
T o ta l 29
bic cystostomy. Both patients had 
an uncomplicated recovery and later 
had the colostomy closed.
Three patients presented with 
rectal bleeding. One had swallowed 
razor blades, which perforated his 
jejunum necessitating emergency 
laparotomy, and the remaining 
blades were extracted from the rec­
tum by rigid sigmoidoscopy during 
the same operation. The two other 
patients presented with rectal bleed­
ing due to retained dildos.
Nine patients had bleeding after 
manipulation of the foreign body in 
the emergency department. Post­
extraction sigmoidoscopy was per­
formed in all patients and showed 
superficial tears in the mucosa of all 
nine. This bleeding was self-limited 
after careful removal of the foreign 
bodies.
Five patients presented with pe-
FIG. 1. Patient presented in emergen­
cy department with vague complaints. 
X-ray film shows metallic densities at 
both ends of foreign body (bedpost), 
which was removed in operating room. 
Note that solid wood (arrows), which 
makes up major component of bedpost, 
is radiolucent.
rianal abscesses; in three the ab­
scesses were due to inadvertently 
ingested pieces of wood and in two 
to trapped chicken bones, which 
had lodged in the para-anal tissues. 
All these foreign bodies were ex­
tracted during incision and drainage 
of the perianal abscess. Two of the 
patients later required anal fis­
tulotomy.
Abdominal radiographs were or­
dered on presentation in 20 pa­
tients. Findings included the image 
of a foreign body (Fig. 1), a full 
bladder in 15 patients who had 
some difficulty voiding after inser­
tion of the foreign body and free air 
in 1. Also, there was moderate 
distension of large bowel and, to a 
lesser extent, small bowel in 15 
patients (Fig. 2).
The foreign bodies were removed 
successfully in the emergency de­
partment in six patients. The for­
eign bodies consisted of two dildos 
with a grasping edge (Fig. 3), a 
rubber glove containing work socks
FIG. 2. Rectangular area of gas in 
rectum corresponded to plastic deodor­
ant bottle. Cap had been removed, and 
mucosa was entrapped in its upper 
end. Observe moderate distension of 
colon proximal to foreign body.
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wrapped about a gauze roll, an 
aerosol can, an apple and a piece of 
wood. In a number of these pa­
tients, lidocaine spray, lidocaine gel 
and 5 to 10 mg of diazepam, given 
intravenously, enabled removal of 
the foreign body in the emergency 
department. The intact apple was 
removed by chipping its side, so 
that a grasping edge was obtained.
Bulging, edematous, entrapped 
mucosa was a feature in two pa­
tients: in one it was trapped in an 
open plastic deodorant bottle and in 
the second in a curtain rod. In the 
operating room under general anes­
thesia and after anal dilatation, the 
plastic bottle (Fig. 2) was divided 
with a scalpel. Similarly, the curtain 
rod was spread open by Kocher 
clamps so that the mucosa could be 
carefully released before removal. 
One glass jar was removed in the 
operating room by a Foley catheter 
passed beyond it; the balloon was 
inflated and withdrawn, pulling out 
the jar.
The mean hospital stay was 3 
days (range from 6 hours to 6
days). The nine patients with bleed­
ing had a longer stay, averaging 4.5 
days. There were no deaths. Post- 
operatively, nine patients underwent 
psychosocial counselling; four had 
major depression, four had stressful 
social problems and one was schizo­
phrenic.
Discussion
Recent reports indicate that sur­
geons should be aware of the prob­
lems related to retained foreign bo­
dies of the rectum.8-9 Our patients 
were almost exclusively male, but 
females with vaginal foreign bodies 
may present to the gynecologist.9
The most common etiology was 
anal eroticism, followed by inges­
tion and lodging from above. An 
attempt to relieve perianal disease 
was an etiologic factor in four pa­
tients. They used an object for anal 
manipulation for pruritus ani and 
prolapsed hemorrhoids. We recom­
mend careful evaluation and treat­
ment of the underlying condition.
FIG. 3. (Left) Radiograph of soft hollow plastic dildo inserted in rectum. Full 
bladder was present, which is frequently found. Dildo was clamped and removed in 
emergency department. (Right) Dildo with clamp still applied.
As in the majority of published 
reports, only two patients in our 
series admitted to a homosexual 
life-style.9
All five patients with perianal 
sepsis had ingested the foreign ob­
ject. These patients had delayed 
presentation; one patient with an 
ingested chicken bone had ongoing 
perianal sepsis for 3 months.
Peritonitis was the major present­
ing complication due to a perforat­
ed rectum in one patient and due to 
a perforated rectum and bladder in 
another. Both patients had psychi­
atric illness and had impaled them­
selves with broom handles. Careful 
evaluation of serious injuries is rec­
ommended in psychiatric patients 
because of their lack of perception 
of the potential danger of impale­
ment. Drainage and proximal colos­
tomy controlled sepsis; both pa­
tients had a smooth recovery.
Although only two of our pa­
tients had major psychiatric illness, 
full psychosocial evaluation by a 
specialist is recommended for pa­
tients who present with severe self- 
inflicted injury or show any signs of 
psychologic instability. A full social 
history revealed problems of loneli­
ness, depression and stress only in 
eight patients, who were subse­
quently referred for psychosocial 
counselling.
Foreign bodies once lodged in the 
rectum were difficult to retrieve, 
since most were smooth and hard. 
In our patients, a glass bottle, bu­
tane can, wooden dildo, broken-off 
broom handle, claves (a wooden 
music instrument), a drumstick and 
a carrot were readily palpated on 
digital examination but could not be 
evacuated. Spasm of the anal 
sphincter and the curve of the sa­
crum tended to hold the lower end 
of the foreign body away from the 
anus (Fig. 4).10 Attempts at grasp­
ing these hard objects occasionally 
resulted in upward migration to the 
sigmoid colon (Fig. 5). We found
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that these could be brought back 
down toward the anal sphincter by 
a gently administered Fleet enema. 
However, general anesthesia re­
laxed the anal sphincter and al-
FIG. 4. Lateral view of pelvis confirms 
that foreign body is in rectum. Plastic 
vibrator is radiolucent, but its metallic 
head is opaque.
FIG. 5. Diagram shows why large hard 
object is difficult to remove. When 
inserted, object enters anus anteriorly, 
moves posteriorly above anal sphinc­
ter, then anteriorly again in sacral 
hollow.
lowed its dilatation so that retrieval 
of the foreign object became easy.
Foreign bodies are classified as 
low-lying or high-lying (at or proxi­
mal to the rectosigmoid junc­
tion).81112 Only soft, low-lying ob­
jects are removed safely in the 
emergency department. In our ex­
perience, attempts to manipulate 
high-lying foreign bodies in the 
emergency department were risky 
and resulted in bleeding. A recom­
mended approach to management is 
shown in Fig. 6.
The unusual shapes of the di­
verse foreign objects retained in the
History
Vague history ■ What is it?
■ Inserted? Swallowed? 
• When?
■ Any symptom?
II. Physical examination, rectal
Positive abdominal findings
I
Abdominal x-ray films, including 
pelvis (anteroposterior and lateral)
Positive findings
• Image of the object
• Moderate distension of the
colon and sometimes small bowel
• Occasional full bladder
• Free air
Object
1 Is low lying 
1 Is soft (e.g., fruits)
- Has edge to grasp
4
IV. A. Management in 
emergency room
•Lidocaine gel 
•Diazepam intravenously 
•Grasping edge and 
removal
• With harder objects, 
avoid upward migration 
and trauma; if difficult, 
proceed to IV, B.
• Rectal bleeding?
■ Abdominal tenderness?
■ Fever?
• Bruising? (forensic aspects)
III. Proctoscopy \
Object
• Is high lying
■ Is hard (e.g., glass bottle) 
1 Has no edges
4
IV. B. Management in 
operating room
1 General anesthesia
• Anal dilatation
■ Transrectal manipulation
• Bimanual manipulation
• Removal
V. Rigid sigmoidoscopy
■ Any muscosal tear?
■ Any other abnormality?
FIG. 6. Recommended approach to management of rectal foreign bodies.
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rectum may oblige the surgeon to 
improvise instruments for extrac­
tion.1-7 We used surgical tenaculae 
to remove objects that had a grasp­
ing edge. Gentle bimanual manipu­
lation of large objects palpable in 
the lower abdomen facilitated re­
trieval of these objects. Generally, 
foreign bodies should be removed in 
the operating room unless they are 
soft and can be easily grasped, in 
which case they may be removed in 
the emergency department, with in­
travenously administered diazepam 
to encourage relaxation of the anal 
sphincter.
The authors thank Roger J. Harris and 
Irene Schwerk of the Department of
Photography of St. Joseph’s Health 
Centre, Toronto.
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PEDIATRIC SURGERY OF THE LIV­
ER, PANCREAS AND SPLEEN. Edit­
ed by Medad Schiller; Series editor: 
Stephen L. Cans. 272 pp. Illust. W.B. 
Saunders Company, London/Harcourt 
Brace Jovanovich, Inc., Philadelphia; 
HBJ-Holt-Saunders Distribution Ser­
vices, Toronto. 1991. $119. ISBN 0 -  
7216-8014-3
This is the first in a new collection 
entitled The Principles and Practice o f 
the Pediatric Surgical Specialties. The 
series editor, Dr. Stephen Cans, enjoys 
an international reputation as an author 
and editor in the field of pediatric 
surgery, and his personal stamp is evi­
dent throughout this monograph. The 
contributors are recognized experts 
from North America and abroad and 
bring with them a vast personal and 
institutional experience, a major asset 
when writing on sometimes very rare 
conditions.
The opening section on the liver and 
biliary tract covers metabolic diseases 
with surgical implications, vascular le­
sions, pyogenic liver abscess, parasitic 
diseases, tumours, infantile obstructive 
jaundice, cholecystitis and cholelithia­
sis, choledochal cyst, portal hyperten­
sion and liver transplantation.
This is perhaps the most uneven 
section of the book because it is impos­
sible to do justice to such a vast and 
complex subject within the space con­
straints imposed by the editors.
Some of the chapters in this section 
are much too limited in content and 
must be complemented by constant ref­
erence to the bibliography in order to 
obtain useful and applicable knowledge 
of the subject. The chapter on liver 
tumours was to me the most notable 
example of this.
It seems that the target audience has 
not been clearly defined — some chap­
ters do not have quite enough for the 
pediatric surgical specialist, yet too 
much for the general readership. For 
example, the chapter on liver transplan­
tation will not be useful to the pediatric 
transplant surgeon, who will find it too 
elementary, yet it contains a number of 
precise technical details that will be of 
little use to other readers.
The section on the pancreas is of 
uniform high quality — pancreatitis and 
pancreatic tumours are thoroughly cov­
ered by Dr. Jay Grosfeld, with illustra­
tive cases from his own extensive expe­
rience. At times, the chapter on tu­
mours becomes a bit too anecdotal, 
perhaps because of the extreme rarity 
of these cases.
Persistent hyperinsulinemic hypogly­
cemia is expertly discussed, with very 
specific and explicit recommendations 
for medical and surgical treatment. A 
complaint can be made that in certain 
other chapters such recommendations 
are so general as to force the reader, 
again, to refer constantly to the bibliog­
raphy. For example, in the chapter on 
portal hypertension it would have been 
useful to be told specifically how and in 
what dose Vasopressin should be ad­
ministered.
The chapter on the spleen is tradi­
tional in approach, but the section on 
postsplenectomy sepsis is very clear on 
specifics — probably one of the most 
informative I have read. The author, 
and those who write in the closing 
chapters on trauma, present compelling 
arguments in favour of conservative 
treatment of solid-viscus injuries in chil­
dren, an approach that has stood the 
test of time and should be extended 
much more than it has been to the 
treatment of adults.
continued on page 183
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Soft Tissue Sarcomas: a Plea for Proper 
Management
Peter L. Munk, MD, CM. FRCPC:* A. Dale Veilet, BSc, MB, BCh, FRCPC;* 
Vivien Bramwell, MB, BS. FRCPCit Robert Bell, MD, FRCSC;$
Alex Hammond, MB, BS, FRCPC;§ Christopher Beauchamp, MD. FRCSC1
Although soft tissue sarcomas are relatively uncommon, they often occur in young 
patients and if properly treated are often curable. Unfortunately, inappropriate 
approaches to biopsy before adequate staging may compromise a successful 
outcome. The roles of diagnostic imaging (particularly magnetic resonance imaging) 
in adequate preoperative evaluation and staging and the fundamental principles of 
surgical management are discussed.
Bien que les sarcomes des tissus mous soient relativement rares, ils surviennent 
souvent chez des jeunes patients. Traites de fa^on appropriee, ils peuvent etre 
gueris. Malheureusement, si la biopsie est abordee de la mauvaise fa<:on avant 
1’etablissement du stade de la maladie, les resultats peuvent etre compromis. On 
commente le role des techniques d’imagerie diagnostique (particulierement 
l’imagerie par resonance magnetique) pour bien evaluer et etablir le stade de la 
maladie en preoperatoire, de meme que les principes fondamentaux du traitement 
chirurgical.
In the light of recent and ongoing developments in the management 
of patients with soft tissue tumours, 
the medical community needs to 
re-evaluate critically the current 
methods used in the diagnosis, 
staging and treatment of such enti­
ties.
Although soft tissue sarcomas 
are not particularly common, they 
are of importance because they 
often affect young patients and be­
cause they are potentially curable. 
Recent advances in diagnosis, surgi­
cal treatment, chemotherapy and 
radiotherapy have improved the 
outlook for these often aggressive 
malignant tumours.1-8 More recent­
ly, magnetic resonance imaging 
(MRI), a radiologic modality that 
provides unparalleled tissue con­
trast, has greatly facilitated accu­
rate staging and follow-up of these 
tumours. Unfortunately, we all too
often see patients with soft tissue 
masses removed by excisional biop­
sy before accurate staging has been 
performed.910 This approach to 
management stems from a common 
belief that most soft tissue masses 
are benign, which is indeed the 
case. Unfortunately, this practice 
greatly compromises the outcome 
for the small number of patients 
who have a malignant soft tissue 
mass, and the practice of excisional 
biopsy before adequate radiologic 
assessment is to be condemned. The 
proper planning of a biopsy, along 
with recognition that radical sur­
gery and chemotherapy or radio­
therapy pre- or postoperatively, or 
both, may be necessary, is impor­
tant and will greatly improve the 
prognosis for these patients.
Diagnosis and Staging
Accurate diagnosis and staging 
should be the first step in the 
management of patients with soft 
tissue tumours.11-13 With the advent 
ot MRI and its routine application, 
potential means of diagnosis and 
regional staging are simultaneously 
available. Although MRI can identi­
fy the correct pathologic subtype in 
only a minority of cases, its 
strength lies in its ability to provide 
greatly superior regional staging of 
the tumour. The presence of ag­
gressive regional characteristics on 
MRI should alert the clinician to the
*Division o f  Magnetic Resonance Imaging, Department o f  Diagnostic Radiology. University o f  
Western Ontario. University Hospital. London, Ont.
fDepartment o f  Medical Oncology. University o f Western Ontario. London Regional Cancer 
Centre. Victoria Hospital. London
f  Division o f  Orthopedic Surgery. University o f  Toronto. Mount Sinai Hospital. Toronto. Ont.
§Department ot Radiation Oncology. London Regional Cancer Centre. Victoria Hospital. London
HDepartment o f  Orthopedics, Vancouver General Hospital. University o f  British Columbia. 
Vancouver. B C
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real possibility that the mass is 
malignant.
Surgical Management
Ideally, surgical management 
should be preceded by staging by 
MRI. The importance of accurate 
delineation of these tumours cannot 
be overemphasized. Precise staging 
will determine treatment alterna­
tives, and MRI can provide accurate 
measurements for comparing thera­
peutic trials. One of the most im­
portant confounding factors in ac­
curate staging, particularly when 
performed by MRI, is distortion of 
the tumour by a previous biopsy. A
biopsy performed before radiologic 
assessment significantly compro­
mises the accuracy of MRI by intro­
ducing extensive soft tissue edema, 
as well as abnormal fluid collections 
due to hematoma and seroma.214"17 
Fluid collections will often track 
along fascial planes, making it diffi­
cult to differentiate between tumour 
spread and postsurgical artifact 
(Fig. 1). Thus, early detection of 
residual or recurrent tumour is al­
most impossible and may signifi­
cantly compromise the patient’s 
chance for cure.
Once the tumour has been prop­
erly staged, a needle core biopsy is 
usually the next step. This may be 
performed by the surgeon or by a
radiologist under computed tomo­
graphic or fluoroscopic guidance. If 
done by a radiologist this individual 
should be experienced with muscu­
loskeletal neoplasia and be aware of 
the importance of choosing a biopsy 
route that will not compromise sur­
gery. Discussion with the referring 
surgeon is often advisable. In the 
case of severely hemorrhagic or 
necrotic tissues, it may be necessary 
to resort to a small incisional biop­
sy.
We therefore advocate proper de­
tailed assessment of soft tissue 
masses before biopsy. Although this 
may result in overinvestigation of 
many benign lesions, it is a small 
price to pay for improved outcome
FIG. 1. Recurrent rhabdomyosarcoma in thigh of 13-year-old girl. (Left) Tr weighted transverse image before infusion of 
contrast medium; repetition time (TR) 800 ms, echo time (TE) 20 ms. There is no obvious abnormality. (Right) After infusion of 
intravenous gadolinium-DTPA (magnetic resonance imaging contrast agent), large enhancing nodule of tumour is demonstrated 
deep within muscle (straight arrows). Feathery areas of increased signal are seen around tumour and tracking along anterior 
fascia (curved arrow), representing postoperative edema and subfascial fluid. This patient had undergone excisional biopsy 
several weeks before undergoing any imaging.
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for patients with malignant soft 
tissue tumours.
The Role of Adjuvant Therapy
Adjuvant therapy has two poten­
tial roles in the management of soft 
tissue sarcomas: first, to improve 
local control and, second, to reduce 
systemic spread. With modern sur­
gical techniques, over 90% of pa­
tients with tumours of the musculo­
skeletal system may be candidates 
for limb salvage procedures, but in 
some cases these will inevitably 
leave close or contaminated margins 
adjacent to critical structures (e.g., 
neurovascular bundles). In this situ­
ation postoperative radiotherapy 
has been shown to reduce the risk 
of local recurrence, and some clini­
cal trials suggest that adjuvant che­
motherapy may also enhance local 
control. The use of chemotherapy 
to reduce systemic spread is still 
controversial, and such treatment is 
best administered in the context of 
a clinical trial.
There is increasing interest in 
preoperative or “neoadjuvant” ther­
apy. For large tumours that are 
marginally operable there are estab­
lished benefits of administering ra­
diotherapy preoperatively.1’9'1344 
The treatment volume is reduced, 
allowing high doses to be applied 
without serious side effects, and the 
operative procedure may be facili­
tated by reduced tumour vascularity 
and a more obvious, palpable fi­
brous capsule. Research techniques 
include the use of brachytherapy 
(implantation of plastic tubes, 
which allow afterloading of radia­
tion sources) and intraoperative ra­
diotherapy.
Neoadjuvant chemotherapy has 
been extremely successful in os­
teosarcoma (in some cases causing 
100% tumour necrosis), and similar 
protocols are being explored in soft 
tissue sarcoma. Early consultation 
with the multidisciplinary team can 
ensure that such advances are made 
available to selected patients who 
might benefit from these treat­
ments.
Role of MRI in Tumour 
Surveillance
In the ideal scenario, adequate 
preoperative surgical staging has 
been performed with MRI, a surgi­
cal and neoadjuvant protocol has 
been agreed upon by the medical 
and radiation oncologists and the 
surgeon, and definitive surgical 
management has been undertaken 
and cure obtained. However, no 
matter how closely this model has 
been followed, tumour surveillance 
will always be an ongoing part of 
the management of these patients. 
Although this requires clinical vigi­
lance, it is imperative that MRI is 
integrated into the routine long­
term surveillance of such patients.
Through this multidisciplinary 
appeal, we hope to draw attention 
to a persistent problem in the man­
agement of patients in Canada with 
soft tissue tumours of the musculo­
skeletal system.
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T h e Advanced Trauma Life Support 
Program in Manitoba: a 5-Year Review
Jameel Ali, MD, FRCSC, FACS; Mary Howard, RN
Twenty Advanced Trauma Life Support (ATLS) courses were conducted at the 
University of Manitoba between 1982 and 1987. There were 302 registrants, 95 of 
whom were from rural communities. Twelve registrants failed the course. The 
impact of the program was assessed by questionnaire (68.8% response overall). The 
response from department heads of surgery in urban hospitals was 87.5% and from 
surgeons in rural areas 50%. Fifty-eight percent of rural surgeons, 62.5% of urban 
surgeons and 75% of urban emergency-department directors claimed they could 
identify those who had attended an ATLS course by the increased confidence 
demonstrated and the use of more timely and appropriate consultation and 
treatment. Thirty percent of rural surgeons, 37% of urban surgeons and 42% of 
emergency-department directors claimed that mortality and morbidity were 
decreased when care was provided by ATLS-trained physicians. The remainder were 
undecided because of lack of information. Ninety-three percent of respondents 
indicated that the course increased their confidence, trauma capability and ability to 
communicate with consultant trauma surgeons. Fifty-two percent thought the course 
should be mandatory for all physicians, and 100% thought it should be mandatory 
for all emergency-department physicians. The data suggest that although most 
physicians treat fewer trauma patients 5 years after their ATLS training, the course 
is still highly recommended, and it has improved trauma care. Although the ATLS 
program was intended primarily for rural physicians, more urban-based physicians 
registered for it.
Vingt cours sur les techniques specialises de maintien des fonctions vitales des 
traumatises (TSMFVT) ont ete donnes a l’Universite du Manitoba entre 1982 et 
1987. II y a eu 302 inscriptions, 95 provenant des milieux ruraux. Douze des 
personnes inscrites au cours ont echoue. Les retombees de ce programme ont ete 
mesurees par questionnaire (avec un taux de reponse de 68,8 %). La reponse des 
chefs de chirurgie en milieu urbain a ete de 87,5 %, alors que celle des chirurgiens 
ruraux etait de 50 %. Cinquante-huit pourcent des chirurgiens ruraux, 62,5 % des 
chirurgiens urbains et 75 % des directeurs des services d’urgence en milieu urbain 
ont affirme pouvoir identifier ceux qui avaient suivi les cours de TSMFVT par la 
confiance accrue que ceux-ci manifestaient et leur usage plus approprie et ordonne 
des methodes de consultation et de traitement. Trente pourcent des chirurgiens 
ruraux, 37% des chirurgiens urbains et 42 % des directeurs de services d’urgence 
ont affirme que la mortalite et la morbidity etaient abaissees quand les soins etaient 
prodigues par des medecins formes en TSMFVT. Les autres se disaient indecis par 
manque d’information appropriee. Quatre-vingt-treize pourcent des respondents ont 
indique que le cours avait accru leur confiance et ameliore leurs aptitudes a traiter 
les traumatises et a communiquer avec les chirurgiens consultants. Cinquante-deux 
pourcent considerent que ce cours devrait etre obligatoire pour tous les medecins, et 
100 % considerent qu’il devrait l’etre pour tous les urgentologues. Ces donnees 
indiquent que meme si la plupart des medecins traitent moins de traumatises 5 ans 
apres leur formation en TSMFVT, ce cours est fortement recommande et il a 
contribue a ameliore les soins aux traumatises. Meme si le cours de TSMFVT etait 
avant tout destine aux medecins ruraux, ce sont surtout des medecins de milieu 
urbain qui se sont inscrits au programme.
The Advanced Trauma Life Sup­port (ATLS) Program originat­
ed in 1979 in Lincoln, Neb., from a 
recognized need to improve the 
trauma care provided by physicians 
who do not deal with major trauma 
on a day-to-day basis.1 The program 
was adopted by The American Col­
lege of Surgeons Committee on 
Trauma and was introduced into 
Canada in 1981. Over 5000 ATLS 
courses have been conducted in 
North America, at which over 
100 000 physicians have been 
trained. This course is a prerequi­
site for employment in most emer­
gency departments in large urban 
centres. It was our impression that 
the spectrum of physicians partici­
pating in the ATLS program was 
quite different from the original 
rural target population of the pro­
gram.
We conducted a survey to deter­
mine the specialties of ATLS physi­
cian-participants, their changing 
patterns of practice after complet­
ing the program and their assess­
ment of the program, as well as the 
assessment by other physicians who 
have observed ATLS-trained physi­
cians.
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Participants and Methods
A review of the 20 ATLS courses 
conducted by the University of Man­
itoba during the period 1982 to 
1987 formed the basis of this sur­
vey.
The registration data and perfor­
mance of the physicians as recorded 
on the ATLS program files were 
used to determine the categories 
and locations of physicians, as well 
as their patterns of practice.
The other major tool used to 
evaluate the program was a ques­
tionnaire, which was sent to the 
following: all ATLS providers who 
had successfully completed the pro­
gram; all emergency-department di­
rectors in Winnipeg; all urban 
heads of surgery departments in 
Winnipeg; and rural general sur­
geons in Manitoba.
Findings
There were 302 participants in 
the program, of whom 12 failed the 
course. The remaining 290 partici­
pants received questionnaires and 
199 responded (69% response rate). 
All emergency-department directors 
in the urban setting responded, 
whereas seven of eight heads of 
urban surgery departments re­
sponded (88% response rate). Of the 
28 rural general surgeons, only 14 
responded (50% response rate). 
With respect to the specialty of the 
participants, 88 were family prac­
tice physicians and 67 were emer­
gency-department physicians. They 
accounted for 51% of those enrolled 
in the program. The remainder of 
the registrants included 30 house 
staff and 117 physicians from the 
various subspecialties in medicine 
and surgery. Overall, the number of 
rural physicians who completed the 
program was 95 (31%) compared 
with 207 (69%) whose practice was 
in the urban setting.
Questionnaire Results
When asked if they could differ­
entiate ATLS physicians from non- 
ATLS physicians by a demonstra­
tion of increased confidence, more 
appropriate treatment and more 
timely and appropriate consultation, 
58% of rural surgeons answered af­
firmatively, compared with 63% of 
urban surgeons and 75% of urban 
emergency-department directors.
The same groups were asked to 
determine whether mortality and 
morbidity were decreased as a result 
of ATLS-physicians’ care; 30% of 
the rural surgeons indicated that 
this was the case compared with 
37% of urban surgeons. Forty-two 
percent of emergency-department 
directors also agreed. However, the 
remainder of the rural surgeons, 
urban surgeons and emergency- 
department directors (70%, 63% and 
57% respectively) said they could 
not tell whether ATLS-physicians' 
care decreased morbidity and mor­
tality, chiefly because no formal 
audit had been conducted to allow 
them to answer the question.
We examined our data to deter­
mine the practice pattern followed 
by the physicians who registered for 
the ATLS course during the period 
1982 to 1987. Information from 
the questionnaire was supplemented 
by data from the offices of those 
physicians who registered as family 
or emergency-department physi­
cians. We found that of the 1982 
registrants, only 6 of 26 registered 
in family practice and emergency- 
department practice at that time 
were still in that type of practice in 
1987, compared with 8 of 32 from 
1983, 9 of 24 from 1984, 8 of 29 
from 1985, 12 of 23 from 1986 and 
12 of 24 from 1987. Thus, of the 
155 physicians (51% of all regis­
trants) representing family practice 
and emergency-department practice 
upon entering the program, only 55 
(18% of all registrants) remained in
family and emergency-department 
practice at the end of the study. 
Twenty-seven percent (53) of the 
respondents joined residency pro­
grams subsequently, most common­
ly in surgery and anesthesia. Forty- 
nine of the respondents were treat­
ing more trauma patients than 
when they registered for the course, 
whereas 99 (50%) were treating 
fewer trauma patients, and the re­
maining 51 indicated no change in 
the number of trauma patients they 
were treating.
Providers ’ Assessment
Of the 199 respondents, 185 
(93%) indicated that the ATLS 
course increased their confidence as 
well as their trauma-care capability 
and their ability to communicate 
with consultant surgeons. One hun­
dred and three (52%) of the respon­
dents indicated that the course 
should be mandatory for all physi­
cians, and all 199 respondents indi­
cated that the course should be 
mandatory for all emergency- 
department physicians. The partici­
pants further indicated that the 
teaching method in the ATLS 
course was superior to that of tradi­
tional courses; 188 (94%) indicated 
that the course was relevant to 
their everyday practice; and all 
would recommend the course to 
their colleagues.
Discussion and Conclusions
Our survey indicates that the 
ATLS course continues to be highly 
regarded by physicians who register 
for this program. Contrary to the 
original intent of the program, 
fewer than one-third of the ATLS 
providers participating in this pro­
gram in the province of Manitoba 
are rural physicians. This agrees 
with our original impression of a 
rapid change in the physician pro-
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file of ATLS providers nationally 
and internationally, especially since 
the program was adopted by the 
American College of Surgeons.
Within 5 years of taking the 
ATLS course, over 50% of physi­
cians changed their specialty, and 
50% indicated that they treat fewer 
trauma patients than when they 
participated in the program. How­
ever, providers, surgeons and emer­
gency-department directors all 
agree that the ATLS course has 
improved trauma care in the prov­
ince of Manitoba. Although these 
impressions of improvement in trau­
ma outcome may be correct, they 
have not yet been substantiated by 
hard data.
The ATLS program was intended 
primarily for rural physicians, but a 
greater number of urban-based phy­
sicians registered for the program, 
apparently because it was recog­
nized that the principles taught in 
the ATLS course apply even more 
directly to the resuscitation of trau­
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This is not a book on surgical tech­
nique. With some exceptions, no de­
tailed descriptions or illustrations of 
pediatric surgical procedures will be 
found here. The emphasis is more on 
the basic science of pediatric surgical 
disorders, and as such this is more a 
text of “surgical pediatrics” than of 
pediatric surgery.
The bibliography is very extensive 
and up-to-date and compensates largely 
for the information gaps in the text.
I found that the illustrations general­
ly were of limited didactic value and 
added little to the text. Either the 
disorder shown was obvious (gallstones 
on ultrasonography) or was not clearly 
demonstrated on the radiograph (inspis­
sated bile syndrome). Some images of 
round lesions in the liver would leave 
even an expert radiologist confounded
ma patients in the urban setting. 
Although this program was initially 
aimed at practising physicians, 
three universities in Canada (the 
University of Manitoba, McGill Uni­
versity and McMaster University) 
have introduced this program to 
senior medical students.2 The 
course has also been conducted in 
the United States, particularly in 
the armed forces medical schools, 
as part of the senior medical stu­
dent undergraduate curriculum.3 
Recognition of the fact that institu­
tion of resuscitative techniques in 
trauma management does not re­
quire a high degree of technologic 
skill has led to the introduction of 
this program in Europe, Australia, 
South America and in some devel­
oping countries.4'5 This review sug­
gests that the ATLS program has 
expanded justifiably beyond its 
original target population of the 
rural American physician to a more 
widely based physician population 
involving those dealing with all as­
without the knowledge of what was 
subsequently found at surgery. The line 
drawings of the segmental anatomy of 
the liver and of a right trisegmentec- 
tomy seemed irrelevant in a chapter 
that contains only two paragraphs on 
technique.
This book would be of interest main­
ly to pediatric surgeons, general sur­
geons, pediatric gastroenterologists and 
residents training in these disciplines. 
Its excellent bibliography provides a 
comprehensive source of information on 
disorders seldom encountered even in 
specialty practice.
Pierre Soucy, MD, FRCSC
Department of Surgery
Children's Hospital of Eastern Ontario
401 Smyth Rd.
Ottawa. ON 
K1H 8L1
pects of trauma. In urban settings 
in North America, trainees in the 
undergraduate and postgraduate 
medical curricula, as well as phys­
icians in both developed and devel­
oping countries of the world, con­
firm that the concepts taught in 
this program are universally appli­
cable to trauma care.
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ATLAS OF SURGICAL PATHOLO­
GY. John L. Turk and Christopher 
D.M. Fletcher. 300 pp. Illust. Raven 
Press, New York. 1992. $231 .25  (US). 
ISBN 0 -3 9 7 -4 4 8 4 3 -0
The title of this lavish volume is a 
misnomer. It is in fact a photographic 
catalogue of gross specimens in the 
Wellcome Museum of Pathology in 
London, England. This collection is 
based on that minority of specimens 
from the Hunterian Museum of the 
Royal College of Surgeons of England 
which survived the College’s destruc­
tion in the air-raids of 1941. It is 
therefore of great historical interest but
continued on page 186
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A Comparison Between Expanded 
Polytetrafluoroethylene and Plasma 
Tetrafluoroethylene Grafts for 
Hemodialysis Access
Philip T. Barron, MB, FRCSC; James L. Wellington, MD, FACS, FRCSC;
John W. Lorimer, MD, FRCSC; C. William Cole, MD, ABS, FRCSC; D. Moher, MSc
Animal studies have indicated that plasma tetrafluoroethylene (TFE) may be a better 
prosthetic material than expanded polytetrafluoroethylene (ePTFE) for 
arteriovenous access in patients who require hemodialysis because it combines the 
advantages of both Dacron and Teflon. A randomized clinical trial to compare the 
two materials was conducted between May 1987 and January 1989. Forty-four 
patients were enrolled, 22 in each group. The status of the grafts was monitored for 
at least 18 months. The patency rate for plasma TFE was 59% and for ePTFE was 
64%. Kaplan-Meier analysis and Wilcoxon testing revealed no statistical differences 
between the two groups. Four grafts became infected, two in each group, and one 
aneurysm developed. Despite its theoretical advantages, plasma TFE was found to be 
similar to ePTFE as a graft material for hemodialysis.
Des etudes animales ont indique que le plasma tetrafluoroethylene (TFE) est 
possiblement un meilleur materiel prosthetique que le polytetrafluoroethylene 
expanse (ePTFE) pour creer une voie d’acces arterioveineuse chez les patients qui 
ont besoin d’hemodialyse, car il associe les avantages du Dacron a ceux du Teflon. 
Une etude clinique randomisee a ete menee entre mai 1987 et janvier 1989, dans le 
but de comparer ces deux materiaux. Quarante-quatre patients ont ete recrutes, 22 
dans chaque groupe. L’etat des greffons a ete surveille pendant au moins 18 mois.
Le taux de permeabilite a ete de 59 % pour le plasma TFE et de 64 % pour le ePTFE. 
L’analyse de Kaplan-Meier et le test de Wilcoxon n’ont revele aucune difference 
entre les deux groupes. Quatre greffons se sont infectes, deux dans chaque groupe, 
et un anevrisme est survenu. Malgre ses avantages theoriques, le plasma TFE s’est 
avere similaire au ePTFE comme materiel de greffon pour l’hemodialyse.
I n patients requiring long-term hemodialysis who have failed 
Cimino-Brescia fistulas or peripher­
al vessels that cannot be used, 
expanded polytetrafluoroethylene 
(ePTFE) (Gore-Tex; W.L. Gore & 
Associates, Flagstaff, Ariz., and Im- 
pra; Impra Inc., Phoenix, Ariz.) has 
become the prosthetic material of 
choice for creating a suitable means
of arteriovenous access. ePTFE has 
properties of inertness and low 
thrombogenicity that make it suit­
able for vascular conduits of small 
diameter. Plasma tetrafluoroe­
thylene (TFE), made from finely 
woven Dacron fibres with a thin 
Teflon coat and reinforced with an 
outer ring of plastic, is a recent 
attempt to combine the superior
tissue incorporation of Dacron with 
the low thrombogenecity of Teflon. 
The high tensile strength and 
woven construction of TFE are said 
to prevent tearing at needle punc­
ture sites and to promote better 
closure after removal of the needle. 
Early experience suggests that plas­
ma TFE is at least equal to ePTFE.1 
To document this, a randomized 
clinical trial was undertaken to 
compare the two materials.
Patients and Methods
All patients in the Eastern Ontar­
io Regional Hemodialysis Program 
at the University of Ottawa were 
eligible for inclusion in the study, 
which was conducted between May 
1987 and January 1989. When a 
prosthetic graft was needed to pro­
vide arteriovenous access for hemo­
dialysis, the patient’s consent to be 
included in the plasma TFE versus 
ePTFE study was obtained. At the 
time of surgery, random assignment 
between the two graft materials was 
made by picking from a series of 
numbered envelopes. No deviation 
from the protocol was allowed and 
the only criterion for non-entry was 
failure to obtain informed consent. 
The grafts were handled according 
to the manufacturer’s instructions, 
and standard techniques for implan­
tation were used. All grafts were 
implanted in the upper limb as 
straight grafts between the radial 
artery and an antecubital vein, or
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the brachial artery and the axillary 
vein. A loop configuration was also 
used in the forearm between the 
brachial artery and an antecubital 
vein. The handling characteristics 
of the grafts were noted, with par­
ticular reference to ease of suturing 
and bleeding from anastomotic su­
ture lines. Immediate postoperative 
complications were recorded, in­
cluding primary nonfunction. Pat­
ency and complication rates at 1, 3, 
6, 12 and 18 months were calculat­
ed, and life-table analysis was per­
formed to compare the patency and 
complication rates of the two mate­
rials. Statistical comparison was 
made using the Peto-Peto Wilcoxon 
test. No grafts were used immedi­
ately after implantation. They were 
usually allowed to mature for up to 
4 weeks. No antibiotics were given 
at the time of implantation. We 
have experienced poor patient com­
pliance in the past when using 
antiplatelet agents. No such agents, 
vasodilators or anticoagulants were 
used in this series to keep the two 
groups as comparable as possible. 
The hemodialysis staff were blinded 
as to the graft material used. The 
access characteristics for hemodial­
ysis were noted, including ease of 
needle puncture, blood flow during 
dialysis and the incidence of hema­
toma and graft infection.
Results
Forty-four patients (20 women 
and 24 men) were enrolled during 
the study period, 22 to each pros­
thetic graft group. The mean age of 
the patients was 61.4 years ± 1 5  
years (± standard error of the 
mean). Sixteen patients were diabet­
ic. There were no significant differ­
ences in the age, sex, cause of renal 
failure and incidence of diabetes 
between the two groups.
Initial difficulties with plasma 
TFE grafts were experienced by all
participating surgeons, particularly 
with respect to bleeding from anas­
tomotic suture lines. With time and 
experience this became less of a 
problem. No difficulties were re­
corded for handling and suturing 
with ePTFE. At 18 months, 14 
ePTFE grafts (64%) and 13 plasma 
TFE grafts (59%) were patent. Elev­
en patients died; 5 had ePTFE 
grafts and 6 had plasma TFE 
grafts. These deaths were consid­
ered to represent graft failures. 
Four patients received renal trans­
plants. There were three primary 
failures for technical reasons, two 
in the ePTFE group and one in the 
plasma TFE group. Analysis indi­
cated no significant difference be­
tween ePTFE and plasma TFE in 
the proportion of patent grafts. The 
95% confidence limits were from 
— 0.13 to +0.41, indicating that 
plasma TFE ranged from 13% 
worse to 41% better than ePTFE. 
Similarly, there was no significant 
difference in the proportion of 
deaths between the groups. Ka- 
plan-Meier analysis revealed a 37% 
survival for the plasma TFE grafts 
and a 53% survival for the ePTFE 
grafts. The Peto-Peto Wilcoxon test 
was used to evaluate the difference 
in graft survival between the two 
graft types. Results indicated no 
significant difference in patency. 
The most significant complication 
was infection (two patients in each 
group). All infections were remote 
from the time of graft implantation, 
and in all cases the graft had to be 
removed to control the infection, 
which was due to Staphylococcus 
aureus in all four cases. None of the 
infections resulted in the patient’s 
death, and there was no limb loss. 
One aneurysm occurred in the plas­
ma TFE group, and the graft re­
quired revision. No differences were 
noted in the ease of needle puncture 
of the grafts, in flow rates dur­
ing dialysis and in hematoma for­
mation.
Discussion
Although several graft materials, 
including bovine carotid artery,2'3 
human umbilical vein,4'5 autoge­
nous saphenous vein67 and Da­
cron,8 have been used for vascular 
access in hemodialysis, ePTFE poly­
mers are now probably the most 
popular. The overall results in this 
study are consistent with those re­
ported by others9-12 and also dem­
onstrate that plasma TFE and 
ePTFE grafts have statistically simi­
lar long-term survival at 18 months. 
As in other series the commonest 
cause of occlusion was intimal hy­
perplasia at the graft-vein anasto­
mosis or just proximal to it. Fortu­
nately, in such cases the graft can 
usually be revised directly by dilata­
tion, angioplasty or bypass of the 
obstructed segment with a new 
graft. Other sources of graft loss 
were transplantation and death 
from intercurrent illness. Approxi­
mately 20% of arteriovenous grafts 
become infected intermittently with­
in 2 years of placement.13 None of 
the grafts in the present series 
became infected at the time of im­
plantation although four (9%) pa­
tients, two in each group, subse­
quently had an abcess related to the 
graft. Although many Teflon graft 
infections can be managed by 
wound debridement and antibiotics, 
all four grafts required removal for 
control. No other long-term compli­
cations, such as a steal syndrome, 
carpal tunnel syndrome or cardiac 
failure, occurred. None of the plas­
ma TFE grafts were used immedi­
ately as has been reported by oth­
ers.14 This would appear to be an 
attractive concept and will be the 
subject of further study by our 
group.
Conclusions
No differences in long-term pat-
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ency or complication rates were 
noted between ePTFE and plasma 
TFE grafts used for arteriovenous 
access in patients on long-term he­
modialysis. With experience the two 
grafts were similar in the ease of 
handling and complications of nee­
dle puncture.
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has little value in contemporary teach­
ing of surgical pathology.
The first and major problem lies in 
the omission of all histopathology; al­
though the foreword assures us that 
the atlas includes a “unique collection 
of . . . histological slides”; in fact, it 
contains only gross specimens, “pots” 
in the vernacular. The average size of 
the photographs is 7 X 9 cm, which is 
minute for a major organ group such as 
uterus, tubes and ovaries, and fails to 
reveal some pertinent lesions. Every 
attempt has been made to retain colour, 
but many specimens have the inevitable 
“washed out” appearance of prolonged 
pickling. There is not much difference 
between 3.195, “Liver, fatty change” 
and 3.197, “Liver, secondary amyloido­
sis.” There are the all too familiar pots 
containing a solitary lump, such as 6.32 
“Adrenal, cortical adenoma with viril­
ism,” 6.34 “Adrenal, cortical metastatic 
carcinoma of bronchus” and 6.35 
“Adrenal, cortical carcinoma.” We can­
not learn much from such specimens,
other than to use them as a jumping-off 
point for a discussion of pathology.
The specimens that are of interest 
and utility fall into several groups. 
There is that minority of conditions in 
which the pathological change is pre­
dominantly gross and best seen in gross 
material, such as diverticula. There are 
conditions once common but now rarely 
seen, such as congenital cardiac malfor­
mations, which are now almost always 
distorted by attempted surgical repair 
by the time they reach the pathologist; 
regrettably, the collection is not strong 
in this section. Pulmonary tuberculosis 
falls into this category, as does speci­
men 4.82 “Acquired strictures” (of the 
penile urethra) dating from 1841, in a 
man dying from the ague. There are the 
massive specimens now made rarely if 
at all, for lack of permission or pa­
tience, for example bone tumours, 
whole heads and whole faces.
What this atlas does emphasize is 
that surgical pathology is not best 
taught by potted specimens. Nothing
can replace attendance in the surgical 
pathology and autopsy rooms, followed 
by the clinicopathological conference 
with colour slides of the gross specimen 
to augment the by-then-preserved speci­
men and to demonstrate histopatholog­
ic features. Surgeons faced with a prob­
lem of diagnosis in the operating room 
have the support of quick-frozen-sec­
tion diagnosis and need not rely on 
their own impressions. Projection mi­
croscopes, television, videotapes and 
the like transmit, record, retain and 
amplify impressions of the moment, for 
more leisured consideration. The best 
use of the atlas is, as the foreword 
hopes, "to open up the Museum to 
much wider use by . . . students . . . 
from all over the world.”
H.E. Emson, MA, MD, FRCPC
Professor of pathology 
Royal University Hospital 
Saskatoon, SK 
S7N 4J9
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NOUVELLES DES PARRAINS
The Canadian Association of General 
Surgeons
The Canadian Surgical Research Fund
This fund was initially established by the Canadian 
Association of General Surgeons (CAGS) and contin­
ues through donations from members and other 
contributors. The executive committee of the fund 
indicates that grants are available for clinical or basic 
research by general surgeons in rural and urban 
practice for projects that will contribute to new 
developments in the field of general surgery.
Grants will be awarded to general surgeons for 
pilot projects and initiation of major research pro­
grams in the field of general surgery in order that 
work may proceed while an application to a major 
granting agency is in process. Reasonable priority 
will be assigned to applications from new members 
during an interval of 2 years following completion of 
residency training in general surgery. The committee 
will consider applications for bridge funding when an 
established investigator experiences a hiatus in the 
source of grant funds or for the purchase of 
equipment essential to the continuation of a project.
Deadline for receipt of applications is May 31, 
1993. Requests for application forms and completed 
submissions should be directed to Dr. John Duff, 
President, CSRF, c /o  Department of Surgery, Uni­
versity Hospital, 339 Windermere Rd., London, ON 
N6A 5A5.
Since 1987, the following research projects have 
been funded for CSRF grantees who have established 
reputations as surgical scientists in Canada: 1987: 
Dr. John Bohnen — the efficacy of liposomal gen­
tamicin against intraleukocytic Escherichia coir, Dr. 
David Fleiszer — genetic analysis of chemically 
induced colon cancer in mice and the effect of highl­
and low-risk diets; Dr. Stewart Hamilton — lymphat­
ic propulsion in hemorrhagic shock; Dr. Richard 
Inculet — host and tumour metabolic changes 
associated with progressive tumour growth and can­
cer cachexia; Dr. Jarley Koo — measurement of 
gastrointestinal mucosal blood flow; Dr. Frederick 
Moffat — immunomodulation in the management of 
intra-abdominal infection in the immunocompromised 
host. 1988: Dr. John Marshall — immunosuppres­
sion in trauma and critical surgical illness: the role of
gut endotoxin and Kupffer cell activation; Dr. Mark 
Meloche — the investigation of reduced immunoge- 
nicity by in vitro culture of pancreatic islets; Dr. 
Lawrence Rosenberg — pancreatic enzyme manipula­
tion — a prophylactic approach to acute pancreatitis. 
1989: Dr. Yvan Douville — etude experimental de la 
guerison de l’endarterectomie au laser exciner; Dr. 
Jarley Koo — a fluorescent microscope and accesso­
ries; Dr. Dale Mercer — studies on the mechanism by 
which antireflux surgery prevents gastroesophageal 
reflux; Dr. Jean-Paul Roy — endocholecystectomie. 
1990: Dr. Hinrich Bitter-Suermann — development 
and analysis of liver preservation solutions; Dr. Jean 
Tchervenkov — the use of donor antigen presenta­
tion in the immediate pretransplant period to induce 
tolerance in solid organ transplantation; Dr. Weiming 
Yu, Dr. James Wright — combined liver/islet trans­
plantation in rats. 1991: Dr. York Hsiang — photo­
dynamic therapy of neointimal hyperplasia; Dr. David 
McCready — evaluation of monoclonal antibody 
Kl-67 as a prognostic factor for breast cancer 
recurrence; Dr. Lawrence Rosenberg, Dr. Gerald 
Fried — the role of cystein proteinases in the 
pathogenesis of acute pancreatitis. 1992: Dr. Jeffrey 
Barjun — laparoscopic versus open inguinal hernia 
repair; Dr. Francis Sutherland — effect of ursodeoxy­
cholic acid on liver allograft rejection in the rat.
Meeting of the Association d’orthopedie de langue 
fran?aise (AOLF)
The third combined meeting of the orthopedic associ­
ations of the French-speaking world (AOLF) was held 
in Quebec in September 1992, just 3 months after 
the combined English meeting in Toronto. The 
meeting of AOLF was a resounding success from 
every point of view, with surgeons, residents and 
researchers from 19 different countries on four 
continents attending the week-long program.
The francophone world is a mosaic of more than 
40 nations where French is spoken as the first or 
second language. These countries span the globe 
from Europe, Africa and the Middle East, through 
Asia and the Indian and Pacific oceans to North 
America, South America and the Caribbean islands.
Canadian Orthopaedic Association
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Member countries and territories are loosely affiliated 
in much the same way as the Commonwealth of 
Nations and are represented by the Paris-based 
Agency for Cultural and Technical Cooperation 
(Agence de cooperation culturelle et technique 
[ACCT]). This agency was formed in 1970 and 
promoted French in educational, technological and 
creative activities.
The ACCT has recently set up an international 
French-language TV network by satellite (T5) to 
improve north-south dialogue and cooperation. Four 
summit meetings have been held in the last 12 years 
in Paris (two), Dakar (Senegal) and Quebec. Jean- 
Louis Roy, the current Secretary-general of ACCT, is 
the second Canadian to hold this position.
Parallel with ACCT is the older Alliance frangaise 
(AF), an independent network of centres in non-fran­
cophone and francophone countries. The AF offers 
courses in French language and culture to 300 000 
students worldwide, half of them in Latin America.
The francophone world exists as a linguistic 
community. Apart from its traditional role as the 
language of diplomacy and romance, French offers 
the people of these countries the opportunity for 
scientific, technological and commercial communica­
tions with the outside world. There are five times as 
many people who speak French in the world today as 
there were a century ago and the number is increas­
ing. Canadian orthopedic surgeons can be proud to 
be a part of this cultural heritage.
Meetings and Courses
The Quebec Scoliosis Society holds its 24th annual 
meeting in Montreal, Apr. 23 to 24, 1993. For 
information please contact: Dr. Benoit Morin, Secre­
tary, Service d’orthopedie, Hopital Sainte-Justine, 
3175 Cote Sainte-Catherine, Montreal, QC H3T 1C5; 
phone: (514) 345-4717, fax: (514) 345-4882.
The University of British Columbia announced that 
its Orthopedic Update Course will be held from June 
10 to 18, 1993. For information, please contact the 
COA Secretariat in Montreal.
A course on spinal disorders, sponsored by the COA, 
will be held Nov. 5 to 7, 1993, in Montreal. The 
course chairman is John P. Kostuik of Baltimore and 
the co-chairman is Alain Jodoin of Montreal. The 
guest speaker will be John Frymoyer of Burlington, 
Vt.
The Canadian Society for Vascular Surgery
Report From the 1993 Spring Executive Meeting
The Executive Committee of the Canadian Society 
for Vascular Surgery met on a very cold weekend in 
early February in Toronto. Dr. Adrien Bouchard 
chaired the meeting, which dealt with a number of 
controversial issues. One of the most important 
issues discussed was maintenance of competence. At 
the direction of the Society, Dr. Bill Cole had 
prepared a working paper on the maintenance and 
assessment of competence. After review of this paper 
at the meeting, it was felt that further discussion was 
required. Dr. Cole was asked to head a subcommittee 
to deal with the ongoing issues of maintenance of 
competence and continuing education for The Cana­
dian Society for Vascular Surgery. The Executive felt 
that these issues were of prime importance.
Another important area for study is that of 
manpower. Drs. John Provan and Ken Harris will 
investigate the predicted need for vascular surgeons, 
both in the community and academic centres. Man­
power issues are of course very topical as ministries 
of health attempt to limit trainee positions. Dr. 
Provan and Dr. Harris would be happy to entertain 
any comments or suggestions that any of the mem­
bers might have.
Canadian Society for Vascular Surgery Scientific 
Meeting
The annual scientific meeting of the Society will be 
held in Vancouver in conjunction with the 62nd 
annual meeting of the Royal College of Physicians 
and Surgeons of Canada. The scientific portion of the 
meeting will start at 14:00 on Friday, Sept. 10, 
1993, and will conclude by 10:30 on Sunday, Sept. 
12, 1993. Currently there are two flights leaving for 
Toronto at noon or shortly thereafter on Sunday. 
The symposium on Saturday, Sept. 11, will be a very 
interesting forum. It will deal with the controversies 
of cerebral vascular disease. Dr. Paul Walker will 
chair this symposium. Dr. David Taylor will speak on 
noninvasive imaging of the cerebral vascular system. 
Dr. Tom Riles, from New York, will discuss the 
prevention of complications in carotid artery surgery, 
and Dr. Jonathan Towne will shed some light on the 
treatment of asymptomatic carotid artery stenosis. A 
panel discussion will follow.
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This year the invited lecturer will be Dr. Jonathan 
Towne from Milwaukee. He is always an entertaining 
and informative speaker and we look forward to his 
lecture.
A total of 17 papers will be presented at the 
meeting. All presenters are encouraged to submit 
their manuscripts to the secretary of the Society. 
These will be submitted for review and consideration 
for publication in the Canadian Journal o f Surgery. 
The Canadian Society for Vascular Surgery is one of 
the sponsoring societies of this journal and we must 
continue to support it.
Canadian Society for Vascular Surgery Ties
After a long time in the design phase, the Canadian 
Society for Vascular Surgery ties are now available. 
They are dark blue with gold and red pin stripes 
separating a series of gold society emblems. A 
quantity of these will be available at the annual 
meeting in Vancouver. For those who cannot wait to 
upgrade their wardrobe, the ties are available at a 
cost of $20 from the secretary’s office.
Registry of Unusual Cases
The secretary would like to establish a Registry of 
Unusual Cases (such as carotid artery aneurysms and 
mesenteric artery aneurysms). If you have had an 
unusual case and wish to know if other members of 
the society have had similar experiences or wish to 
include your case as part of a series of reports, please 
let the secretary know so that this information can be 
disseminated.
How Can We Help Keep You Up to Date?
Please let us know what information you would like 
to see in the Society news pages so that we can keep 
you up to date on all issues of importance within the 
Society. Information or suggestions can be submitted 
or obtained by writing to either the secretary or the 
treasurer.
Useful Addresses
Office of the secretary: Dr. Kenneth A. Harris, 
Vascular Surgery, Victoria Hospital, 375 South St.,
London, ON N6A 4G5; phone: (519) 667-6780. 
Office of the president: Dr. Adrien Bouchard, Ottawa 
General Hospital, 501 Smyth Rd., Ottawa, ON 
K1H 8L6; phone: (613) 737-8539.
Canadian Society of Cardiovascular and 
Thoracic Surgeons
The Society will conduct its annual scientific and 
business meeting in conjunction with the 62nd 
annual meeting of the Royal College of Physicians 
and Surgeons of Canada on Sept. 10 and 11, 1993, 
in Vancouver. This year’s Wilfred Bigelow Lecture 
will be delivered by Dr. Gerald Buckberg of the 
University of California, Los Angeles, on the topic of 
the development and current status of cardioplegic 
protection of the myocardium for cardiac surgery.
The Society will conduct two symposia, one on 
postgraduate medical education, chaired by Dr. David 
Mulder of McGill University, and one on current 
therapies for intrathoracic malignant tumours, 
chaired by Dr. Richard Finley of the University of 
British Columbia. The free communication sessions 
will be conducted as oral and poster presentations.
The Society is pleased to cosponsor two symposia, 
one on thoracoscopic surgery with the Canadian 
Society of Endoscopic Surgery and the other on lung 
transplantation with the Canadian Thoracic Society.
The annual business meeting of the Canadian 
Society of Cardiovascular and Thoracic Surgeons will 
be held on Friday, Sept. 10, at a noon luncheon, and 
the annual president’s reception and dinner is sched­
uled for Friday evening, Sept. 10, 1993.
Canadian Society of Surgical Oncology
The following surgical oncology fellowships are 
available in Canada: Division of Surgical Oncology, 
Department of Surgery, University of Calgary, Calga­
ry. Contact: Dr. Walley J. Temple,Tom Baker Cancer 
Centre, 1331 -  29th St. NW, Calgary, AB T2N 4N2. 
Department of Surgery, McGill University, Montreal. 
Contact: Dr. Henry R. Shibata, S10.22, Royal Victo­
ria Hospital, 687 Pine Ave. W, Montreal, QC 
H3A 1A1. Division of General Surgery, University of 
Toronto, Toronto. Contact: Dr. Lome E. Rotstein, 
Toronto General Hospital, Eaton Wing, 7th Fir., 200 
Elizabeth St., Toronto, ON M5G 2C4.
These are 1- to 2-year funded positions available
CJS, VOL. 36, NO. 2, APRIL 1993 189
SPONSORS' NEWS
July 1, 1993. Surgeons interested in these fellow­
ships should have completed an accredited general 
surgery residency program at a North American 
university and be eligible for accreditation. Prefer­
ence will be given to candidates eligible for Canadian 
licensure. Applicants should submit a letter of appli­
cation with a current curriculum vitae and the names 
of three referees to the contact person for the 
program.
2nd Annual Scientific Meeting
The Second Annual Scientific Meeting of the Society
BOOK REVIEWS
continued from page 186
will be held at 08:00, Saturday, Apr. 17, 1993, at the 
Queen Elizabeth Hotel in Montreal. The morning 
session will feature research paper presentations. The 
afternoon session, held in conjunction with the 
National Cancer Institute of Canada’s spring meet­
ing, will be a consensus conference on thyroid 
cancer. Further details may be obtained from: Dr. 
Walley J. Temple, President, CSSO, Tom Baker 
Cancer Centre, 1331 -  29th St. NW, Calgary, AB 
T2N 4N2; phone: (403) 670-1914; fax: (403) 283- 
1651 or Dr. David R. McCready, Secretary-treasurer, 
Suite 502, 60 Grosvenor St., Toronto, ON M5S 1B6; 
phone: (416) 323-7747; fax: (416) 921-4275.
TECHNIQUES IN THERAPEUTIC 
ENDOSCOPY. 2nd edition. Joseph E. 
Geenan, David E. Fleischer, Jerome D. 
Waye. 250 pp. Illust. Raven Press, 
New York. 1992. $119.00. ISBN 1- 
56375-018-X
Endoscopic therapy, which is now the 
preferred treatment for many diseases 
of the gastrointestinal tract, is a con­
stantly changing field, and it is difficult 
to keep abreast of the changes unless 
one is actively involved in therapeutic 
endoscopy. A multitude of books are 
available, describing various technical 
aspects. Therefore, a number of ques­
tions must be answered about this 
book: Is it different from others on the 
market? Do we need another book 
describing the techniques of endoscopic 
therapy? II so, should this be one of the 
recommended books on the subject?
This text is written by three well- 
known gastroenterologists — Geenen, 
Fleisher and Waye — who are experts 
in their specific fields. The authors 
intended this book to be read by trained
endoscopists who want to carry out a 
new procedure. It is also directed to 
endoscopists who have some experience 
with therapeutic endoscopy but want to 
refamiliarize themselves with the tech­
nique or the new equipment.
Unfortunately the authors have not 
been very successful in their mandate. 
Many chapters are deficient in sub­
stance and detail. In the chapter on 
gastrointestinal bleeding there is no 
clear-cut division between therapeutic 
endoscopy for upper and lower intesti­
nal bleeding lesions. There is no men­
tion that a surgeon, if possible, should 
be present at gastroscopy for active 
upper gastrointestinal bleeding. The 
statement that a patient should be in­
tubated if there is blood in the esopha­
gus is at variance with the experience of 
most endoscopists.
The common techniques of endo­
scopic sclerosis of esophageal varices 
and bleeding gastric ulcers are inade­
quately described. New techniques such 
as endoscopic ligation of bleeding eso­
phageal varices are deficient in detail. In
the chapter on esophageal diseases, 
currently favoured techniques are not 
described in adequate detail.
Although the chapter on endoscopic 
gastrostomy is detailed, more informa­
tion is needed on percutaneous radi­
ologic drainage, a technique that is 
carried out in many hospitals. The 
chapters on endoscopic papillotomy, bi­
liary obstruction and pancreatic endos­
copy are well done.
In view of the availability of many 
excellent books on therapeutic endosco­
py, this text does not fulfil the require­
ments for yet another book on the 
subject. At best it can be recommended 
tor the resident or fellow in gastroenter­
ology or surgery who wants an intro­
duction to certain techniques of thera­
peutic endoscopy.
Harry S. Himal, MD, FRCSC, FACS
General and colorectal surgery 
Suite 3-801
Toronto Western Hospital 
399 Bathurst St.
Toronto, ON 
M5T 2S8
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The Canadian Journal o f  Surgery is pleased to accept classified advertisements. The deadline is 1 month before issue date. Classified rates: $58 
for the first 40 words or less, additional words 750 each (additional $23 for frame). Special Display under 100 words, 55 X 55 mm, $135. $17 
charge (first insertion only) for CJS reply box numbers. Display rates available on request. VISA, MASTERCARD AND AM ERICAN 
EXPRESS ACCEPTED.
Copy should be mailed to: Beverley Kirkpatrick, Manager, Classified Advertising, Canadian Journal o f  Surgery, PO Box 8650, Ottawa, ON 
K1G 0G8. Tel: (613) 731-9331. Fax: (613) 523-0824.
Send all box number replies to: Box . . . , Canadian Journal o f  Surgery, PO Box 8650, Ottawa, ON K1G 0G8.
Le Journal canadien de chirurgie accepte volontiers les annonces classees. Celles-ci doivent etre revues au Journal au plus tard 1 mois avant la 
date de parution. Tarifs des annonces classees 58 $ jusqu’a 40 mots et 75 0 par mot supp lem enta l (23 $ pour encadrement au trait). Encadre 
special jusqu’a 100 mots, 55 X 55 mm, 135 $. L ’emploi d’une boite-reponse au Journal donne lieu a la perception d’un supplement de 17 $ 
(pour la premiere insertion seulement). Tarifs des encadres grand format disponibles sur demande. VISA, MASTERCARD ET AM ERICAN 
EXPRESS ACCEPTES.
La texte des annonces doit etre adresse a : Beverley Kirkpatrick, Gestionnaire des annonces classees, Journal canadien de chirurgie, CP 8650, 
Ottawa, ON K1G 0G8. T e l : (613) 731-9331. Fax : (613) 523-0824.
Veuillez faire parvenir les reponses aux numeros de boites a I'adresse suivante : Boite . . . , Journal canadien de chirurgie, CP 8650, Ottawa, 
ON K1G 0G8.
ORTHOPEDIC SURGEON
Dawson Creek and District Hospital is 
the major referral hospital for the Peace 
River area of British Columbia, serving a 
population of approximately 60 000.
Nestled in the Peace River Valley, close 
to the Rocky Mountains, alpine skiing 
and farmland, Dawson Creek is a vibrant 
community and home of the famous Mile 
‘O’ of the Alaska Highway.
Explore the benefits of what Dawson 
Creek has to offer by forwarding your 
curriculum vitae, in confidence, to:
Mr. Robert B. Lea  
Executive D irector 
Daw son C reek and D istrict Hospital 
11100 -1 3  S treet 
Dawson Creek, BC V1G  3W 8  
Tel (604) 782-8501  
Fax (6 0 4 )7 8 2 -9 4 2 5
— S93-147
F O O T H I L L S  H O S P I T A L
A university hospital where specialized teams offer personal care.
Be a partner in maintaining our standard of excellence.
Trauma Surgeons
ICU/Trauma Care & 
Orthopaedic Trauma Care
Foothills Hospital has two challenging opportunities for surgical specialists 
with extra training in trauma care.
Your professional profile includes Royal College of Canada certification in 
general surgery and at least two years'post-fellowship experience, one of 
which was spent in a recognized training programme in either ICU/trauma 
care or orthopaedic trauma care with AO training a pre-requisite. These 
appointments will be based at Foothills Hospital under an on-site contract.
It is expected that an academic university appointment will be proposed at 
a level commensurate with training and experience.
In addition, you must be eligible for general licensure by the College of 
Physicians and Surgeons of Alberta and provide proof o f appropriate 
coverage by the Canadian Medical Protection Association.
Foothills Hospital offers an attractive salary, and a competitive and 
innovative benefits package. Enjoy lifestyle amenities such as proximity 
to the mountains, affordable housing, and a short commuting distance. 
Applicants are invited to submit a resume, indicating their area of expertise 
and including the names of three referees, by May 1, 1993, to:
Foothills Hospital
Dr. R .M . Preshaw, Acting Director 
Departm ent of Surgery, Foothills Hospital 
1403  - 29 Street N .W .
Calgary, Alberta T 2N  2T9 _ S9 3 -1 4 9
CLASSIFIED ADVERTISING Unlike a  tabloid or new spaper that is read  today  and discarded tom orrow , an  a d v e r­
tisem ent in the Classified Advertising section of C JS  is read today and re rea d  tom orrow .
C JS  is the only Canadian publication exclusively for surgeons. No other C an a d ian  surgical publication reach es  over 6 0 0 0  
subscribers every 2 months, giving w ide coverage for your advertising dollar.
A verage issue readership of C JS  (8 1 % ) is am ong the highest of any m edical journal in C anada, th e  la tes t re ad e r- 
ship studies confirm the best and m ost cost efficient w ay to reach C an a d ian  surgeons is through the pages  o f C JS.
LET C JS  C L A S S IF IE D  A D S  W O R K  F O R  Y O U  - cjs-i
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CLINICAL FELLOWSHIP 
AVAILABLE
IN CARDIOVASCULAR SURGERY 
BEGINNING JULY 1, 1993
There is an opportunity for considerable 
surgical experience with a busy adult cardi­
ac surgical team (650 pumps/year). Ideal 
for surgeon awaiting a position or between 
residencies. Eligibility for Ontario general or 
educational licence necessary. Salary ac­
cording to experience or fee for service if 
applicable.
Replies to:
Dr. Bernard S. Goldman
Head, Cardiovascular Surgery
Sunnybrook Health Science Centre
2075  Bayview Ave., Ste. H410
Toronto. ON
M 4N 3M 5
Tel (416) 480-6070
Fax (416) 480-6072 -S93-136
GENERAL SURGEON
Second general surgeon required for the town 
of Milton in southern Ontario. This 103-bed 
hospital serves a population of 35 000 with a 
large catchment area; 16 general practitioners, 
an internist, radiologist, obstetrician and one 
other general surgeon comprise the active 
medical staff. Several other surgical subspecial­
ties available. State-of-the-art laparoscopic 
equipment available. Milton is located within 
easy access to two university medical centres 
and provides great recreational opportunities. 
Applications to:
Dr. L. Robinson
Chair, Manpower Committee
Milton District Hospital
30 Derry Rd. E
Milton, ON L9T 2X5
Tel (416) 878-2383
Fax (416) 878-0498. —S93-146
SURGEONS-VASCULAR 
AND ORTHOPEDIC
MSI currently has 311 outstanding 
practice opportunities in solo, group, 
clinic and HMO settings throughout 
the U.S. These include coastal and 
southeastern areas. We want to pres­
ent these practices to you and be a 
problem solver. There is no charge to 
you for this service.
Call our
surgical specialists 
(404) 653-7360 .
-S93-143
North York Branson Hospital, a 
3 0 0 -b ed  active treatm ent 
suburban Toronto community 
facility, seeks a well trained
General
Surgeon
Appropriate training in a sub­
specialty is encouraged.
Submit your curriculum vitae to: 
Dr. S. Feinberg, Head o f 
Section o f General Surgery, 
North York Branson Hospital, 
55 5  Finch Avenue West, 
Willowdale, Ontario M 2R1N5.
f#
GENERAL SURGEON: ON -  Well-estab­
lished group practice is looking to replace a 
retiring partner/surgeon to serve a communi­
ty of 30 000 + located 25 minutes west of 
London. Town population 10 000+ . Fully 
computerized, modern clinic adjacent to a 
fully accredited, well-equipped hospital using 
116 acute care beds. Busy emergency de­
partment. Preference will be given to or- 
thopedics/gynecology. Essentials include la­
paroscopy skills and fellowship status. One- 
in-three on-call schedule for this pleasant 
community. Large referral base guaranteed. 
Associate to full partnership attainable. 
Please contact or send CV to: Steven Wong, 
c/o Strathroy Medical Clinic, 376 Carrie 
St., Strathroy, ON N7G 3E3; tel: (519) 
245-0430. -S92-128
CLINICAL SPINE FELLOWSHIP -  This 
1-year spinal fellowship offers comprehensive 
training, dealing with the surgical and conser­
vative management of disorders of the spine, 
ie. spinal deformities as seen in congenital, 
developmental and neoplastic conditions, spi­
nal trauma, as well as degenerative disc 
disease. The fellowship also entails clinical 
research and, if interested, participation in 
basic biomechanical research. Applications 
for the 1-year clinical spinal fellowship are 
now being accepted for January 1994. Please 
direct enquiries to: Drs. Stewart Bailey and 
Kevin Gurr, 345 Westminster Ave., Lon­
don, ON N6C 4V3. -S93-150
PHYSICIAN ASSISTANT IN NEURO­
SURGERY: NF -  Applications are invited for 
the position of physician assistant in neuro­
surgery. The post becomes vacant July 1, 
1993 and is for a period of 1 year (renew­
able). The Provincial Neurosurgery Unit is 
based at the Health Sciences Centre and you 
will be expected to assist at the Janeway 
Children's Hospital. Previous experience in 
surgery and the Medical Council of Canada 
evaluating examination is required. Salary: 
$67 471. In accordance with Canadian immi­
gration requirements, priority will be given to 
Canadian citizens and permanent residents. 
Closing date for this advertisement is May 31, 
1993. For further information, contact: Dr. 
F.B. Maroun, Chairman, Department of 
Surgery, The General Hospital, Health Sci­
ences Centre, St. John's, NF A1B 3V6.
-S93-151
American Medical Association 
146
Canadian Medical Association 
118
Davis & Geek
Protect Point Outside Back Cover
Frosst
Vasotec IV 160, 161, Inside Back 
Cover
Johnson & Johnson Medical 
Products
Microtouch Inside Front Cover 
Vicryl 108
Miles Canada Inc.
Cipro IV 168 A,B,C,D, 169
Parke-Davis
Anusol-HC 128
Roussel Canada Inc.
Proctosedyl HC 117
Smith & Nephew 
Allevyn 106
JCC, VOL. 36, N° 2, AVRIL 1993 For prescribing information see page 160 —192
■ <
4
*
NOT RECOMMENDED DURING PREGNANCY
BEFORE PRESCRIBING, PLEASE SEE PRESCRIBING INFORMATION
" Trademark Merck & Co., Inc./Merck Frosst Canada Inc., R.U. [pA AB 
RNT-93-CDN-6657-JA 1-----------
^  MERCK FROSST
FROSST
DIV. OF MERCK FROSST CANADA INC. 
KIRKLAND, QUEBEC
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